parent_name,parent_smiles,parent_inchi,metabolite_name,metabolite_smiles,metabolite_inchi,enzymes,fingerprint_similarity,reaction_types
Ademetionine,C[S+](CCC(N)C(=O)[O-])CC1OC(N2C=NC3=C2N=CN=C3N)C(O)C1O,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27?/m0/s1",S-Adenosylhomocysteine,NC1=C2N=CN(C3OC(CSCCC(N)C(=O)O)C(O)C3O)C2=NC=N1,ZJUKTBDSGOFHSH-WFMPWKQPSA-N,,0.98,
Biocytin,NC(CCCCNC(=O)CCCCC1SCC2NC(=O)NC21)C(=O)O,,Biotin,O=C(O)CCCCC1SCC2NC(=O)NC21,"InChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/t6-,7-,9-/m0/s1",,0.88,
Dihydrolipoamide,N=C(O)CCCCC(S)CCS,,Lipoic acid,O=C(O)CCCCC1CCSS1,"InChI=1S/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10)/t7-/m1/s1","Dihydrolipoyl dehydrogenase, mitochondrial, Glycine cleavage system H protein, mitochondrial",0.4,
Folic acid,NC1=NC(=O)C2=NC(CNC3=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C3)=CN=C2N1,"InChI=1S/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s1",Tetrahydrofolic acid,NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C3)N2)N1,"InChI=1S/C19H23N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,11-12,21,23H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,20,22,25,26,30)/t11?,12-/m0/s1",Dihydrofolate reductase,0.54,
Cholecalciferol,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCCC(C)C,"InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1","(23S)-23,25-dihdroxy-24-oxovitamine D3 23-(beta-glucuronide)",C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CC(OC1OC(C(=O)O)C(O)C(O)C1O)C(=O)C(C)(C)O,USYNZBLVOOXNSN-ARRWHRBTSA-N,,0.44,
Cholecalciferol,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCCC(C)C,"InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1",Calcifediol,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCCC(C)(C)O,"InChI=1S/C27H44O2/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23+,24-,25+,27-/m1/s1",Vitamin D 25-hydroxylase,0.97,
Calcifediol,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCCC(C)(C)O,"InChI=1S/C27H44O2/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23+,24-,25+,27-/m1/s1",Calcitriol,C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O,"InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1","25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",0.87,
Fluvoxamine,COCCCCC(=NOCCN)C1=CC=C(C(F)(F)F)C=C1,"InChI=1S/C15H21F3N2O2/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18/h5-8H,2-4,9-11,19H2,1H3/b20-14+",fluvoxamino acid,NCCON=C(CCCC(=O)O)C1=CC=C(C(F)(F)F)C=C1,KUIZEDQDELAFQK-XDHOZWIPSA-N,Cytochrome P450 1A2,0.91,
Ramipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1C(C(=O)O)CC2CCCC21,"InChI=1S/C23H32N2O5/c1-3-30-23(29)18(13-12-16-8-5-4-6-9-16)24-15(2)21(26)25-19-11-7-10-17(19)14-20(25)22(27)28/h4-6,8-9,15,17-20,24H,3,7,10-14H2,1-2H3,(H,27,28)/t15-,17-,18-,19-,20-/m0/s1",Ramiprilat,CC(NC(CCC1=CC=CC=C1)C(=O)O)C(=O)N1C(C(=O)O)CC2CCCC21,KEDYTOTWMPBSLG-HILJTLORSA-N,Liver esterases,0.92,
Amphetamine,CC(N)CC1=CC=CC=C1,"InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3",Norephedrine,CC(N)C(O)C1=CC=CC=C1,DLNKOYKMWOXYQA-VXNVDRBHSA-N,Cytochrome P450 2D6,0.61,
4-hydroxyamphetamine,CC(N)CC1=CC=C(O)C=C1,GIKNHHRFLCDOEU-UHFFFAOYSA-N,4-Hydroxynorephedrine,CC(N)C(O)C1=CC=C(O)C=C1,JAYBQRKXEFDRER-HZGVNTEJSA-N,,0.67,
Benzoic acid,O=C(O)C1=CC=CC=C1,WPYMKLBDIGXBTP-UHFFFAOYSA-N,Hippuric acid,O=C(O)CNC(=O)C1=CC=CC=C1,QIAFMBKCNZACKA-UHFFFAOYSA-N,,0.28,
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",N-Methylnicotinium,CN1CCCC1C1=CC=C[N+](C)=C1,HIOROZIUERMMRQ-UHFFFAOYSA-N,,0.82,
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",Nicotine imine,C[N+]1=CCCC1C1=CC=CN=C1,GTQXYYYOJZZJHL-UHFFFAOYSA-N,"Cytochrome P450 2A6, Cytochrome P450 2B6",0.56,
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,,0.79,
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",Nornicotine,C1=CN=CC(C2CCCN2)=C1,MYKUKUCHPMASKF-UHFFFAOYSA-N,,0.86,
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",Nicotine glucuronide,CN1CCCC1C1=C[N+](C2OC(C(=O)[O-])C(O)C(O)C2O)=CC=C1,SAWAIULJDYFLPD-SOAFEQHCSA-N,"UDP-glucuronosyltransferase 1-4, UDP-glucuronosyltransferase 1-9",0.38,
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",Norcotinine,O=C1CCC(C2=CN=CC=C2)N1,FXFANIORDKRCCA-UHFFFAOYSA-N,,0.73,
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",Nicotine-1'-N-oxide,C[N+]1([O-])CCCC1C1=CN=CC=C1,RWFBQHICRCUQJJ-UHFFFAOYSA-N,Dimethylaniline monooxygenase [N-oxide-forming] 3,0.75,
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone,CN(CCCC(=O)C1=CC=CN=C1)N=O,FLAQQSHRLBFIEZ-UHFFFAOYSA-N,,0.39,
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol,CN(CCCC(O)C1=CN=CC=C1)N=O,OGRXKBUCZFFSTL-UHFFFAOYSA-N,,0.38,
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",2'-Hydroxynicotine,CN1CCCC1(O)C1=CC=CN=C1,,Cytochrome P450 2A6,0.66,
Nicotine imine,C[N+]1=CCCC1C1=CC=CN=C1,GTQXYYYOJZZJHL-UHFFFAOYSA-N,Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,Aldehyde oxidase,0.5,
Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,Cotinine N-oxide,CN1C(=O)CCC1C1=C[N+]([O-])=CC=C1,CIPULDKLIIVIER-VIFPVBQESA-N,,0.88,
Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,3'-Hydroxycotinine,CN1C(=O)C(O)CC1C1=CN=CC=C1,XOKCJXZZNAUIQN-IENPIDJESA-N,Cytochrome P450 2A6,0.8,
Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,Nornicotine,C1=CN=CC(C2CCCN2)=C1,MYKUKUCHPMASKF-UHFFFAOYSA-N,,0.67,
Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,Nicotine-1'-N-oxide,C[N+]1([O-])CCCC1C1=CN=CC=C1,RWFBQHICRCUQJJ-UHFFFAOYSA-N,Dimethylaniline monooxygenase [N-oxide-forming] 3,0.65,
Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,Cotinine glucuronide,CN1C(=O)CCC1C1=C[N+](C2OC(C(=O)[O-])C(O)C(O)C2O)=CC=C1,XWZCZWKUGIQPJD-UHFFFAOYSA-N,"UDP-glucuronosyltransferase 1-4, UDP-glucuronosyltransferase 1-9",0.46,
Lorazepam,O=C1NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2Cl)=NC1O,"InChI=1S/C15H10Cl2N2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20)",Lorazepam glucuronide,O=C(O)C1OC(OC2N=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N=C2O)C(O)C(O)C1O,IWOJSSFCRQKNKN-IFBJMGMISA-N,,0.52,
Bortezomib,CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1",Bortezomib metabolite M1,CC(C)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,NEIDLJIPMZVISC-DOTOQJQBSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2D6, Cytochrome P450 3A4",0.77,
Bortezomib,CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1",Bortezomib metabolite M34,CC(C)CC(=O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,WREPYMVPDVCLPX-HNNXBMFYSA-N,,0.8,
Bortezomib,CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1",Bortezomib metabolite M23 or M24 (1),CC(C)C=CNC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,ISSYHCZWYPLNBR-FDMDGMSGSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Cytochrome P450 1A2, Cytochrome P450 2D6",0.72,
Bortezomib,CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1",Bortezomib metabolite M23 or M24 (2),CC(C)=CCNC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,HRTUPFKOFWTBTM-INIZCTEOSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Cytochrome P450 1A2, Cytochrome P450 2D6",0.76,
Bortezomib metabolite M1,CC(C)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,NEIDLJIPMZVISC-DOTOQJQBSA-N,Bortezomib metabolite M3,NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,KTQJEBWLYWKXRA-NSHDSACASA-N,,0.76,
Bortezomib metabolite M1,CC(C)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,NEIDLJIPMZVISC-DOTOQJQBSA-N,Bortezomib metabolite M5,CC(C)(O)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,OPMJHASCCIGLJS-GOEBONIOSA-N,,0.95,
Bortezomib metabolite M2,CC(C)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,NEIDLJIPMZVISC-RDJZCZTQSA-N,Bortezomib metabolite M8,CC(C)CC(O)NC(=O)C(NC(=O)C1=CN=CC=N1)C(O)C1=CC=CC=C1,BLVVPFHWFHYTBM-PYNWJHIZSA-N,Cytochrome P450 3A4,0.83,
Bortezomib metabolite M1,CC(C)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,NEIDLJIPMZVISC-DOTOQJQBSA-N,Bortezomib metabolite M25,CC(C)C(O)C(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,IVVZGLULYNUZDU-BZELLKQSSA-N,,0.91,
Bortezomib metabolite M3,NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,KTQJEBWLYWKXRA-NSHDSACASA-N,Bortezomib metabolite M4,O=C(NC(CC1=CC=CC=C1)C(=O)O)C1=CN=CC=N1,DWYZPDHMMZGQAP-NSHDSACASA-N,,0.74,
Bortezomib metabolite M8,CC(C)CC(O)NC(=O)C(NC(=O)C1=CN=CC=N1)C(O)C1=CC=CC=C1,BLVVPFHWFHYTBM-PYNWJHIZSA-N,Bortezomib metabolite M33,NC(=O)C(NC(=O)C1=CN=CC=N1)C(O)C1=CC=CC=C1,ASDAHTNZOSVDNQ-PXYINDEMSA-N,,0.79,
Carbidopa,CC(CC1=CC(O)=C(O)C=C1)(NN)C(=O)O,"InChI=1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/t10-/m0/s1","3,4-Dihydroxyphenylacetone",CC(=O)CC1=CC(O)=C(O)C=C1,JQXBETDGCMQLMK-UHFFFAOYSA-N,,0.45,
Carbidopa,CC(CC1=CC(O)=C(O)C=C1)(NN)C(=O)O,"InChI=1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/t10-/m0/s1",3-(3-hydroxyphenyl)-2-methyllactic acid,CC(O)(CC1=CC(O)=CC=C1)C(=O)O,DQCFPKHWBJEWFV-UHFFFAOYSA-N,,0.48,
Carbidopa,CC(CC1=CC(O)=C(O)C=C1)(NN)C(=O)O,"InChI=1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/t10-/m0/s1",3-(3-hydroxyphenyl)-2-methylpropionic acid,CC(CC1=CC(O)=CC=C1)C(=O)O,ZTHRBJCNTAYZRE-UHFFFAOYSA-N,,0.57,
Carbidopa,CC(CC1=CC(O)=C(O)C=C1)(NN)C(=O)O,"InChI=1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/t10-/m0/s1","3-(3,4-dihydroxyphenyl)-2-methylpropionic acid",CC(CC1=CC(O)=C(O)C=C1)C(=O)O,GIIOASILGOFVPI-UHFFFAOYSA-N,,0.67,
Carbidopa,CC(CC1=CC(O)=C(O)C=C1)(NN)C(=O)O,"InChI=1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/t10-/m0/s1",3-(4-hydroxy-3-methoxyphenyl)-2-methyllactic acid,COC1=C(O)C=CC(CC(C)(O)C(=O)O)=C1,YNNLUYGFVUZDAD-UHFFFAOYSA-N,,0.5,
Carbidopa,CC(CC1=CC(O)=C(O)C=C1)(NN)C(=O)O,"InChI=1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/t10-/m0/s1",3-(4-hydroxy-3-methoxyphenyl)-2-methylpropionic acid,COC1=C(O)C=CC(CC(C)C(=O)O)=C1,XUQXZROVMZNKPO-UHFFFAOYSA-N,,0.59,
Tramadol,COC1=CC=CC(C2(O)CCCCC2CN(C)C)=C1,"InChI=1S/C16H25NO2/c1-17(2)12-14-7-4-5-10-16(14,18)13-8-6-9-15(11-13)19-3/h6,8-9,11,14,18H,4-5,7,10,12H2,1-3H3",O-Desmethyltramadol,CN(C)CC1CCCCC1(O)C1=CC(O)=CC=C1,UWJUQVWARXYRCG-UHFFFAOYSA-N,Cytochrome P450 2D6,0.93,
Tramadol,COC1=CC=CC(C2(O)CCCCC2CN(C)C)=C1,"InChI=1S/C16H25NO2/c1-17(2)12-14-7-4-5-10-16(14,18)13-8-6-9-15(11-13)19-3/h6,8-9,11,14,18H,4-5,7,10,12H2,1-3H3",N-Desmethyltramadol,CNCC1CCCCC1(O)C1=CC(OC)=CC=C1,VUMQHLSPUAFKKK-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6",0.97,
O-Desmethyltramadol,CN(C)CC1CCCCC1(O)C1=CC(O)=CC=C1,UWJUQVWARXYRCG-UHFFFAOYSA-N,O-Desmethyl-tramado glucuronide,CN(C)CC1CCCCC1(O)C1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC=C1,DSBGQRZOJXSECT-UHFFFAOYSA-N,"UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 1-8",0.56,
O-Desmethyltramadol,CN(C)CC1CCCCC1(O)C1=CC(O)=CC=C1,UWJUQVWARXYRCG-UHFFFAOYSA-N,"N,O-didesmethyltramadol",CNCC1CCCCC1(O)C1=CC(O)=CC=C1,CJXNQQLTDXASSR-OCCSQVGLSA-N,Cytochrome P450 2D6,0.97,
N-Desmethyltramadol,CNCC1CCCCC1(O)C1=CC(OC)=CC=C1,VUMQHLSPUAFKKK-UHFFFAOYSA-N,"N,O-didesmethyltramadol",CNCC1CCCCC1(O)C1=CC(O)=CC=C1,CJXNQQLTDXASSR-OCCSQVGLSA-N,Cytochrome P450 2D6,0.93,
N-Desmethyltramadol,CNCC1CCCCC1(O)C1=CC(OC)=CC=C1,VUMQHLSPUAFKKK-UHFFFAOYSA-N,"N,N-didesmethyltramadol",COC1=CC=CC(C2(C)CCCCC2CN)=C1,ZEXALIOABWHLJM-UKRRQHHQSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6",0.6,
"N,O-didesmethyltramadol",CNCC1CCCCC1(O)C1=CC(O)=CC=C1,CJXNQQLTDXASSR-OCCSQVGLSA-N,"N,N,O-tridesmethyl-tramadol",NCC1CCCCC1(O)C1=CC(O)=CC=C1,MJTYLDGVLFSXDG-YPMHNXCESA-N,,0.92,
"N,N-didesmethyltramadol",COC1=CC=CC(C2(C)CCCCC2CN)=C1,ZEXALIOABWHLJM-UKRRQHHQSA-N,"N,N,O-tridesmethyl-tramadol",NCC1CCCCC1(O)C1=CC(O)=CC=C1,MJTYLDGVLFSXDG-YPMHNXCESA-N,,0.59,
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3",Theobromine,CN1C=NC2=C1C(=O)NC(=O)N2C,"InChI=1S/C7H8N4O2/c1-10-3-8-5-4(10)6(12)9-7(13)11(5)2/h3H,1-2H3,(H,9,12,13)","Cytochrome P450 1A2, Cytochrome P450 2E1",0.9,
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3",Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)","Cytochrome P450 1A2, Cytochrome P450 2E1, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 3A4",0.91,
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3","1,3,7-Trimethyluric acid",CN1C(=O)C2=C(NC(=O)N2C)N(C)C1=O,BYXCFUMGEBZDDI-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 1A2, Cytochrome P450 2E1",0.95,
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3","1,7-dimethylxanthine",CN1C(=O)NC2=C(C1=O)N(C)C=N2,QUNWUDVFRNGTCO-UHFFFAOYSA-N,Cytochrome P450 1A2,0.85,
"1,7-dimethylxanthine",CN1C(=O)NC2=C(C1=O)N(C)C=N2,QUNWUDVFRNGTCO-UHFFFAOYSA-N,"1,7-Dimethyluric acid",CN1C(=O)NC2=C(C1=O)N(C)C(=O)N2,NOFNCLGCUJJPKU-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2A6",0.95,
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)",1-Methylxanthine,CN1C(=O)NC2=C(NC=N2)C1=O,MVOYJPOZRLFTCP-UHFFFAOYSA-N,Cytochrome P450 1A2,0.82,
"1,7-dimethylxanthine",CN1C(=O)NC2=C(C1=O)N(C)C=N2,QUNWUDVFRNGTCO-UHFFFAOYSA-N,5-Acetylamino-6-formylamino-3-methyluracil,CC(=O)NC1=C(NC=O)NC(=O)N(C)C1=O,RDZNZFGKEVDNPK-UHFFFAOYSA-N,Arylamine N-acetyltransferase 2,0.34,
"1,7-dimethylxanthine",CN1C(=O)NC2=C(C1=O)N(C)C=N2,QUNWUDVFRNGTCO-UHFFFAOYSA-N,1-Methylxanthine,CN1C(=O)NC2=C(NC=N2)C1=O,MVOYJPOZRLFTCP-UHFFFAOYSA-N,Xanthine dehydrogenase/oxidase,0.88,
1-Methylxanthine,CN1C(=O)NC2=C(NC=N2)C1=O,MVOYJPOZRLFTCP-UHFFFAOYSA-N,1-Methyluric acid,CN1C(=O)NC2=C(NC(=O)N2)C1=O,QFDRTQONISXGJA-UHFFFAOYSA-N,Xanthine dehydrogenase/oxidase,0.94,
Sildenafil,CCCC1=NN(C)C2=C1N=C(C1=CC(S(=O)(=O)N3CCN(C)CC3)=CC=C1OCC)NC2=O,"InChI=1S/C22H30N6O4S/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29)","N-Desmethyl sildenafil (UK-103,320)",CCCC1=NN(C)C2=C1NC(C1=C(OCC)C=CC(S(=O)(=O)N3CCNCC3)=C1)=NC2=O,UZTKBZXHEOVDRL-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Cytochrome P450 2D6, Cytochrome P450 2C9",0.99,
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,"InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2",2-Chloroticlopidine,ClC1=CC2=C(CCN(CC3=CC=CC=C3Cl)C2)S1,INYHLAYOOFHUNE-UHFFFAOYSA-N,Myeloperoxidase,0.85,
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,"InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2",2-Oxoticlopidine,O=C1C=C2CN(CC3=CC=CC=C3Cl)CCC2S1,DJZQIXWGIZIETJ-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19",0.32,
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,"InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2",Dehydrogenated ticlopidine,ClC1=CC=CC=C1CN1C=CC2=C(C=CS2)C1,BNJVHGHQYHAEDJ-UHFFFAOYSA-N,Myeloperoxidase,0.56,
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,"InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2",Ticlopidine N-oxide,[O-][N+]1(CC2=CC=CC=C2Cl)CCC2=C(C=CS2)C1,YEICEJCPALKCAT-UHFFFAOYSA-N,Myeloperoxidase,0.78,
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,"InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2",7-Hydroxyticlopidine,OC1CN(CC2=CC=CC=C2Cl)CC2=C1SC=C2,GWHGEZHHJDSDMI-UHFFFAOYSA-N,,0.8,
2-Oxoticlopidine,O=C1C=C2CN(CC3=CC=CC=C3Cl)CCC2S1,DJZQIXWGIZIETJ-UHFFFAOYSA-N,Active metabolite of Ticlopidine,O=C(O)CC1CN(CC2=CC=CC=C2Cl)CCC1S,LDXFVLBQZWBGBA-UHFFFAOYSA-N,,0.44,
Ticlopidine S-oxide,O=S1C=CC2=C1CCN(CC1=CC=CC=C1Cl)C2,SSVDYGNPKZJQKO-UHFFFAOYSA-N,Ticlopidine S-oxide dimer,O=S1C2=C(CN(CC3=C(Cl)C=CC=C3)CC2)C2C1C1C3=C(CCN(CC4=C(Cl)C=CC=C4)C3)C2S1=O,YIQPCHDIFABADG-UHFFFAOYSA-N,,0.42,
Thienodihydropyridinium,ClC1=CC=CC=C1CN1C=C2C=C[S+]=C2CC1,RLTCLQFOWWSHJX-UHFFFAOYSA-N,Thienopyridinium,ClC1=CC=CC=C1C[N+]1=CC2=C(C=C1)SC=C2,OQXLLGWEACZMFD-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Myeloperoxidase",0.24,
Thienodihydropyridinium,ClC1=CC=CC=C1CN1C=C2C=C[S+]=C2CC1,RLTCLQFOWWSHJX-UHFFFAOYSA-N,Ticlopidine lactam analog (M8),O=C1C2=C(CCN1CC1=CC=CC=C1Cl)SC=C2,KQQBLQBNIVSMLU-UHFFFAOYSA-N,Cytochrome P450 3A4,0.32,
Midodrine,COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1,"InChI=1S/C12H18N2O4/c1-17-8-3-4-11(18-2)9(5-8)10(15)7-14-12(16)6-13/h3-5,10,15H,6-7,13H2,1-2H3,(H,14,16)",desglymidodrine,COC1=CC(C(O)CN)=C(OC)C=C1,VFRCNXKYZVQYLX-UHFFFAOYSA-N,,0.81,
Torasemide,CC1=CC(NC2=C(S(=O)(=O)NC(=O)NC(C)C)C=NC=C2)=CC=C1,"InChI=1S/C16H20N4O3S/c1-11(2)18-16(21)20-24(22,23)15-10-17-8-7-14(15)19-13-6-4-5-12(3)9-13/h4-11H,1-3H3,(H,17,19)(H2,18,20,21)",Torasemide M1 (hydroxytorsemide),CC(C)NC(=O)NS(=O)(=O)C1=CNC=CC1=NC1=CC=CC(CO)=C1,WCYVLAMJCQZUCR-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9",0.57,
Eletriptan,CN1CCCC1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,"InChI=1S/C22H26N2O2S/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3/t19-/m1/s1",N-Desmethyleletriptan,O=S(=O)(CCC1=CC2=C(C=C1)NC=C2CC1CCCN1)C1=CC=CC=C1,HHTDENYTSCXDFO-GOSISDBHSA-N,"Cytochrome P450 2D6, Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2C19",0.96,
Eletriptan,CN1CCCC1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,"InChI=1S/C22H26N2O2S/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3/t19-/m1/s1",Eletriptan N-oxide,C[N+]1([O-])CCCC1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,QXXCIRSBRHOOJE-PHSANKKPSA-N,Prostaglandin G/H synthase 1,0.91,
Glimepiride,CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(C)CC3)C=C2)C1=O,"InChI=1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30)/t16-,19-",Cyclohexyl hydroxymethyl glimepiride,CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(CO)CC3)C=C2)C1=O,YUNQMQLWOOVHKI-UHFFFAOYSA-N,Cytochrome P450 2C9,0.97,
Cyclohexyl hydroxymethyl glimepiride,CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(CO)CC3)C=C2)C1=O,YUNQMQLWOOVHKI-UHFFFAOYSA-N,Cyclohexyl carboxyl glimepiride,CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(C(=O)O)CC3)C=C2)C1=O,MMZLACCSCMGVHL-UHFFFAOYSA-N,Alcohol dehydrogenase [NADP(+)],0.97,
Indinavir,CC(C)(C)NC(=O)C1CN(CC2=CN=CC=C2)CCN1CC(O)CC(CC1=CC=CC=C1)C(=O)NC1C2=CC=CC=C2CC1O,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",Metabolite M6,CC(C)(C)N=C(O)C1CNCCN1CC(O)CC(CC1=CC=CC=C1)C(O)=NC1C2=CC=CC=C2CC1O,MKMGKCALCCOODL-GVPWJHIJSA-N,Cytochrome P450 3A4,0.53,
Temazepam,CN1C(=O)C(O)N=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,"InChI=1S/C16H13ClN2O2/c1-19-13-8-7-11(17)9-12(13)14(18-15(20)16(19)21)10-5-3-2-4-6-10/h2-9,15,20H,1H3",Oxazepam,O=C1NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=NC1O,ADIMAYPTOBDMTL-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19",0.87,
Temazepam,CN1C(=O)C(O)N=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,"InChI=1S/C16H13ClN2O2/c1-19-13-8-7-11(17)9-12(13)14(18-15(20)16(19)21)10-5-3-2-4-6-10/h2-9,15,20H,1H3",Oxazepam glucuronide,O=C(O)C1OC(OC2N=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N=C2O)C(O)C(O)C1O,FIKQKGFUBZQEBL-IFBJMGMISA-N,,0.49,
Nevirapine,CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,"InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)",12-Hydroxynevirapine,OCC1=C2N=C(O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,SEBABOMFNCVZGF-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 3A4, Cytochrome P450 3A5",0.65,
Nevirapine,CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,"InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)",2-Hydroxynevirapine,CC1=CC(O)=NC2=C1N=C(O)C1=C(N=CC=C1)N2C1CC1,LFZSOJABLBVGRJ-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.64,
Nevirapine,CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,"InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)",8-Hydroxynevirapine,CC1=C2N=C(O)C3=C(N=CC(O)=C3)N(C3CC3)C2=NC=C1,DZPVEPLRIKDBFC-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 2B6, Cytochrome P450 3A4",0.64,
Nevirapine,CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,"InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)",3-Hydroxynevirapine,CC1=C2N=C(O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1O,DANIONWINZEYME-UHFFFAOYSA-N,Cytochrome P450 2B6,0.64,
2-Hydroxynevirapine,CC1=CC(O)=NC2=C1N=C(O)C1=C(N=CC=C1)N2C1CC1,LFZSOJABLBVGRJ-UHFFFAOYSA-N,2-hydroxynevirapine glucuronide,CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=NC2=C1N=C(O)C1=C(N=CC=C1)N2C1CC1,RNMZKTLILDCQOC-KUSYAZKWSA-N,,0.82,
8-Hydroxynevirapine,CC1=C2N=C(O)C3=C(N=CC(O)=C3)N(C3CC3)C2=NC=C1,DZPVEPLRIKDBFC-UHFFFAOYSA-N,8-hydroxynevirapine glucuronide,CC1=CC=NC2=C1NC(=O)C1=C(N=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=C1)N2C1CC1,IVZWGLRSSHUFTI-WCYOCWRHSA-N,,0.66,
3-Hydroxynevirapine,CC1=C2N=C(O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1O,DANIONWINZEYME-UHFFFAOYSA-N,3-hydroxynevirapine glucuronide,CC1=C2N=C(OC3OC(C(=O)O)C(O)C(O)C3O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1O,GDAAYOYNGMRKSI-IQSUWLOCSA-N,,0.81,
Cladribine,NC1=C2N=CN(C3CC(O)C(CO)O3)C2=NC(Cl)=N1,"InChI=1S/C10H12ClN5O3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H2,12,14,15)/t4-,5+,6+/m0/s1",2-chloro-2'-deoxyadenosine-5'-triphosphate,NC1=C2N=CN(C3CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O3)C2=NC(Cl)=N1,PZCJNHCKXRBBNN-KVQBGUIXSA-N,,0.86,
Mesalazine,NC1=CC(C(=O)O)=C(O)C=C1,"InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)",N-acetyl-5-ASA (Ac-5-ASA),CC(=O)NC1=CC(C(=O)O)=C(O)C=C1,GEFDRROBUCULOD-UHFFFAOYSA-N,Arylamine N-acetyltransferase 1,0.72,
Dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N)C=C2)C=C1,"InChI=1S/C12H12N2O2S/c13-9-1-5-11(6-2-9)17(15,16)12-7-3-10(14)4-8-12/h1-8H,13-14H2",Monoacetyldapsone,CC(=O)NC1=CC=C(S(=O)(=O)C2=CC=C(N)C=C2)C=C1,WDOCBIHNYYQINH-UHFFFAOYSA-N,Arylamine N-acetyltransferase 2,0.74,
dapsone hydroxylamine,NC1=CC=C(S(=O)(=O)C2=CC=C(NO)C=C2)C=C1,IYDSJDWESCGRKW-UHFFFAOYSA-N,Nitroso-dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N=O)C=C2)C=C1,UAQFAHXMXOCEAD-UHFFFAOYSA-N,,0.78,
Nitroso-dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N=O)C=C2)C=C1,UAQFAHXMXOCEAD-UHFFFAOYSA-N,Dapsone mercaptal intermediate,NC1=CC=C(S(=O)(=O)C2=CC=C(N(O)SSCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C=C2)C=C1,ILXGRDMMHISXAH-ROUUACIJSA-N,,0.31,
Dapsone mercaptal intermediate,NC1=CC=C(S(=O)(=O)C2=CC=C(N(O)SSCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C=C2)C=C1,ILXGRDMMHISXAH-ROUUACIJSA-N,Dapsone GSH conjugate,NC1=CC=C(S(=O)(=O)C2=CC=C(NS(=O)SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C=C2)C=C1,IHKJTFLXUFDQKZ-OZTHWQDPSA-N,,0.85,
Phenytoin,O=C1NC(=O)C(C2=CC=CC=C2)(C2=CC=CC=C2)N1,"InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)",Phenytoin arene-oxide,O=C1NC(=O)C(C2=CC3OC3C=C2)(C2=CC=CC=C2)N1,WBRFFCOFWKCXFD-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.39,
Phenytoin arene-oxide,O=C1NC(=O)C(C2=CC3OC3C=C2)(C2=CC=CC=C2)N1,WBRFFCOFWKCXFD-UHFFFAOYSA-N,Phenytoin dihydrodiol,O=C1NC(=O)C(C2=CC(O)C(O)C=C2)(C2=CC=CC=C2)N1,FEEKFEKCXIDMIS-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2A6, Cytochrome P450 2C19, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 2E1, Cytochrome P450 3A4, Epoxide hydrolase 1",0.96,
Phenytoin arene-oxide,O=C1NC(=O)C(C2=CC3OC3C=C2)(C2=CC=CC=C2)N1,WBRFFCOFWKCXFD-UHFFFAOYSA-N,Hydroxyphenytoin,OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C=C2)C(O)=N1,XEEDURHPFVXALT-UHFFFAOYSA-N,,0.31,
Hydroxyphenytoin,OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C=C2)C(O)=N1,XEEDURHPFVXALT-UHFFFAOYSA-N,Phenytoin catechol,O=C1NC(=O)C(C2=CC=CC=C2)(C2=CC(O)=C(O)C=C2)N1,WWEKVOUOQUHVHS-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 3A5, Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 3A7, Cytochrome P450 2B6, Cytochrome P450 2D6",0.37,
Phenytoin dihydrodiol,O=C1NC(=O)C(C2=CC(O)C(O)C=C2)(C2=CC=CC=C2)N1,FEEKFEKCXIDMIS-UHFFFAOYSA-N,Phenytoin catechol,O=C1NC(=O)C(C2=CC=CC=C2)(C2=CC(O)=C(O)C=C2)N1,WWEKVOUOQUHVHS-UHFFFAOYSA-N,,0.44,
Anagrelide,O=C1CN2CC3=C(Cl)C(Cl)=CC=C3N=C2N1,"InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)","6,7-dichloro-3-hydroxy-1,5 dihydro-imidazo[2,1-b]quinazolin-2-one",O=C1NC2=NC3=CC=C(Cl)C(Cl)=C3CN2C1O,KAXTUTDKZVOONF-UHFFFAOYSA-N,Cytochrome P450 1A2,0.85,
"6,7-dichloro-3-hydroxy-1,5 dihydro-imidazo[2,1-b]quinazolin-2-one",O=C1NC2=NC3=CC=C(Cl)C(Cl)=C3CN2C1O,KAXTUTDKZVOONF-UHFFFAOYSA-N,"2-amino-5,6-dichloro-3,4,-dihydroquinazoline",NC1=NCC2=C(C=CC(Cl)=C2Cl)N1,VBKOTIVQMCTTAQ-UHFFFAOYSA-N,Cytochrome P450 1A2,0.4,
Ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,"InChI=1S/C16H24N2O/c1-3-9-18(10-4-2)11-8-13-6-5-7-15-14(13)12-16(19)17-15/h5-7H,3-4,8-12H2,1-2H3,(H,17,19)",N-despropyl ropinirole,CCCNCCC1=CC=CC2=C1CC(=O)N2,VKDWFHAQOZYATG-UHFFFAOYSA-N,Cytochrome P450 1A2,0.96,
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)",3-methylxanthine,CN1C(=O)NC(=O)C2=C1N=CN2,GMSNIKWWOQHZGF-UHFFFAOYSA-N,Cytochrome P450 1A2,0.86,
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)",Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,RYYVLZVUVIJVGH-UHFFFAOYSA-N,,0.91,
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)","1,3-dimethyluric acid",CN1C(=O)C2=C(NC(=O)N2)N(C)C1=O,OTSBKHHWSQYEHK-UHFFFAOYSA-N,Cytochrome P450 2E1,0.94,
Liothyronine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(=O)O,"InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1",Monoiodothyronine,NC(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C=C1)C(=O)O,,,0.88,
Liothyronine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(=O)O,"InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1",Tiratricol,O=C(O)CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1,"InChI=1S/C14H9I3O4/c15-9-6-8(1-2-12(9)18)21-14-10(16)3-7(4-11(14)17)5-13(19)20/h1-4,6,18H,5H2,(H,19,20)",,0.69,
Liothyronine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(=O)O,"InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1",Triiodothyronine sulfate,NC(CC1=CC(I)=C(OC2=CC(I)=C(OS(=O)(=O)O)C=C2)C(I)=C1)C(=O)O,XBQYQXVJBNDCGY-LBPRGKRZSA-N,,0.79,
Disopyramide,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,"InChI=1S/C21H29N3O/c1-16(2)24(17(3)4)15-13-21(20(22)25,18-10-6-5-7-11-18)19-12-8-9-14-23-19/h5-12,14,16-17H,13,15H2,1-4H3,(H2,22,25)",mono-isopropyl-disopyramide,CC(C)NCCC(C(=N)O)(C1=CC=CC=C1)C1=CC=CC=N1,UWNSWIXIVDMCHZ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.57,
Lidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,"InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)",3-hydroxylidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC(O)=C1C,PMGUCIDDSCRAMY-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 3A7",0.72,
Lidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,"InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)",monoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC=C1C,WRMRXPASUROZGT-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 3A7",0.92,
Lidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,"InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)","2,6-Dimethylaniline (2,6-Xylidine)",CC1=CC=CC(C)=C1N,UFFBMTHBGFGIHF-UHFFFAOYSA-N,,0.34,
3-hydroxylidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC(O)=C1C,PMGUCIDDSCRAMY-UHFFFAOYSA-N,3-Hydroxymonoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC(O)=C1C,YITCMQBVWIHTTA-UHFFFAOYSA-N,,0.95,
monoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC=C1C,WRMRXPASUROZGT-UHFFFAOYSA-N,3-Hydroxymonoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC(O)=C1C,YITCMQBVWIHTTA-UHFFFAOYSA-N,,0.7,
monoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC=C1C,WRMRXPASUROZGT-UHFFFAOYSA-N,"2,6-Dimethylaniline (2,6-Xylidine)",CC1=CC=CC(C)=C1N,UFFBMTHBGFGIHF-UHFFFAOYSA-N,,0.37,
monoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC=C1C,WRMRXPASUROZGT-UHFFFAOYSA-N,Glycinexylidide (GX),CC1=CC=CC(C)=C1NC(=O)CN,IXYVBZOSGGJWCW-UHFFFAOYSA-N,,0.88,
"2,6-Dimethylaniline (2,6-Xylidine)",CC1=CC=CC(C)=C1N,UFFBMTHBGFGIHF-UHFFFAOYSA-N,2-Amino-3-methylbenzoate,CC1=C(N)C(C(=O)O)=CC=C1,WNAJXPYVTFYEST-UHFFFAOYSA-N,,0.43,
Glycinexylidide (GX),CC1=CC=CC(C)=C1NC(=O)CN,IXYVBZOSGGJWCW-UHFFFAOYSA-N,"2,6-Dimethylaniline (2,6-Xylidine)",CC1=CC=CC(C)=C1N,UFFBMTHBGFGIHF-UHFFFAOYSA-N,,0.42,
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,"InChI=1S/C16H25NO2/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16/h6-9,15,18-19H,3-5,10-12H2,1-2H3","N,O-Didesmethylvenlafaxine",CNCC(C1=CC=C(O)C=C1)C1(O)CCCCC1,MMSWXJSQCAEDLK-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Cytochrome P450 2C9",0.95,
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,"InChI=1S/C16H25NO2/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16/h6-9,15,18-19H,3-5,10-12H2,1-2H3",O-Desmethylvenlafaxine glucuronide,NCC(C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1(O)CCCCC1,VNRFTNKWISCOMJ-KUIQUDTGSA-N,,0.49,
"N,O-Didesmethylvenlafaxine",CNCC(C1=CC=C(O)C=C1)C1(O)CCCCC1,MMSWXJSQCAEDLK-UHFFFAOYSA-N,"N,O-didesmethylvenlafaxine glucuronide",CNCC(C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1(O)CCCCC1,UDNAJOOLWIWCAW-SQBZNDFJSA-N,,0.52,
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Estriol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(O)C2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,0.74,
Morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1",Codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1",,0.99,
Morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1",Normorphine,OC1=C2OC3C(O)C=CC4C5CC(=C2C43CCN5)C=C1,ONBWJWYUHXVEJS-UHFFFAOYSA-N,,0.98,
Morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1",Morphine glucuronide,CN1CCC23C4=C5OC2C(OC2OC(C(=O)O)C(O)C(O)C2O)C=CC3C1CC4=CC=C5O,"InChI=1S/C23H27NO9/c1-24-7-6-23-10-3-5-13(31-22-17(28)15(26)16(27)19(33-22)21(29)30)20(23)32-18-12(25)4-2-9(14(18)23)8-11(10)24/h2-5,10-11,13,15-17,19-20,22,25-28H,6-8H2,1H3,(H,29,30)/t10-,11+,13-,15-,16-,17+,19-,20-,22+,23-/m0/s1","UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-8, UDP-glucuronosyltransferase 2B15, UDP-glucuronosyltransferase 2B4, UDP-glucuronosyltransferase 1-3",0.9,
Morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1",morphine-3-glucuronide,CCCN(C)C(CC)C1C=CC(O)C2OC3=C(OC4OC(C)C(O)C(O)C4O)C=CC=C3C12,VTXHJADFMAGEOX-MHOAFJCYSA-N,"UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 1-1",0.79,
Ropivacaine,CCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,"InChI=1S/C17H26N2O/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20)/t15-/m0/s1",3-hydroxyropivacaine,CCCN1CCCCC1C(=O)NC1=C(C)C(O)=CC=C1C,IXOVDWXTIIYVOJ-AWEZNQCLSA-N,Cytochrome P450 1A2,0.83,
Tenofovir disoproxil,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N)N=CN=C21)OCOC(=O)OC(C)C,"InChI=1S/C19H30N5O10P/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22)/t14-/m1/s1",Tenofovir Monophosphate,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)OP(=O)(O)O,BQDRSOMUPPCKPB-ZCFIWIBFSA-N,"Adenylate kinase 2, mitochondrial, Adenylate kinase 4, mitochondrial",0.76,
Tenofovir Monophosphate,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)OP(=O)(O)O,BQDRSOMUPPCKPB-ZCFIWIBFSA-N,Tenofovir Diphosphate,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)OP(=O)(O)OP(=O)(O)O,IACQCQDWSIQSRP-ZCFIWIBFSA-N,"Nucleoside diphosphokinase, Creatine Kinases",0.92,
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,"InChI=1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1",6-alpha-hydroxydesogestrel,C#CC1(O)CCC2C3CC(O)C4=CCCCC4C3C(=C)CC21CC,GHFIULBLMLVLDK-GDLCRWSOSA-N,,0.87,
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,"InChI=1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1",16-hydroxy-desogestrel,C#CC1(O)C(O)CC2C3CCC4=CCCCC4C3C(=C)CC21CC,QGTKZJGOIVJHGG-DVUPJZBUSA-N,,0.85,
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,"InChI=1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1",Desogestrel-17-sulfate,C#CC1(OS(=O)(=O)[O-])CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,XLVAWWOSRWJYBK-BPIQYHPVSA-M,,0.72,
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,"InChI=1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1",15-alpha-hydroxydesogestrel,C#CC1(O)CC(O)C2C3CCC4=CCCCC4C3C(=C)CC21CC,RWVQLLLACWCLQR-YBAWMFKNSA-N,,0.87,
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,"InChI=1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1",2-hydroxydesogestrel,C#CC1(O)CCC2C3CCC4=CCC(O)CC4C3C(=C)C(CC)C21,OAJXJBAOKDVIQW-KSVDVDHBSA-N,,0.81,
3alpha-Hydroxydesogestrel,C#CC1(O)CCC2C3CCC4=CC(O)CCC4C3C(=C)CC21CC,ZMLDTNLDYRJTAZ-JASYKLOUSA-N,Etonogestrel,C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3C(=C)CC21CC,"InChI=1S/C22H28O2/c1-4-21-13-14(3)20-17-9-7-16(23)12-15(17)6-8-18(20)19(21)10-11-22(21,24)5-2/h2,12,17-20,24H,3-4,6-11,13H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1",3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,0.8,
Valproic acid,CCCC(CCC)C(=O)O,"InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)",2-ene-Valproic acid,CCC=C(CCC)C(=O)O,ZKNJEOBYOLUGKJ-FNORWQNLSA-N,,0.24,
Valproic acid,CCCC(CCC)C(=O)O,"InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)",(3Z)-2-Propylpent-3-enoic acid (3Z-Ene-VPA),CC=CC(CCC)C(=O)O,WTMAHJABDOHPDJ-HYXAFXHYSA-N,,0.43,
4-ene-Valproic acid,C=CCC(CCC)C(=O)O,UMYDNZXEHYSVFY-UHFFFAOYSA-N,"2,4-Diene-VPA",C=CC=C(CCC)C(=O)O,UUILWXIBBZVJDU-FNORWQNLSA-N,,0.25,
4-Hydroxyvalproic acid,CCCC(CC(C)O)C(=O)O,OASKNPCLIHUTTL-UHFFFAOYSA-N,2-n-Propyl-4-oxopentanoic acid,CCCC(CC(C)=O)C(=O)O,HJRMYVTYHORJKC-UHFFFAOYSA-N,,0.54,
5-Hydroxyvalproic acid,CCCC(CCCO)C(=O)O,ZIWBCJXKYKOLJK-UHFFFAOYSA-N,2-Propylglutaric acid,CCCC(CCC(=O)O)C(=O)O,IFNXFIJXYVEYLF-UHFFFAOYSA-N,,0.85,
3-Hydroxyvalproic acid,CCCC(C(=O)O)C(O)CC,LLPFTSMZBSRZDV-UHFFFAOYSA-N,3-Oxovalproic acid,CCCC(C(=O)O)C(=O)CC,PPYHXKUZTSZTQU-UHFFFAOYSA-N,,0.45,
2-ene-Valproic acid,CCC=C(CCC)C(=O)O,ZKNJEOBYOLUGKJ-FNORWQNLSA-N,3-Hydroxyvalproic acid,CCCC(C(=O)O)C(O)CC,LLPFTSMZBSRZDV-UHFFFAOYSA-N,,0.19,
2-n-Propyl-4-oxopentanoic acid,CCCC(CC(C)=O)C(=O)O,HJRMYVTYHORJKC-UHFFFAOYSA-N,2-Propylsuccinic acid,CCCC(CC(=O)O)C(=O)O,QLTZBYGZXPKHLF-UHFFFAOYSA-N,,0.65,
Acetaminophen,CC(=O)NC1=CC=C(O)C=C1,"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)",Acetaminophen glucuronide,CC(=O)NC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,IPROLSVTVHAQLE-BYNIDDHOSA-N,"UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-6, UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 2B15, UDP-glucuronosyltransferase 1-10",0.22,
Acetaminophen,CC(=O)NC1=CC=C(O)C=C1,"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)",Acetaminophen sulfate,CC(=O)NC1=CC=C(OS(=O)(=O)O)C=C1,IGTYILLPRJOVFY-UHFFFAOYSA-N,"Sulfotransferase 1A1, Sulfotransferase 1A3/1A4, Bile salt sulfotransferase",0.62,
E-10-Hydroxyamitriptyline,CN(C)CCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,GHWBJXOKAFHZAI-SFQUDFHCSA-N,E-10-Hydroxynortriptyline,CNCCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,VAGXZGJKNUNLHK-LFIBNONCSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C19, Cytochrome P450 2C9, Cytochrome P450 3A4",0.99,
E-10-Hydroxynortriptyline,CNCCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,VAGXZGJKNUNLHK-LFIBNONCSA-N,E-10-Hydroxydesmethylnortriptyline,NCCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,PIEVJGJKDMQGSG-XNTDXEJSSA-N,,0.99,
Desmethylnortriptyline,NCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,PTQFRALDEONNOA-UHFFFAOYSA-N,E-10-Hydroxydesmethylnortriptyline,NCCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,PIEVJGJKDMQGSG-XNTDXEJSSA-N,Cytochrome P450 2D6,0.72,
Floxuridine,O=C1NC(=O)N(C2CC(O)C(CO)O2)C=C1F,"InChI=1S/C9H11FN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1",5-fluorouracil,O=C1NC=C(F)C(=O)N1,GHASVSINZRGABV-UHFFFAOYSA-N,"Thymidine phosphorylase, Cytochrome P450 2A6",0.22,
Hydromorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3C1C5,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2,4,10-11,16,19H,3,5-8H2,1H3/t10-,11+,16-,17-/m0/s1",Norhydromorphone,O=C1CCC2C3CC4=C5C(=C(O)C=C4)OC1C52CCN3,SWIRXSKBBSJXGY-UIHHKEIPSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9",0.98,
Indomethacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)O,"InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)",5-Hydroxyindomethacin,CC1=C(CC(=O)O)C2=C(C=CC(O)=C2)N1C(=O)C1=CC=C(Cl)C=C1,KMLNWQPYFBIALN-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.97,
Indomethacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)O,"InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)",Indomethacin acyl glucuronide,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,QCBWEVBGELGABM-CZLVRFMKSA-N,UDP-glucuronosyltransferase 1-1,0.8,
Indomethacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)O,"InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)",Deacyl indomethacin,COC1=CC2=C(C=C1)NC(C)=C2CC(=O)O,TXWGINUZLBAKDF-UHFFFAOYSA-N,Liver carboxylesterase 1,0.6,
Ipratropium,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)C1=CC=CC=C1)C2,"InChI=1S/C20H30NO3/c1-14(2)21(3)16-9-10-17(21)12-18(11-16)24-20(23)19(13-22)15-7-5-4-6-8-15/h4-8,14,16-19,22H,9-13H2,1-3H3/q+1/t16-,17+,18+,19?,21?",N-isopropylnortropium methobromide,C=C(C(=O)OC1CC2CCC(C1)[N+]2(C)C(C)C)C1=CC=CC=C1,APBFGXKTZSOWLK-JRJNBHHRSA-N,,0.72,
Ipratropium,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)C1=CC=CC=C1)C2,"InChI=1S/C20H30NO3/c1-14(2)21(3)16-9-10-17(21)12-18(11-16)24-20(23)19(13-22)15-7-5-4-6-8-15/h4-8,14,16-19,22H,9-13H2,1-3H3/q+1/t16-,17+,18+,19?,21?",Phenylacetic acid,O=C(O)CC1=CC=CC=C1,"InChI=1S/C8H8O2/c9-8(10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,9,10)",,0.2,
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,"InChI=1S/C21H27NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3","2-Ethyl-1,5-dimethyl-3,3-diphenylpyrrolinium (EDDP)",CC=C1N(C)C(C)CC1(C1=CC=CC=C1)C1=CC=CC=C1,AJRJPORIQGYFMT-RMOCHZDMSA-N,"Cytochrome P450 2D6, Cytochrome P450 3A4, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2C19, Cytochrome P450 2C9",0.45,
"2-Ethyl-1,5-dimethyl-3,3-diphenylpyrrolinium (EDDP)",CC=C1N(C)C(C)CC1(C1=CC=CC=C1)C1=CC=CC=C1,AJRJPORIQGYFMT-RMOCHZDMSA-N,"2-Ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP)",CCC1=NC(C)CC1(C1=CC=CC=C1)C1=CC=CC=C1,UPZKJIHNKKJIKX-UHFFFAOYSA-N,Cytochrome P450 3A7,0.4,
Olanzapine,CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCN(C)CC2)S1,"InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3",7-hydroxyolanzapine,CC1=CC2=C(NC3=C(C=C(O)C=C3)N=C2N2CCN(C)CC2)S1,SMNUCABXNXAPBY-UHFFFAOYSA-N,Cytochrome P450 1A2,0.96,
Omeprazole,COC1=CC2=C(C=C1)N=C(S(=O)CC1=NC=C(C)C(OC)=C1C)N2,"InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)",5-Hydroxyomeprazole,COC1=CC2=C(C=C1)N=C(S(=O)CC1=NC=C(CO)C(OC)=C1C)N2,CMZHQFXXAAIBKE-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4",0.94,
Omeprazole,COC1=CC2=C(C=C1)N=C(S(=O)CC1=NC=C(C)C(OC)=C1C)N2,"InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)",5'-O-Desmethyl omeprazole,COC1=C(C)C=NC(C[S+]([O-])C2=NC3=CC(O)=CC=C3N2)=C1C,TWXDTVZNDQKCOS-UHFFFAOYSA-N,Cytochrome P450 2C19,0.77,
Omeprazole,COC1=CC2=C(C=C1)N=C(S(=O)CC1=NC=C(C)C(OC)=C1C)N2,"InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)",Omeprazole sulfone,COC1=CC2=C(C=C1)N=C(S(=O)(=O)CC1=C(C)C(OC)=C(C)C=N1)N2,IXEQEYRTSRFZEO-UHFFFAOYSA-N,Cytochrome P450 3A4,0.94,
Omeprazole,COC1=CC2=C(C=C1)N=C(S(=O)CC1=NC=C(C)C(OC)=C1C)N2,"InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)",3-Hydroxyomeprazole,COC1=CC2=C(C=C1)N=C(S(=O)CC1=C(CO)C(OC)=C(C)C=N1)N2,IGVYIWUGJPECAJ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.92,
Pyrazinamide,NC(=O)C1=NC=CN=C1,"InChI=1S/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9)",5-hydroxypyrazinamide,NC(=O)C1=CNC(=O)C=N1,XENWQEOTDAQROM-UHFFFAOYSA-N,Aldehyde oxidase,0.69,
Terfenadine,CC(C)(C)C1=CC=C(C(O)CCCN2CCC(C(O)(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C=C1,"InChI=1S/C32H41NO2/c1-31(2,3)26-18-16-25(17-19-26)30(34)15-10-22-33-23-20-29(21-24-33)32(35,27-11-6-4-7-12-27)28-13-8-5-9-14-28/h4-9,11-14,16-19,29-30,34-35H,10,15,20-24H2,1-3H3",fexofenadine,CC(C)(C(=O)O)C1=CC=C(C(O)CCCN2CCC(C(O)(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C=C1,RWTNPBWLLIMQHL-UHFFFAOYSA-N,Cytochrome P450 3A4,0.85,
Clobazam,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,"InChI=1S/C16H13ClN2O2/c1-18-13-8-7-11(17)9-14(13)19(16(21)10-15(18)20)12-5-3-2-4-6-12/h2-9H,10H2,1H3",N-desmethylclobazam,O=C1CC(=O)N(C2=CC=CC=C2)C2=C(C=CC(Cl)=C2)N1,RRTVVRIFVKKTJK-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 3A4, Cytochrome P450 2B6, Cytochrome P450 3A5, Cytochrome P450 3A7, Cytochrome P450 1A2, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 2C18",0.85,
Clobazam,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,"InChI=1S/C16H13ClN2O2/c1-18-13-8-7-11(17)9-14(13)19(16(21)10-15(18)20)12-5-3-2-4-6-12/h2-9H,10H2,1H3",4'-hydroxyclobazam,CN1C(=O)CC(=O)N(C2=CC=C(O)C=C2)C2=C1C=CC(Cl)=C2,NKSXJAYACJZMBM-UHFFFAOYSA-N,"Cytochrome P450 2C18, Cytochrome P450 2C19",0.95,
Tioguanine,NC1=NC(=S)C2=C(N=CN2)N1,"InChI=1S/C5H5N5S/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",Thioguanosine monophosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)O)C(O)C1O)C=N2,BPZXYEUJBFHASJ-UUOKFMHZSA-N,Hypoxanthine-guanine phosphoribosyltransferase,0.34,
Thioguanosine monophosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)O)C(O)C1O)C=N2,BPZXYEUJBFHASJ-UUOKFMHZSA-N,Methyl-thioguanosine monophosphate,CSC1N=C(N)NC2=C1N=CN2C1OC(COP(=O)(O)O)C(O)C1O,VLFVFMNOAJKLEN-AFPKLJJXSA-N,Thiopurine S-methyltransferase,0.61,
Thioguanosine monophosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)O)C(O)C1O)C=N2,BPZXYEUJBFHASJ-UUOKFMHZSA-N,Thioguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,IUTNWRFYTFZSEK-UUOKFMHZSA-N,,0.96,
Thioguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,IUTNWRFYTFZSEK-UUOKFMHZSA-N,Thioguanosine triphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,QENYANNAQSWPLM-UUOKFMHZSA-N,,0.98,
Thioguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,IUTNWRFYTFZSEK-UUOKFMHZSA-N,Thiodeoxyguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)O)O1)C=N2,ZVLMDCYHIBYREW-KVQBGUIXSA-N,,0.93,
Thiodeoxyguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)O)O1)C=N2,ZVLMDCYHIBYREW-KVQBGUIXSA-N,Thiodeoxyguanosine triphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O1)C=N2,BXZRFHUVVWIHMV-KVQBGUIXSA-N,,0.98,
Chlorzoxazone,O=C1NC2=C(C=CC(Cl)=C2)O1,"InChI=1S/C7H4ClNO2/c8-4-1-2-6-5(3-4)9-7(10)11-6/h1-3H,(H,9,10)",6-hydroxychlorzoxazone,OC1=NC2=C(C=C(O)C(Cl)=C2)O1,AGLXDWOTVQZHIQ-UHFFFAOYSA-N,Cytochrome P450 2E1,0.52,
Mefloquine,OC(C1=CC(C(F)(F)F)=NC2=C1C=CC=C2C(F)(F)F)C1CCCCN1,"InChI=1S/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2","2,8-bis-trifluoromethyl-4-quinoline carboxylic acid",O=C(O)C1=CC(C(F)(F)F)=NC2=C1C=CC=C2C(F)(F)F,QJTJIQBSZLFWFS-UHFFFAOYSA-N,Cytochrome P450 3A4,0.65,
Clozapine,CN1CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1,"InChI=1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3",Clozapine N-oxide,C[N+]1([O-])CCN(C2=NC3=C(C=CC(Cl)=C3)NC3=CC=CC=C23)CC1,OGUCZBIQSYYWEF-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 1A2, Dimethylaniline monooxygenase [N-oxide-forming] 3, Cytochrome P450 2C19, Cytochrome P450 3A5, Cytochrome P450 2D6, Cytochrome P450 2C9, Cytochrome P450 2E1",0.95,
Clozapine,CN1CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1,"InChI=1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3",Clozapine 5-N-glucuronide,CN1CCN(C2=NC3=C(C=CC(Cl)=C3)N(C3OC(C(=O)O)C(O)C(O)C3O)C3=CC=CC=C23)CC1,YWWIDMPXCSUNRD-VZWAGXQNSA-N,"UDP-glucuronosyltransferase 1-4, UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 2B10",0.6,
Norepinephrine,NCC(O)C1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1",Norepinephrine sulfate,NCC(O)C1=CC(O)=C(OS(=O)(=O)O)C=C1,CVJMZWLHUCMEKO-ZETCQYMHSA-N,,0.63,
Norepinephrine,NCC(O)C1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1",3-Methoxy-4-Hydroxyphenylglycol sulfate,COC1=C(O)C=CC(C(CO)OS(=O)(=O)O)=C1,SBKADJXSGGTEPN-UHFFFAOYSA-N,,0.46,
Mirtazapine,CN1CCN2C3=C(C=CC=N3)CC3=CC=CC=C3C2C1,"InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3",mirtazapine-N-oxide,C[N+]1([O-])CCN2C3=C(C=CC=N3)CC3=CC=CC=C3C2C1,GAFCUVMEBFTFQJ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.93,
Mirtazapine,CN1CCN2C3=C(C=CC=N3)CC3=CC=CC=C3C2C1,"InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3",N-desmethylmirtazapine,C1=CC=C2C(=C1)CC1=C(N=CC=C1)N1CCNCC21,FGLAMNFOHWVQOH-UHFFFAOYSA-N,Cytochrome P450 3A4,0.97,
Mirtazapine,CN1CCN2C3=C(C=CC=N3)CC3=CC=CC=C3C2C1,"InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3",8-hydroxymirtazapine,CN1CCN2C3=NC=C(O)C=C3CC3=CC=CC=C3C2C1,DAWYIZBOUQIVNX-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2D6",0.94,
Dydrogesterone,CC(=O)C1CCC2C3C=CC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C21H28O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4-5,12,16-19H,6-11H2,1-3H3/t16-,17+,18-,19+,20+,21+/m0/s1",20-dihydrodydrogesterone,C=C1C=C2C=CC3C(CCC4(C)C(C(C)C)CCC34)C2(C)CC1,YUDUQGLCBDGGNA-UHFFFAOYSA-N,,0.65,
Mexiletine,CC1=C(OCC(C)N)C(C)=CC=C1,"InChI=1S/C11H17NO/c1-8-5-4-6-9(2)11(8)13-7-10(3)12/h4-6,10H,7,12H2,1-3H3",2-hydroxymexiletine,CC1=C(OCC(C)N)C(CO)=CC=C1,XMJYSMLLWRQQAE-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2D6",0.77,
Mexiletine,CC1=C(OCC(C)N)C(C)=CC=C1,"InChI=1S/C11H17NO/c1-8-5-4-6-9(2)11(8)13-7-10(3)12/h4-6,10H,7,12H2,1-3H3",p-hydroxymexiletine,CC1=C(OCC(C)N)C(C)=CC(O)=C1,YWOSWRCXWBDSRQ-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2D6",0.85,
Tacrine,NC1=C2CCCCC2=NC2=CC=CC=C12,"InChI=1S/C13H14N2/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1,3,5,7H,2,4,6,8H2,(H2,14,15)",1-hydroxytacrine,N=C1C2=C(CCCC2O)NC2=CC=CC=C12,HLVVITIHAZBPKB-UHFFFAOYSA-N,Cytochrome P450 1A2,0.58,
Valrubicin,CCCCC(=O)OCC(=O)C1(O)CC2=C(O)C3=C(C(=O)C4=C(OC)C=CC=C4C3=O)C(O)=C2C(OC2CC(NC(=O)C(F)(F)F)C(O)C(C)O2)C1,"InChI=1S/C34H36F3NO13/c1-4-5-9-21(40)49-13-20(39)33(47)11-16-24(19(12-33)51-22-10-17(27(41)14(2)50-22)38-32(46)34(35,36)37)31(45)26-25(29(16)43)28(42)15-7-6-8-18(48-3)23(15)30(26)44/h6-8,14,17,19,22,27,41,43,45,47H,4-5,9-13H2,1-3H3,(H,38,46)/t14-,17-,19-,22-,27+,33-/m0/s1",N-trifluoroacetyladriamycinol,COC1=CC=CC2=C1C(=O)C1=C(C2=O)C(O)=C2CC(O)(C(O)CO)CC(OC3CC(N=C(O)C(F)(F)F)C(O)C(C)O3)C2=C1O,TWMWXCYMYAQOTO-UHFFFAOYSA-N,,0.88,
Valrubicin,CCCCC(=O)OCC(=O)C1(O)CC2=C(O)C3=C(C(=O)C4=C(OC)C=CC=C4C3=O)C(O)=C2C(OC2CC(NC(=O)C(F)(F)F)C(O)C(C)O2)C1,"InChI=1S/C34H36F3NO13/c1-4-5-9-21(40)49-13-20(39)33(47)11-16-24(19(12-33)51-22-10-17(27(41)14(2)50-22)38-32(46)34(35,36)37)31(45)26-25(29(16)43)28(42)15-7-6-8-18(48-3)23(15)30(26)44/h6-8,14,17,19,22,27,41,43,45,47H,4-5,9-13H2,1-3H3,(H,38,46)/t14-,17-,19-,22-,27+,33-/m0/s1",N-trifluoroacetyladriamycin,COC1=CC=CC2=C1C(=O)C1=C(C2=O)C(O)=C2CC(O)(C(=O)CO)CC(OC3CC(NC(=O)C(F)(F)F)C(O)C(C)O3)C2=C1O,RQIOYWADAKTIJC-XUKKXQNXSA-N,,0.99,
Digoxin,CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CC(O)C5(C)C(C7=CC(=O)OC7)CCC65O)C4)OC3C)OC2C)CC(O)C1O,"InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3/t19-,20-,21-,23-,24+,25-,26-,27+,28+,29+,30+,31-,33+,34+,35+,36-,37-,38-,39+,40+,41+/m1/s1",Dihydrodigoxin,CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CC(O)C5(C)C(C7COC(=O)C7)CCC65O)C4)OC3C)OC2C)CC(O)C1O,,,0.71,
Carisoprodol,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,"InChI=1S/C12H24N2O4/c1-5-6-12(4,7-17-10(13)15)8-18-11(16)14-9(2)3/h9H,5-8H2,1-4H3,(H2,13,15)(H,14,16)",Meprobamate,CCCC(C)(COC(N)=O)COC(N)=O,"InChI=1S/C9H18N2O4/c1-3-4-9(2,5-14-7(10)12)6-15-8(11)13/h3-6H2,1-2H3,(H2,10,12)(H2,11,13)",Cytochrome P450 2C19,0.72,
Progesterone,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1",Pregnanolone,CC(=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C,,,0.42,
Sorafenib,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(C(F)(F)F)=C(Cl)C=C3)C=C2)=C1,"InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)",Sorafenib N-oxide,CNC(=O)C1=[N+]([O-])C=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)C=C2)=C1,,Cytochrome P450 3A4,0.88,
Sorafenib,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(C(F)(F)F)=C(Cl)C=C3)C=C2)=C1,"InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)",Sorafenib beta-D-Glucuronide,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)N(C3=CC(C(F)(F)F)=C(Cl)C=C3)C3OC(C(=O)O)C(O)C(O)C3O)C=C2)=C1,HALZWBPBJOJUOZ-UHFFFAOYSA-N,UDP-glucuronosyltransferase 1-9,0.53,
Griseofulvin,COC1=CC(=O)CC(C)C12OC1=C(C2=O)C(OC)=CC(OC)=C1Cl,"InChI=1S/C17H17ClO6/c1-8-5-9(19)6-12(23-4)17(8)16(20)13-10(21-2)7-11(22-3)14(18)15(13)24-17/h6-8H,5H2,1-4H3/t8-,17+/m1/s1",6-methyl-griseofulvin,COC1=CC(=O)CC(C)C12OC1=C(C2=O)C(OC)=CC(C)=C1Cl,QNPINWFXONNRKM-XLFHBGCDSA-N,,0.97,
Eszopiclone,CN1CCN(C(=O)OC2C3=NC=CN=C3C(=O)N2C2=NC=C(Cl)C=C2)CC1,"InChI=1S/C17H17ClN6O3/c1-22-6-8-23(9-7-22)17(26)27-16-14-13(19-4-5-20-14)15(25)24(16)12-3-2-11(18)10-21-12/h2-5,10,16H,6-9H2,1H3/t16-/m0/s1",Zopiclone N-oxide,C[N+]1([O-])CCN(C(=O)OC2C3=C(N=CC=N3)C(=O)N2C2=NC=C(Cl)C=C2)CC1,IPTIKKTXLHVRKN-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2E1",0.98,
Alprazolam,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,"InChI=1S/C17H13ClN4/c1-11-20-21-16-10-19-17(12-5-3-2-4-6-12)14-9-13(18)7-8-15(14)22(11)16/h2-9H,10H2,1H3",4-hydroxyalprazolam,CC1=NN=C2C(O)N=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,CEYGCFLPQFNPST-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 2C9",0.87,
Alprazolam,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,"InChI=1S/C17H13ClN4/c1-11-20-21-16-10-19-17(12-5-3-2-4-6-12)14-9-13(18)7-8-15(14)22(11)16/h2-9H,10H2,1H3",alpha-Hydroxyalprazolam,OCC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,ZURUZYHEEMDQBU-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A5, Cytochrome P450 3A4",0.93,
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",Phenoxyacetic acid derivative of rosiglitazone,O=C(O)COC1=CC=C(CC2SC(=O)NC2=O)C=C1,SXAASESEPRXRTR-UHFFFAOYSA-N,,0.71,
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",N-Desmethylrosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=CC=CC=N3)C=C2)S1,ZJQTVMXUIGXRMR-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9",0.56,
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",para-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=NC=C(O)C=C1,AGQGGZNSVNKGDU-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9",0.6,
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",N-Despyridinyl rosiglitazone,CNCCOC1=CC=C(CC2SC(=O)NC2=O)C=C1,BPSKNLFJDYBECE-UHFFFAOYSA-N,,0.76,
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",ortho-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=C(O)C=CC=N1,KQXWMUFVDAFGPU-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9",0.58,
N-Desmethylrosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=CC=CC=N3)C=C2)S1,ZJQTVMXUIGXRMR-UHFFFAOYSA-N,N-Desmethyl-ortho-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=C(O)C=CC=N3)C=C2)S1,GWVBGLUFILBNNY-UHFFFAOYSA-N,,0.55,
ortho-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=C(O)C=CC=N1,KQXWMUFVDAFGPU-UHFFFAOYSA-N,N-Desmethyl-ortho-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=C(O)C=CC=N3)C=C2)S1,GWVBGLUFILBNNY-UHFFFAOYSA-N,,0.6,
N-Desmethylrosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=CC=CC=N3)C=C2)S1,ZJQTVMXUIGXRMR-UHFFFAOYSA-N,N-Desmethyl-para-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=CC=C(O)C=N3)C=C2)S1,SVUUNTJZVPNZSL-UHFFFAOYSA-N,,0.56,
para-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=NC=C(O)C=C1,AGQGGZNSVNKGDU-UHFFFAOYSA-N,N-Desmethyl-para-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=CC=C(O)C=N3)C=C2)S1,SVUUNTJZVPNZSL-UHFFFAOYSA-N,,0.59,
ortho-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=C(O)C=CC=N1,KQXWMUFVDAFGPU-UHFFFAOYSA-N,ortho-O-Glucuronide rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=NC=CC=C1OC1OC(C(=O)O)C(O)C(O)C1O,YDRMOALONMVDNG-TUCRDTSBSA-N,,0.52,
ortho-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=C(O)C=CC=N1,KQXWMUFVDAFGPU-UHFFFAOYSA-N,ortho-O-Sulfate rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=C(OS(=O)(=O)O)C=CC=N1,ZVSPRKOUHTZIGH-UHFFFAOYSA-N,,0.6,
N-Desmethylrosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=CC=CC=N3)C=C2)S1,ZJQTVMXUIGXRMR-UHFFFAOYSA-N,N-Desmethyl glucuronide rosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=NC=CC=C3OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)S1,NLGMKXBTZZJJFK-UHFFFAOYSA-N,,0.54,
para-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=NC=C(O)C=C1,AGQGGZNSVNKGDU-UHFFFAOYSA-N,para-O-Glucuronide rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=N1,QGESYIGEZXWVIN-AZNQAGSMSA-N,,0.52,
para-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=NC=C(O)C=C1,AGQGGZNSVNKGDU-UHFFFAOYSA-N,para-O-Sulfate rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=C(OS(=O)(=O)O)C=N1,WAGUBJKZLRLKGR-UHFFFAOYSA-N,,0.61,
N-Desmethyl-ortho-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=C(O)C=CC=N3)C=C2)S1,GWVBGLUFILBNNY-UHFFFAOYSA-N,N-Desmethyl-ortho-O-sulfate rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=C(OS(=O)(=O)O)C=CC=N3)C=C2)S1,HOMPAUSQZJYDFA-UHFFFAOYSA-N,,0.82,
N-Desmethyl-para-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=CC=C(O)C=N3)C=C2)S1,SVUUNTJZVPNZSL-UHFFFAOYSA-N,N-Desmethyl para-O-sulfate rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=CC=C(OS(=O)(=O)O)C=N3)C=C2)S1,ULPCBLHRDLQTTD-UHFFFAOYSA-N,,0.86,
Acetohexamide,CC(=O)C1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1,"InChI=1S/C15H20N2O4S/c1-11(18)12-7-9-14(10-8-12)22(20,21)17-15(19)16-13-5-3-2-4-6-13/h7-10,13H,2-6H2,1H3,(H2,16,17,19)",Hydroxyhexamide,CC(O)C1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1,VQDAEOYLIBGCHE-UHFFFAOYSA-N,,0.85,
Phenoxymethylpenicillin,CC1(C)SC2C(NC(=O)COC3=CC=CC=C3)C(=O)N2C1C(=O)O,"InChI=1S/C16H18N2O5S/c1-16(2)12(15(21)22)18-13(20)11(14(18)24-16)17-10(19)8-23-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1",6-aminopenicillanic acid,CC1(C)SC2C(N)C(=O)N2C1C(=O)O,NGHVIOIJCVXTGV-ALEPSDHESA-N,,0.85,
Phenoxymethylpenicillin,CC1(C)SC2C(NC(=O)COC3=CC=CC=C3)C(=O)N2C1C(=O)O,"InChI=1S/C16H18N2O5S/c1-16(2)12(15(21)22)18-13(20)11(14(18)24-16)17-10(19)8-23-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1",Penicilloic acid,CC1(C)SC(C(NC(=O)CC2=CC=CC=C2)C(=O)O)NC1C(=O)O,HCYWNSXLUZRKJX-UHFFFAOYSA-N,,0.62,
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C21,"InChI=1S/C17H20N2S/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19/h3-6,8-11H,7,12-13H2,1-2H3",3-Hydroxypromazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC(O)=CC=C21,FCWHSDRYYOAXGG-UHFFFAOYSA-N,,0.86,
Zolpidem,CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(C)C=CC3=N2)C=C1,"InChI=1S/C19H21N3O/c1-13-5-8-15(9-6-13)19-16(11-18(23)21(3)4)22-12-14(2)7-10-17(22)20-19/h5-10,12H,11H2,1-4H3",Methoxyzolpidem derivative (M3),CC1=CN2C(CC(=O)N(C)C)=C(C3=CC=C(CO)C=C3)N=C2C=C1,MKLBTYQCCMFWQI-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4, Cytochrome P450 1A2, Cytochrome P450 2D6",0.98,
Zolpidem,CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(C)C=CC3=N2)C=C1,"InChI=1S/C19H21N3O/c1-13-5-8-15(9-6-13)19-16(11-18(23)21(3)4)22-12-14(2)7-10-17(22)20-19/h5-10,12H,11H2,1-4H3",Methoxyzolpidem derivative (M4),CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(CO)C=CC3=N2)C=C1,OIIJRMHQIDOMPL-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 1A2, Cytochrome P450 2D6",0.96,
Methoxyzolpidem derivative (M4),CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(CO)C=CC3=N2)C=C1,OIIJRMHQIDOMPL-UHFFFAOYSA-N,Zolpidem carboxylic acid derivative (M2),CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(C(=O)O)C=CC3=N2)C=C1,RFUGIBAONXDHRM-UHFFFAOYSA-N,,0.95,
Famciclovir,CC(=O)OCC(CCN1C=NC2=CN=C(N)N=C21)COC(C)=O,"InChI=1S/C14H19N5O4/c1-9(20)22-6-11(7-23-10(2)21)3-4-19-8-17-12-5-16-14(15)18-13(12)19/h5,8,11H,3-4,6-7H2,1-2H3,(H2,15,16,18)",6-oxo-famciclovir,CC(=O)OCC(CCN1C=NC2=C1NC(=N)N=C2O)COC(C)=O,KQURMIWGELPUHQ-UHFFFAOYSA-N,Aldehyde oxidase,0.65,
Trifluridine,O=C1NC(=O)N(C2CC(O)C(CO)O2)C=C1C(F)(F)F,"InChI=1S/C10H11F3N2O5/c11-10(12,13)4-2-15(9(19)14-8(4)18)7-1-5(17)6(3-16)20-7/h2,5-7,16-17H,1,3H2,(H,14,18,19)/t5-,6+,7+/m0/s1",5-carboxy-2'-deoxyuridine,O=C(O)C1=CN(C2CC(O)C(CO)O2)C(=O)N=C1O,GAGYTXTVUMXAOC-XVMARJQXSA-N,,0.69,
Allopurinol,OC1=NC=NC2=C1C=NN2,"InChI=1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10)",oxypurinol,O=C1NC(=O)C2=C(NN=C2)N1,HXNFUBHNUDHIGC-UHFFFAOYSA-N,,0.43,
Gemcitabine,NC1=NC(=O)N(C2OC(CO)C(O)C2(F)F)C=C1,"InChI=1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1","2',2'-Difluorodeoxyuridine",O=C1N=C(O)C=CN1C1OC(CO)C(O)C1(F)F,,Cytidine deaminase,0.87,
Gemcitabine,NC1=NC(=O)N(C2OC(CO)C(O)C2(F)F)C=C1,"InChI=1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1",Gemcitabine Monophosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)O)C(O)C2(F)F)C=C1,KNTREFQOVSMROS-QPPQHZFASA-N,"Deoxycytidine kinase, Thymidine kinase 2, mitochondrial",0.92,
Gemcitabine Monophosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)O)C(O)C2(F)F)C=C1,KNTREFQOVSMROS-QPPQHZFASA-N,"2,2-difluorodeoxyuridine monophosphate",O=C1C=CN(C2OC(COP(=O)(O)O)C(O)C2(F)F)C(=O)N1,APSMIPKDENVCML-WETFRILZSA-N,Deoxycytidylate deaminase,0.89,
Gemcitabine Monophosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)O)C(O)C2(F)F)C=C1,KNTREFQOVSMROS-QPPQHZFASA-N,Gemcitabine diphosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)OP(=O)(O)O)C(O)C2(F)F)C=C1,FRQISCZGNNXEMD-QPPQHZFASA-N,UMP-CMP kinase,0.95,
Gemcitabine diphosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)OP(=O)(O)O)C(O)C2(F)F)C=C1,FRQISCZGNNXEMD-QPPQHZFASA-N,Gemcitabine triphosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C2(F)F)C=C1,YMOXEIOKAJSRQX-QPPQHZFASA-N,Nucleoside diphosphate kinase A,0.97,
Teniposide catechol derivative,COC1=CC(C2C3=CC4=C(C=C3C(OC3OC5COC(C6=CC=CS6)OC5C(O)C3O)C3COC(=O)C23)OCO4)=CC(O)=C1O,HFNGFXBXLSRAKX-LRXLMJOTSA-N,Teniposide o-quinone derivative,COC1=CC(C2C3=CC4=C(C=C3C(OC3OC5COC(C6=CC=CS6)OC5C(O)C3O)C3COC(=O)C23)OCO4)=CC(=O)C1=O,SUZOUIWTKWTHGX-LRXLMJOTSA-N,Myeloperoxidase,0.79,
Lansoprazole,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,"InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)",Hydroxylansoprazole,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC(O)=CC=C2N1,,"Cytochrome P450 2C19, Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 2C8",0.94,
Levothyroxine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(=O)O,"InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1",Liothyronine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(=O)O,"InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1",Thyroxine 5-deiodinase,0.99,
Loratadine,CCOC(=O)N1CCC(=C2C3=C(C=C(Cl)C=C3)CCC3=C2N=CC=C3)CC1,"InChI=1S/C22H23ClN2O2/c1-2-27-22(26)25-12-9-15(10-13-25)20-19-8-7-18(23)14-17(19)6-5-16-4-3-11-24-21(16)20/h3-4,7-8,11,14H,2,5-6,9-10,12-13H2,1H3",Descarboethoxyloratadine,ClC1=CC2=C(C=C1)C(=C1CCNCC1)C1=C(C=CC=N1)CC2,JAUOIFJMECXRGI-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2D6, Cytochrome P450 2C19, Cytochrome P450 1A1",0.91,
Prazosin,COC1=C(OC)C=C2C(N)=NC(N3CCN(C(=O)C4=CC=CO4)CC3)=NC2=C1,"InChI=1S/C19H21N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22)","2,4-diamino-6,7-dimethoxyquinazoline",COC1=C(OC)C=C2C(N)=NC(N)=NC2=C1,ZCIPYVXKMWNKLZ-UHFFFAOYSA-N,,0.63,
2-hydroxyimipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(O)=CC=C21,ROTCPJFWLNDKHU-UHFFFAOYSA-N,2-hydroxy-imipramine glucuronide,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C21,CBEJFHYWZSCYSD-LYVDORBWSA-N,,0.56,
Ketorolac,O=C(C1=CC=CC=C1)C1=CC=C2C(C(=O)O)CCN12,"InChI=1S/C15H13NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13/h1-7,11H,8-9H2,(H,18,19)",4-hydroxy ketorolac,O=C(C1=CC=C(O)C=C1)C1=CC=C2C(C(=O)O)CCN12,PIQMOWBWPFGZMW-UHFFFAOYSA-N,,0.97,
Tenoxicam,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=CS2)S1(=O)=O,"InChI=1S/C13H11N3O4S2/c1-16-10(13(18)15-9-4-2-3-6-14-9)11(17)12-8(5-7-21-12)22(16,19)20/h2-7,17H,1H3,(H,14,15,18)",5'-Hydroxytenoxicam,CN1C(=C(O)NC2=NC=C(O)C=C2)C(=O)C2=C(C=CS2)S1(=O)=O,INPPRTDYEGRTIU-RAXLEYEMSA-N,Cytochrome P450 2C9,0.63,
Dronabinol,CCCCCC1=CC2=C(C(O)=C1)C1C=C(C)CCC1C(C)(C)O2,"InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1",11-Hydroxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(CO)=CC21,YCBKSSAWEUDACY-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Cytochrome P450 2C9",0.97,
Dronabinol,CCCCCC1=CC2=C(C(O)=C1)C1C=C(C)CCC1C(C)(C)O2,"InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1",7-beta-Hydroxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1C(O)CC(C)=CC21,DJCKLUPKZRLTPE-CMVHYPBASA-N,Cytochrome P450 3A4,0.92,
Dronabinol,CCCCCC1=CC2=C(C(O)=C1)C1C=C(C)CCC1C(C)(C)O2,"InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1",8-Hydroxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CC(O)C(C)=CC21,INKUWBOHCFHXTJ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.91,
Dronabinol,CCCCCC1=CC2=C(C(O)=C1)C1C=C(C)CCC1C(C)(C)O2,"InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1","9-alpha,10-alpha-epoxyhexahydrocannabinol",CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC3(C)OC3C21,VSQGBNUBIDZRPJ-UHFFFAOYSA-N,"Prostaglandin G/H synthase 1, Cytochrome P450 3A4",0.68,
8-Hydroxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CC(O)C(C)=CC21,INKUWBOHCFHXTJ-UHFFFAOYSA-N,"8,11-Dihydroxy-delta-9-THC",CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CC(O)C(CO)=CC21,XTDYIISRNODHHT-UHFFFAOYSA-N,,0.98,
11-Hydroxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(CO)=CC21,YCBKSSAWEUDACY-UHFFFAOYSA-N,"8,11-Dihydroxy-delta-9-THC",CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CC(O)C(CO)=CC21,XTDYIISRNODHHT-UHFFFAOYSA-N,,0.92,
11-Hydroxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(CO)=CC21,YCBKSSAWEUDACY-UHFFFAOYSA-N,11-Nor-9-carboxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(C(=O)O)=CC21,YOVRGSHRZRJTLZ-UHFFFAOYSA-N,Cytochrome P450 2C9,0.94,
Montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,"InChI=1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-/m1/s1",Montelukast metabolite M1,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,SXJRVQZUUOADNS-FCHGAEMMSA-N,,0.75,
Montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,"InChI=1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-/m1/s1",Montelukast metabolite M2a,CC(C)(O)C1=CC=CC=C1CCC(C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1)S(=O)CC1(CC(=O)O)CC1,QFTNWCBEAVHLQA-XNHCCDLUSA-N,"Cytochrome P450 3A4, Cytochrome P450 2A6",0.91,
Montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,"InChI=1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-/m1/s1",Montelukast metabolite M5a,CC(C)(O)C1=CC=CC=C1C(O)CC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,CHRNGXJVKOMERP-SIOAQITRSA-N,Cytochrome P450 3A4,0.94,
Montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,"InChI=1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-/m1/s1",Montelukast metabolite M6a,CC(O)(CO)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,UFQIEVSCRCMNLW-SHISVWIYSA-N,Cytochrome P450 2C9,0.95,
Norfluoxetine,NCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,WIQRCHMSJFFONW-UHFFFAOYSA-N,Norfluoxetine alcohol,OCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,WMLVVHKCLDWGLW-UHFFFAOYSA-N,,0.86,
4-Trifluoromethylphenol,OC1=CC=C(C(F)(F)F)C=C1,BAYGVMXZJBFEMB-UHFFFAOYSA-N,Hippuric acid,O=C(O)CNC(=O)C1=CC=CC=C1,QIAFMBKCNZACKA-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 3A4",0.15,
Norfluoxetine,NCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,WIQRCHMSJFFONW-UHFFFAOYSA-N,4-Trifluoromethylphenol,OC1=CC=C(C(F)(F)F)C=C1,BAYGVMXZJBFEMB-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 3A4",0.34,
Norfluoxetine,NCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,WIQRCHMSJFFONW-UHFFFAOYSA-N,Norfluoxetine glucuronide,O=C(O)C1OC(ONCCC(OC2=CC=C(C(F)(F)F)C=C2)C2=CC=CC=C2)C(O)C(O)C1O,LUIHTMWIRNJSNW-FRYOACGXSA-N,UDP-glucuronosyltransferases (UGTs),0.46,
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,"InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3",hydroxychlorpromazine,CN(C)CCCN1C2=C(C=C(O)C=C2)SC2=C1C=C(Cl)C=C2,HICFFJZGXWEIHN-UHFFFAOYSA-N,Cytochrome P450 2D6,0.89,
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,"InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3",chlorpromazine-N-oxide,C[N+](C)([O-])CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,LFDFWIIFGRXCFR-UHFFFAOYSA-N,,0.98,
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,"InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3",dedimethylchlorpromazine,NCCCN1C2=C(C=CC=C2)SC2=C1C=C(Cl)C=C2,ZTQZBABFEUDZFE-UHFFFAOYSA-N,,0.98,
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,"InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3",demonomethylchlorpromazine,CNCCCN1C2=C(C=CC=C2)SC2=C1C=C(Cl)C=C2,YHFXGBOUSIKGMZ-UHFFFAOYSA-N,,0.99,
Hydroxycelecoxib,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO)C=C2)C=C1,ICRSYPPLGADZKA-UHFFFAOYSA-N,Carboxycelecoxib,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O)C=C2)C=C1,WTHNOVFEXONZMI-UHFFFAOYSA-N,"Alcohol dehydrogenase 1A, Alcohol dehydrogenase 1B",0.96,
Carboxycelecoxib,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O)C=C2)C=C1,WTHNOVFEXONZMI-UHFFFAOYSA-N,Celecoxib glucuronide,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C=C1,BMBHPAUFWUKYDR-AVPDHNOJSA-N,UDP-glucuronosyltransferases (UGTs),0.69,
Brimonidine,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,"InChI=1S/C11H10BrN5/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8/h1-4H,5-6H2,(H2,15,16,17)",2-oxobrimonidine,O=C1C=NC2=C(C=CC(NC3=NCCN3)=C2Br)N1,BUVCZMAMYHMOPB-UHFFFAOYSA-N,Aldehyde oxidase,0.9,
Brimonidine,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,"InChI=1S/C11H10BrN5/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8/h1-4H,5-6H2,(H2,15,16,17)",3-oxobrimonidine ,OC1=NC2=C(C=CC(NC3=NCCN3)=C2Br)NC1,VYULKJXHCILWPG-UHFFFAOYSA-N,Aldehyde oxidase,0.42,
Pefloxacin,CCN1C=C(C(=O)O)C(=O)C2=CC(F)=C(N3CCN(C)CC3)C=C21,"InChI=1S/C17H20FN3O3/c1-3-20-10-12(17(23)24)16(22)11-8-13(18)15(9-14(11)20)21-6-4-19(2)5-7-21/h8-10H,3-7H2,1-2H3,(H,23,24)",Pefloxacin N-oxide,CC[N+]1([O-])C=C(C(=O)O)C(=O)C2=CC(F)=C(N3CCN(C)CC3)C=C21,LJTKAUAKTFMWRP-UHFFFAOYSA-N,,0.46,
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,"InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2",1-Pyrimidinylpiperazine,C1=CN=C(N2CCNCC2)N=C1,MRBFGEHILMYPTF-UHFFFAOYSA-N,Cytochrome P450 3A4,0.42,
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,"InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2",Buspirone N-oxide,O=C1CC2(CCCC2)CC(=O)N1CCCC[N+]1([O-])CCN(C2=NC=CC=N2)CC1,PXFOIYSPRVISSG-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 2D6",0.86,
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,"InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2",3-Hydroxybuspirone,O=C1CC2(CCC(O)C2)CC(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,RQGHABOPJRYOEZ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.89,
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,"InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2",5-Hydroxybuspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(C2=NC=C(O)C=N2)CC1,WKAUDMPUKWYRBF-UHFFFAOYSA-N,Cytochrome P450 3A4,0.92,
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,"InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2",6'-Hydroxybuspirone,O=C1CC2(CCCC2)C(O)C(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,KOZNAHJIJGCFJJ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.74,
Fosinopril,CCC(=O)OC(OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1CC(C2CCCCC2)CC1C(=O)O)C(C)C,"InChI=1S/C30H46NO7P/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24/h5,7-8,13-14,22,24-26,30H,4,6,9-12,15-21H2,1-3H3,(H,34,35)/t25-,26+,30+,39+/m1/s1",Fosinoprilat,O=C(O)C1CC(C2CCCCC2)CN1C(=O)CP(=O)(O)CCCCC1=CC=CC=C1,WOIWWYDXDVSWAZ-RTWAWAEBSA-N,,0.76,
Cefotaxime,CON=C(C(=O)NC1C(=O)N2C(C(=O)O)=C(COC(C)=O)CSC12)C1=CSC(N)=N1,"InChI=1S/C16H17N5O7S2/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26)/b20-9-/t10-,14-/m1/s1",Desacetyl-cefotaxime,CON=C(C(O)=NC1C(=O)N2C(C(=O)O)=C(CO)CSC12)C1=CSC(=N)N1,FHYWAOQGXIZAAF-GHXIOONMSA-N,,0.76,
Zidovudine,CC1=CN(C2CC(N=[N+]=[N-])C(CO)O2)C(=O)NC1=O,"InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1",3'-azido-3'-deoxy-5'- O-beta-D-glucopyranuronosylthymidine,CC1=CN(C2CC(N=[N+]=[N-])C(COC3OC(C(=O)O)C(O)C(O)C3O)O2)C(=O)N=C1O,NFXAJWJJNLWLOV-OTQDERTISA-N,,0.69,
Zidovudine,CC1=CN(C2CC(N=[N+]=[N-])C(CO)O2)C(=O)NC1=O,"InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1",3'-Aminothymidine,CC1=CN(C2CC(N)C(CO)O2)C(=O)NC1=O,ADVCGXWUUOVPPB-XLPZGREQSA-N,,0.93,
Oxycodone,COC1=C2OC3C(=O)CCC4(O)C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1",noroxycodone,COC1=C2OC3C(=O)CCC4(O)C5CC(=C2C34CCN5)C=C1,RIKMCJUNPCRFMW-ISWURRPUSA-N,Cytochrome P450 3A4,0.98,
Oxycodone,COC1=C2OC3C(=O)CCC4(O)C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1",alpha-oxycodol,COC1=C2OC3C(O)CCC4(O)C5CC(=C2C34CCN5C)C=C1,LHTAJTFGGUDLRH-FHHXKLHRSA-N,,0.93,
oxymorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3(O)C1C5,UQCNKQCJZOAFTQ-ISWURRPUSA-N,beta-oxymorphol,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)CCC3(O)C1C5,AABLHGPVOULICI-LQPBRMSDSA-N,,0.93,
oxymorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3(O)C1C5,UQCNKQCJZOAFTQ-ISWURRPUSA-N,noroxymorphone,O=C1CCC2(O)C3CC4=C5C(=C(O)C=C4)OC1C52CCN3,HLMSIZPQBSYUNL-IPOQPSJVSA-N,Cytochrome P450 3A4,0.98,
noroxycodone,COC1=C2OC3C(=O)CCC4(O)C5CC(=C2C34CCN5)C=C1,RIKMCJUNPCRFMW-ISWURRPUSA-N,alpha-noroxycodol,COC1=C2OC3C(O)CCC4(O)C5CC(=C2C34CCN5)C=C1,KFWOOLJUSYSBAD-NZQXGWJPSA-N,,0.92,
Flutamide,CC(C)C(=O)NC1=CC(C(F)(F)F)=C([N+](=O)[O-])C=C1,"InChI=1S/C11H11F3N2O3/c1-6(2)10(17)15-7-3-4-9(16(18)19)8(5-7)11(12,13)14/h3-6H,1-2H3,(H,15,17)",2-hydroxyflutamide,CC(C)(O)C(O)=NC1=CC(C(F)(F)F)=C([N+](=O)[O-])C=C1,YPQLFJODEKMJEF-UHFFFAOYSA-N,Cytochrome P450 1A2,0.57,
Haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,"InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2",4-(4-chlorophenyl)-4-hydroxypiperidine,OC1(C2=CC=C(Cl)C=C2)CCNCC1,LZAYOZUFUAMFLD-UHFFFAOYSA-N,Cytochrome P450 3A4,0.66,
Haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,"InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2",Reduced haloperidol,OC(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,WNZBBTJFOIOEMP-UHFFFAOYSA-N,"Carbonyl reductase [NADPH] 1, Cytochrome P450 3A4",0.84,
Haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,"InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2","Haloperidol 1,2,3,6-tetrahydropyridine",O=C(CCCN1CC=C(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,ZNOLNAPJKOYTHY-UHFFFAOYSA-N,Cytochrome P450 3A4,0.51,
Haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,"InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2",fluorobenzoylpropionic acid,O=C(O)CCC(=O)C1=CC(F)=C(F)C=C1,GYDFFFKCUNUZEL-UHFFFAOYSA-N,Cytochrome P450 1A2,0.37,
Reduced haloperidol,OC(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,WNZBBTJFOIOEMP-UHFFFAOYSA-N,Haloperidol reduced pyridinium ion derivative,OC(CCC[N+]1=CC=C(C2=CC=C(Cl)C=C2)C=C1)C1=CC=C(F)C=C1,CESYFZMRVQIRNB-UHFFFAOYSA-N,,0.39,
"Haloperidol 1,2,3,6-tetrahydropyridine",O=C(CCCN1CC=C(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,ZNOLNAPJKOYTHY-UHFFFAOYSA-N,Haloperidol pyridinium ion derivative,O=C(CCCN1C=CC(=C2C=CC(=[Cl+])C=C2)C=C1)C1=CC=C(F)C=C1,KAPIKUHBALFONG-UHFFFAOYSA-N,,0.45,
Haloperidol reduced pyridinium ion derivative,OC(CCC[N+]1=CC=C(C2=CC=C(Cl)C=C2)C=C1)C1=CC=C(F)C=C1,CESYFZMRVQIRNB-UHFFFAOYSA-N,Haloperidol pyridinium ion derivative,O=C(CCCN1C=CC(=C2C=CC(=[Cl+])C=C2)C=C1)C1=CC=C(F)C=C1,KAPIKUHBALFONG-UHFFFAOYSA-N,Cytochrome P450 3A4,0.27,
Ritonavir,CC(C)C1=NC(CN(C)C(=O)NC(C(=O)NC(CC2=CC=CC=C2)CC(O)C(CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)C(C)C)=CS1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",Ritonavir metabolite M1,CC(C)C1=NC(CN(C)C(=O)NC(C(=O)NC(CC2=CC=CC=C2)CC(O)C(N)CC2=CC=CC=C2)C(C)C)=CS1,IQKWCORIMSRQGZ-AMEOFWRWSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4",0.86,
Ritonavir,CC(C)C1=NC(CN(C)C(=O)NC(C(=O)NC(CC2=CC=CC=C2)CC(O)C(CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)C(C)C)=CS1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",Ritonavir metabolite M11,CNC(=O)NC(C(=O)NC(CC1=CC=CC=C1)CC(O)C(CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1)C(C)C,UVQJGJZZUNOHCX-MNUOIFNESA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.8,
Ritonavir,CC(C)C1=NC(CN(C)C(=O)NC(C(=O)NC(CC2=CC=CC=C2)CC(O)C(CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)C(C)C)=CS1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",N-Desmethylritonavir,CC(C)C1=NC(CN=C(O)NC(C(O)=NC(CC2=CC=CC=C2)CC(O)C(CC2=CC=CC=C2)N=C(O)OCC2=CN=CS2)C(C)C)=CS1,SQANVQYLDPEULW-QJANCWQKSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4, Cytochrome P450 2D6",0.51,
Ritonavir,CC(C)C1=NC(CN(C)C(=O)NC(C(=O)NC(CC2=CC=CC=C2)CC(O)C(CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)C(C)C)=CS1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",Hydroxy Ritonavir,CC(C)C(NC(=O)N(C)CC1=CSC(C(C)(C)O)=N1)C(=O)NC(CC1=CC=CC=C1)CC(O)C(CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1,CLEDZMPJHBBTNZ-QJANCWQKSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.95,
Dextrothyroxine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(=O)O,"InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m1/s1",Thyroxine sulfate,NC(CC1=CC(I)=C(OC2=CC(I)=C(OS(=O)(=O)O)C(I)=C2)C(I)=C1)C(=O)O,QYXIJUZWSSQICT-LBPRGKRZSA-N,,0.79,
Aminocaproic acid,NCCCCCC(=O)O,"InChI=1S/C6H13NO2/c7-5-3-1-2-4-6(8)9/h1-5,7H2,(H,8,9)",Adipic acid,O=C(O)CCCCC(=O)O,WNLRTRBMVRJNCN-UHFFFAOYSA-N,,0.69,
Dextromethorphan,COC1=CC2=C(C=C1)CC1C3CCCCC23CCN1C,"InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m1/s1",Dextrorphan,CN1CCC23CCCCC2C1CC1=C3C=C(O)C=C1,"InChI=1S/C17H23NO/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17/h5-6,11,14,16,19H,2-4,7-10H2,1H3/t14-,16+,17+/m1/s1","Cytochrome P450 2D6, Cytochrome P450 2C9",0.96,
Dextromethorphan,COC1=CC2=C(C=C1)CC1C3CCCCC23CCN1C,"InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m1/s1",(+)-3-Methoxymorphinan,COC1=CC=C2CC3NCCC4(CCCCC34)C2=C1,ILNSWVUXAPSPEH-PVAVHDDUSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6, Cytochrome P450 2D6, Cytochrome P450 2C9",0.94,
(+)-3-Methoxymorphinan,COC1=CC=C2CC3NCCC4(CCCCC34)C2=C1,ILNSWVUXAPSPEH-PVAVHDDUSA-N,3-Hydroxymorphinan,OC1=CC2=C(C=C1)CC1NCCC23CCCCC13,IYNWSQDZXMGGGI-KBMXLJTQSA-N,Cytochrome P450 2D6,0.96,
3-Hydroxymorphinan,OC1=CC2=C(C=C1)CC1NCCC23CCCCC13,IYNWSQDZXMGGGI-KBMXLJTQSA-N,3-Hydroxymorphinan O-glucuronide,O=C(O)C1OC(OC2=CC3=C(C=C2)CC2NCCC34CCCCC24)C(O)C(O)C1O,QYVMECDBFFRIEZ-DESFNQSRSA-N,"UDP-glucuronosyltransferases (UGTs), UDP-glucuronosyltransferase 2B4, UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 2B15, UDP-glucuronosyltransferase 2B17",0.65,
3-Hydroxymorphinan,OC1=CC2=C(C=C1)CC1NCCC23CCCCC13,IYNWSQDZXMGGGI-KBMXLJTQSA-N,3-Hydroxymorphinan sulfate,O=S(=O)(O)OC1=CC2=C(C=C1)CC1NCCC23CCCCC13,KYOWUZONPGRBFN-KBMXLJTQSA-N,,0.87,
Albendazole,CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2,"InChI=1S/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)",albendazole sulfone,CCCS(=O)(=O)C1=CC2=C(C=C1)N=C(N=C(O)OC)N2,CLSJYOLYMZNKJB-UHFFFAOYSA-N,,0.57,
Albendazole,CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2,"InChI=1S/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)",albendazole sulfoxide,CCCS(=O)C1=CC=C2NC(NC(=O)OC)=NC2=C1,VXTGHWHFYNYFFV-UHFFFAOYSA-N,,0.86,
Trandolapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21,"InChI=1S/C24H34N2O5/c1-3-31-24(30)19(14-13-17-9-5-4-6-10-17)25-16(2)22(27)26-20-12-8-7-11-18(20)15-21(26)23(28)29/h4-6,9-10,16,18-21,25H,3,7-8,11-15H2,1-2H3,(H,28,29)/t16-,18+,19-,20-,21-/m0/s1",Trandolaprilat,CC(NC(CCC1=CC=CC=C1)C(=O)O)C(=O)N1C(C(=O)O)CC2CCCCC21,AHYHTSYNOHNUSH-HXFGRODQSA-N,,0.92,
Trandolapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21,"InChI=1S/C24H34N2O5/c1-3-31-24(30)19(14-13-17-9-5-4-6-10-17)25-16(2)22(27)26-20-12-8-7-11-18(20)15-21(26)23(28)29/h4-6,9-10,16,18-21,25H,3,7-8,11-15H2,1-2H3,(H,28,29)/t16-,18+,19-,20-,21-/m0/s1",Diketopiperazine,O=C1NC(CC2=CN=CN2)C(=O)N2CCCCC12,LCXWQHWWTPOAFI-UWVGGRQHSA-N,,0.4,
Carteolol,CC(C)(C)NCC(O)COC1=CC=CC2=C1CCC(=O)N2,"InChI=1S/C16H24N2O3/c1-16(2,3)17-9-11(19)10-21-14-6-4-5-13-12(14)7-8-15(20)18-13/h4-6,11,17,19H,7-10H2,1-3H3,(H,18,20)",8-Hydroxycarteolol,CC(C)(C)NCC(O)COC1=C2CCC(O)=NC2=C(O)C=C1,TVZJLAKRXHGVOK-UHFFFAOYSA-N,Cytochrome P450 2D6,0.55,
Cyclophosphamide,O=P1(N(CCCl)CCCl)NCCCO1,"InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)",4-Hydroxycyclophosphamide,O=P1(N(CCCl)CCCl)NC(O)CCO1,RANONBLIHMVXAJ-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 2B6, Cytochrome P450 2C19, Cytochrome P450 3A7",0.76,
4-Hydroxycyclophosphamide,O=P1(N(CCCl)CCCl)NC(O)CCO1,RANONBLIHMVXAJ-UHFFFAOYSA-N,4-Ketocyclophosphamide,O=C1CCOP(=O)(N(CCCl)CCCl)N1,VBMZHOCORXMDJU-UHFFFAOYSA-N,Cytochrome P450 3A7,0.62,
4-Hydroxycyclophosphamide,O=P1(N(CCCl)CCCl)NC(O)CCO1,RANONBLIHMVXAJ-UHFFFAOYSA-N,Aldophosphamide,NP(=O)(OCCC=O)N(CCCl)CCCl,QMGUSPDJTPDFSF-UHFFFAOYSA-N,,0.52,
Aldophosphamide,NP(=O)(OCCC=O)N(CCCl)CCCl,QMGUSPDJTPDFSF-UHFFFAOYSA-N,Carboxyphosphamide,NP(=O)(OCCC(=O)O)N(CCCl)CCCl,QLAKAJLYYGOZQL-UHFFFAOYSA-N,,0.92,
Aldophosphamide,NP(=O)(OCCC=O)N(CCCl)CCCl,QMGUSPDJTPDFSF-UHFFFAOYSA-N,Alcophosphamide,NP(=O)(OCCCO)N(CCCl)CCCl,BZGFIGVSVQRQBJ-UHFFFAOYSA-N,"Alcohol dehydrogenase 1A, Alcohol dehydrogenase [NADP(+)]",0.89,
Aldophosphamide,NP(=O)(OCCC=O)N(CCCl)CCCl,QMGUSPDJTPDFSF-UHFFFAOYSA-N,Phosphoramide Mustard,NP(=O)(O)N(CCCl)CCCl,RJXQSIKBGKVNRT-UHFFFAOYSA-N,,0.56,
Mephenytoin,CCC1(C2=CC=CC=C2)NC(=O)N(C)C1=O,"InChI=1S/C12H14N2O2/c1-3-12(9-7-5-4-6-8-9)10(15)14(2)11(16)13-12/h4-8H,3H2,1-2H3,(H,13,16)",S-Nirvanol,CCC1(C2=CC=CC=C2)N=C(O)N=C1O,UDTWZFJEMMUFLC-NSHDSACASA-N,Cytochrome P450 2B6,0.34,
Mephenytoin,CCC1(C2=CC=CC=C2)NC(=O)N(C)C1=O,"InChI=1S/C12H14N2O2/c1-3-12(9-7-5-4-6-8-9)10(15)14(2)11(16)13-12/h4-8H,3H2,1-2H3,(H,13,16)",Nirvanol,CCC1(C2=CC=CC=C2)NC(=O)NC1=O,UDTWZFJEMMUFLC-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2B6",0.86,
Mephenytoin,CCC1(C2=CC=CC=C2)NC(=O)N(C)C1=O,"InChI=1S/C12H14N2O2/c1-3-12(9-7-5-4-6-8-9)10(15)14(2)11(16)13-12/h4-8H,3H2,1-2H3,(H,13,16)",S-4-Hydroxymephenytoin,CCC1(C2=CC=C(O)C=C2)N=C(O)N(C)C1=O,OQPLORUDZLXXPD-LBPRGKRZSA-N,Cytochrome P450 2C19,0.48,
Rofecoxib,CS(=O)(=O)C1=CC=C(C2=C(C3=CC=CC=C3)C(=O)OC2)C=C1,"InChI=1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-10H,11H2,1H3",Dihydro-5-hydroxyrofecoxib,CS(=O)(=O)C1=CC=C(C2C(O)OC(=O)C2C2=CC=CC=C2)C=C1,KETRNDQFHQCNAX-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.42,
Rofecoxib,CS(=O)(=O)C1=CC=C(C2=C(C3=CC=CC=C3)C(=O)OC2)C=C1,"InChI=1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-10H,11H2,1H3","Rofecoxib-threo-3,4-dihydrohydroxy acid",CS(=O)(=O)C1=CC=C(C(CO)C(C(=O)O)C2=CC=CC=C2)C=C1,BBBDYOCLJIKLKC-HZPDHXFCSA-N,Prostaglandin G/H synthase 1,0.4,
"Rofecoxib-erythro-3,4-dihydrohydroxy acid",CS(=O)(=O)C1=CC=C(C(CO)C(C(=O)O)C2=CC=CC=C2)C=C1,BBBDYOCLJIKLKC-JKSUJKDBSA-N,cis-Dihydrorofecoxib,CS(=O)(=O)C1=CC=C(C2COC(=O)C2C2=CC=CC=C2)C=C1,PHCFUFKRCHEUTJ-CVEARBPZSA-N,,0.86,
5-Hydroxyrofecoxib,CS(=O)(=O)C1=CC=C(C2=C(C3=CC=CC=C3)C(=O)OC2O)C=C1,NCBVUSNBLYMFPP-UHFFFAOYSA-N,5-Hydroxyrofecoxib O-glucuronide,CS(=O)(=O)C1=CC=C(C2=C(C3=CC=CC=C3)C(=O)OC2OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,LHTQNDXIYIUWMV-JSXGDUDQSA-N,UDP-glucuronosyltransferases (UGTs),0.64,
Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC1CCC2=CC=CC=C2N(CC(=O)O)C1=O,"InChI=1S/C24H28N2O5/c1-2-31-24(30)20(14-12-17-8-4-3-5-9-17)25-19-15-13-18-10-6-7-11-21(18)26(23(19)29)16-22(27)28/h3-11,19-20,25H,2,12-16H2,1H3,(H,27,28)/t19-,20-/m0/s1",Benazeprilat,O=C(O)CN1C(=O)C(NC(CCC2=CC=CC=C2)C(=O)O)CCC2=CC=CC=C21,"InChI=1S/C22H24N2O5/c25-20(26)14-24-19-9-5-4-8-16(19)11-13-17(21(24)27)23-18(22(28)29)12-10-15-6-2-1-3-7-15/h1-9,17-18,23H,10-14H2,(H,25,26)(H,28,29)/t17-,18-/m0/s1",,0.94,
Zafirlukast,COC1=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2,"InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)",Zafirlukast metabolite M5,COC1=C(CC2=CN(CO)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,HZAQOSFFIGVMDH-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.98,
Zafirlukast,COC1=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2,"InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)",Zafirlukast metabolite M1,COC1=C(CC2=CN(C)C3=C2C=C(N)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,HNBZIIQASMYNPG-UHFFFAOYSA-N,,0.91,
Zafirlukast metabolite M1,COC1=C(CC2=CN(C)C3=C2C=C(N)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,HNBZIIQASMYNPG-UHFFFAOYSA-N,Zafirlukast metabolite M2,COC1=C(CC2=CN(C)C3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,XZEKBYKKJYHZAZ-UHFFFAOYSA-N,"Arylamine N-acetyltransferase 1, Arylamine N-acetyltransferase 2",0.95,
Zafirlukast metabolite M5,COC1=C(CC2=CN(CO)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,HZAQOSFFIGVMDH-UHFFFAOYSA-N,Zafirlukast metabolite M8,COC1=C(CC2=CNC3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,FJVVJMGKCIJNGX-UHFFFAOYSA-N,,0.91,
Zafirlukast metabolite M2,COC1=C(CC2=CN(C)C3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,XZEKBYKKJYHZAZ-UHFFFAOYSA-N,Zafirlukast metabolite M4,COC1=C(CC2=CN(CO)C3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,NWOVAURISFBNOF-UHFFFAOYSA-N,,0.97,
Zafirlukast metabolite M8,COC1=C(CC2=CNC3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,FJVVJMGKCIJNGX-UHFFFAOYSA-N,Zafirlukast metabolite M3,COC1=C(CC2=CNC3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,TVYYLXWJXOTTDN-UHFFFAOYSA-N,,0.92,
Zafirlukast metabolite M4,COC1=C(CC2=CN(CO)C3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,NWOVAURISFBNOF-UHFFFAOYSA-N,Zafirlukast metabolite M3,COC1=C(CC2=CNC3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,TVYYLXWJXOTTDN-UHFFFAOYSA-N,,0.9,
Piroxicam,CN1C(C(=O)NC2=NC=CC=C2)=C(O)C2=C(C=CC=C2)S1(=O)=O,"InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20)",5'-Hydroxypiroxicam,CN1C(C(O)=NC2=NC=C(O)C=C2)=C(O)C2=CC=CC=C2S1(=O)=O,CCKOORANQAQKKV-UHFFFAOYSA-N,Cytochrome P450 2C9,0.69,
Lamotrigine,NC1=NC(N)=C(C2=C(Cl)C(Cl)=CC=C2)N=N1,"InChI=1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)",lamotrigine-2-N-glucuronide,NC1=C(C2=C(Cl)C(Cl)=CC=C2)N=[N+](C2OC(C(=O)O)C(O)C(O)C2O)C(N)=N1,IEVMENHZPOWVGO-XPORZQOISA-O,UDP-glucuronosyltransferases (UGTs),0.48,
Hydroxyzine,OCCOCCN1CCN(C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)CC1,"InChI=1S/C21H27ClN2O2/c22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25/h1-9,21,25H,10-17H2",Cetirizine,O=C(O)COCCN1CCN(C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)CC1,"InChI=1S/C21H25ClN2O3/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26/h1-9,21H,10-16H2,(H,25,26)","Cytochrome P450 3A4, Cytochrome P450 3A5",0.95,
Bosentan metabolite Ro 48-5033,COC1=CC=CC=C1OC1=C(OCCO)N=C(C2=NC=CC=N2)N=C1NS(=O)(=O)C1=CC=C(C(C)(C)CO)C=C1,FAJQMBCLPZWTQJ-UHFFFAOYSA-N,Bosentan metabolite Ro 64-1056,CC(C)(CO)C1=CC=C(S(=O)(=O)NC2=NC(C3=NC=CC=N3)=NC(OCCO)=C2OC2=CC=CC=C2O)C=C1,JXXCMZWROOURSZ-UHFFFAOYSA-N,,0.99,
Bosentan metabolite Ro 47-8634,CC(C)(C)C1=CC=C(S(=O)(=O)NC2=NC(C3=NC=CC=N3)=NC(OCCO)=C2OC2=CC=CC=C2O)C=C1,STTLKJGYAWXIPP-UHFFFAOYSA-N,Bosentan metabolite Ro 64-1056,CC(C)(CO)C1=CC=C(S(=O)(=O)NC2=NC(C3=NC=CC=N3)=NC(OCCO)=C2OC2=CC=CC=C2O)C=C1,JXXCMZWROOURSZ-UHFFFAOYSA-N,,0.98,
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,"InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)","10,11-Epoxycarbamazepine",NC(=O)N1C2=CC=CC=C2C2OC2C2=CC=CC=C21,ZRWWEEVEIOGMMT-UHFFFAOYSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4, Cytochrome P450 2C8",0.49,
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,"InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)","Carbamazepine 2,3-epoxide",NC(=O)N1C2=CC3OC3C=C2C=CC2=CC=CC=C21,AUCXBTOAZTYKIN-UHFFFAOYSA-N,,0.31,
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,"InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)",3-hydroxycarbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=C(O)C=C21,QQCFBZCATDIWTH-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6",0.84,
3-hydroxycarbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=C(O)C=C21,QQCFBZCATDIWTH-UHFFFAOYSA-N,"2,3-Dihydroxycarbamazepine",NC(=O)N1C2=CC=CC=C2C=CC2=CC(O)=C(O)C=C21,YITIUNLDWDJVSI-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 3A4, Cytochrome P450 3A5",0.89,
"Carbamazepine 2,3-epoxide",NC(=O)N1C2=CC3OC3C=C2C=CC2=CC=CC=C21,AUCXBTOAZTYKIN-UHFFFAOYSA-N,2-hydroxycarbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC(O)=CC=C21,VPZIYMMSJFWLSP-UHFFFAOYSA-N,,0.33,
"10,11-Epoxycarbamazepine",NC(=O)N1C2=CC=CC=C2C2OC2C2=CC=CC=C21,ZRWWEEVEIOGMMT-UHFFFAOYSA-N,"10,11-Dihydroxycarbamazepine",N=C(O)N1C2=CC=CC=C2C(O)C(O)C2=CC=CC=C21,PRGQOPPDPVELEG-KBPBESRZSA-N,Epoxide hydrolase 1,0.66,
2-hydroxycarbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC(O)=CC=C21,VPZIYMMSJFWLSP-UHFFFAOYSA-N,2-hydroxyiminostilbene,OC1=CC=C2NC3=CC=CC=C3C=CC2=C1,FKCUOSGTQJAUQX-UHFFFAOYSA-N,Cytochrome P450 3A4,0.62,
Cisatracurium,COC1=C(OC)C=C(CC2C3=C(C=C(OC)C(OC)=C3)CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCC3=C(C=C(OC)C(OC)=C3)C2CC2=CC(OC)=C(OC)C=C2)C=C1,"InChI=1S/C53H72N2O12/c1-54(22-18-38-32-48(62-7)50(64-9)34-40(38)42(54)28-36-14-16-44(58-3)46(30-36)60-5)24-20-52(56)66-26-12-11-13-27-67-53(57)21-25-55(2)23-19-39-33-49(63-8)51(65-10)35-41(39)43(55)29-37-15-17-45(59-4)47(31-37)61-6/h14-17,30-35,42-43H,11-13,18-29H2,1-10H3/q+2/t42-,43-,54-,55-/m1/s1",laudanosine,COC1=C(OC)C=C(CC2C3=CC(OC)=C(OC)C=C3CCN2C)C=C1,KGPAYJZAMGEDIQ-UHFFFAOYSA-N,,0.82,
Vinblastine,CCC1(O)CC2CN(CCC3=C(NC4=C3C=CC=C4)C(C(=O)OC)(C3=C(OC)C=C4C(=C3)C35CCN6CC=CC(CC)(C(OC(C)=O)C(O)(C(=O)OC)C3N4C)C65)C2)C1,"InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37-,38+,39+,42-,43+,44+,45-,46-/m0/s1",Desacetylvinblastine,CCC1(O)CC2CN(CCC3=C(NC4=CC=CC=C34)C(C(=O)OC)(C3=C(OC)C=C4C(=C3)C35CCN6CC=CC(CC)(C(O)C(O)(C(=O)OC)C3N4C)C65)C2)C1,NDMPLJNOPCLANR-CYJJREDESA-N,Cytochrome P450 3A4,0.99,
Fenoprofen,CC(C(=O)O)C1=CC(OC2=CC=CC=C2)=CC=C1,"InChI=1S/C15H14O3/c1-11(15(16)17)12-6-5-9-14(10-12)18-13-7-3-2-4-8-13/h2-11H,1H3,(H,16,17)",Fenoprofen glucuronide,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=CC(OC2=CC=CC=C2)=C1,KXAAUVHIGIFUSM-RVLIQFCMSA-N,,0.38,
Fenoprofen,CC(C(=O)O)C1=CC(OC2=CC=CC=C2)=CC=C1,"InChI=1S/C15H14O3/c1-11(15(16)17)12-6-5-9-14(10-12)18-13-7-3-2-4-8-13/h2-11H,1H3,(H,16,17)",4'-hydroxyfenoprofen glucuronide,CC(C(=O)O)C1=CC(OC2=CC=C(OC3C(O)C(O)OC(C(=O)O)C3O)C=C2)=CC=C1,FPPVBAMKHUAIOP-OYQCQVHHSA-N,,0.4,
Fenfluramine,CCNC(C)CC1=CC=CC(C(F)(F)F)=C1,"InChI=1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3",norfenfluramine,CC(N)CC1=CC(C(F)(F)F)=CC=C1,MLBHFBKZUPLWBD-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 1A2",0.88,
Clonidine,ClC1=CC=CC(Cl)=C1NC1=NCCN1,"InChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)",4-Hydroxyclonidine,OC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1,NTWBRPXHGAXREI-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 1A1, Cytochrome P450 3A5",0.84,
Valaciclovir,CC(C)C(N)C(=O)OCCOCN1C=NC2=C1NC(N)=NC2=O,"InChI=1S/C13H20N6O4/c1-7(2)8(14)12(21)23-4-3-22-6-19-5-16-9-10(19)17-13(15)18-11(9)20/h5,7-8H,3-4,6,14H2,1-2H3,(H3,15,17,18,20)/t8-/m0/s1",Acyclovir,NC1=NC(=O)C2=C(N1)N(COCCO)C=N2,"InChI=1S/C8H11N5O3/c9-8-11-6-5(7(15)12-8)10-3-13(6)4-16-2-1-14/h3,14H,1-2,4H2,(H3,9,11,12,15)",Valacyclovir hydrolase,0.87,
Valdecoxib metabolite M2,CC1=C(C2=CC=C(S(=O)(=O)NO)C=C2)C(C2=CC=CC=C2)=NO1,ONTHNDYCEKOFIC-UHFFFAOYSA-N,Valdecoxib metabolite M7,CC1=C(C2=CC=C(S(=O)O)C=C2)C(C2=CC=CC=C2)=NO1,MCGQPKHGAPQIDC-UHFFFAOYSA-N,,0.84,
Valdecoxib metabolite M2,CC1=C(C2=CC=C(S(=O)(=O)NO)C=C2)C(C2=CC=CC=C2)=NO1,ONTHNDYCEKOFIC-UHFFFAOYSA-N,Valdecoxib metabolite M5,O=S(=O)(NO)C1=CC=C(C2=C(CO)ON=C2C2=CC=CC=C2)C=C1,QUJNXRZCTHMBKO-UHFFFAOYSA-N,,0.92,
Valdecoxib metabolite M1,NS(=O)(=O)C1=CC=C(C2=C(CO)ON=C2C2=CC=CC=C2)C=C1,UJSFKTUZOASIPA-UHFFFAOYSA-N,Valdecoxib metabolite M5,O=S(=O)(NO)C1=CC=C(C2=C(CO)ON=C2C2=CC=CC=C2)C=C1,QUJNXRZCTHMBKO-UHFFFAOYSA-N,,0.96,
Valdecoxib metabolite M1,NS(=O)(=O)C1=CC=C(C2=C(CO)ON=C2C2=CC=CC=C2)C=C1,UJSFKTUZOASIPA-UHFFFAOYSA-N,Valdecoxib metabolite M4,NS(=O)(=O)C1=CC=C(C2=C(C(=O)O)ON=C2C2=CC=CC=C2)C=C1,AEAVMNLZENBJSN-UHFFFAOYSA-N,,0.87,
Valdecoxib metabolite M1,NS(=O)(=O)C1=CC=C(C2=C(CO)ON=C2C2=CC=CC=C2)C=C1,UJSFKTUZOASIPA-UHFFFAOYSA-N,Valdecoxib metabolite M3,NS(=O)(=O)C1=CC=C(C2=C(CO)ON=C2C2=CC(O)=CC=C2)C=C1,PESVSSPYDIXETJ-UHFFFAOYSA-N,,0.92,
Valdecoxib metabolite M9,CC1=C(C2=CC=C(S(N)(=O)=O)C=C2)C(C2=CC(O)=CC=C2)=NO1,IAVWHASLRCBDDK-UHFFFAOYSA-N,Valdecoxib metabolite M3,NS(=O)(=O)C1=CC=C(C2=C(CO)ON=C2C2=CC(O)=CC=C2)C=C1,PESVSSPYDIXETJ-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.92,
Valdecoxib metabolite M7,CC1=C(C2=CC=C(S(=O)O)C=C2)C(C2=CC=CC=C2)=NO1,MCGQPKHGAPQIDC-UHFFFAOYSA-N,Valdecoxib metabolite M8,CC1=C(C2=CC=C(S(=O)(=O)O)C=C2)C(C2=CC=CC=C2)=NO1,LLWOSCPRJRUVST-UHFFFAOYSA-N,,0.96,
Voriconazole,CC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,"InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1",Voriconazole N-Oxide,CC(C1=C(F)C=[N+]([O-])C=N1)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,KPLFPLUCFPRUHU-MGPLVRAMSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 3A7",0.96,
Voriconazole,CC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,"InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1",4-Hydroxyvoriconazole,OCC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,BGPPSFHHAYWTMX-LRDDRELGSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 3A7",0.96,
4-Hydroxyvoriconazole,OCC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,BGPPSFHHAYWTMX-LRDDRELGSA-N,4-Hydroxyvoriconazole 4-O-glucuronide,O=C(O)C1OC(OCC(C2=NC=NC=C2F)C(O)(CN2C=NC=N2)C2=C(F)C=C(F)C=C2)C(O)C(O)C1O,RTNOBOYTQNLUHP-ORKWUBDLSA-N,,0.84,
Voriconazole N-Oxide,CC(C1=C(F)C=[N+]([O-])C=N1)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,KPLFPLUCFPRUHU-MGPLVRAMSA-N,"UK-51,060",O=C(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,XCHRPVARHBCFMJ-UHFFFAOYSA-N,,0.32,
"UK-215,364",OC(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,NQNSXRYFTHGTTO-UHFFFAOYSA-N,Voriconazole O-glucuronide derivative (1),O=C(O)C1OC(OC2=CC(F)=C(C(O)CN3C=NC=N3)C=C2)C(O)C(O)C1O,XNZQDIJYTGCNLO-SHIOMWLHSA-N,,0.43,
Levocarnitine,C[N+](C)(C)CC(O)CC(=O)[O-],"InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/t6-/m1/s1",[3H]-gamma-Butyrobetaine,C[N+](C)(C)CCCC(=O)O,JHPNVNIEXXLNTR-UHFFFAOYSA-O,,0.63,
Enalapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1CCCC1C(=O)O,"InChI=1S/C20H28N2O5/c1-3-27-20(26)16(12-11-15-8-5-4-6-9-15)21-14(2)18(23)22-13-7-10-17(22)19(24)25/h4-6,8-9,14,16-17,21H,3,7,10-13H2,1-2H3,(H,24,25)/t14-,16-,17-/m0/s1",Enalaprilat,CC(NC(CCC1=CC=CC=C1)C(=O)O)C(=O)N1CCCC1C(=O)O,LZFZMUMEGBBDTC-QEJZJMRPSA-N,,0.9,
Nizatidine,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(CN(C)C)=N1,"InChI=1S/C12H21N5O2S2/c1-13-11(6-17(18)19)14-4-5-20-8-10-9-21-12(15-10)7-16(2)3/h6,9,13-14H,4-5,7-8H2,1-3H3",N2-monodes-methylnizatidine,CNCC1=NC(CSCCNC(=C[N+](=O)[O-])NC)=CS1,QDLSRAPBCBFIQC-UXBLZVDNSA-N,,0.95,
Diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)",3'-Hydroxydiclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC(O)=C1Cl,HYPJZSYXUWYJDG-UHFFFAOYSA-N,Cytochrome P450 2C9,0.8,
Fluticasone propionate,CCC(=O)OC1(C(=O)SCF)C(C)CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,"InChI=1S/C25H31F3O5S/c1-5-20(31)33-25(21(32)34-12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15+,16+,18+,19+,22+,23+,24+,25+/m1/s1",fluticasone 17beta-carboxylic acid,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)O,QSVBUQTYFQFEHC-FULJYSEXSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 3A7",0.74,
Thiopental,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,"InChI=1S/C11H18N2O2S/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)",Pentobarbital,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,"InChI=1S/C11H18N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)",,0.74,
Sulindac,CC1=C(CC(=O)O)C2=CC(F)=CC=C2C1=CC1=CC=C(S(C)=O)C=C1,"InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-",Sulindac sulfide,CSC1=CC=C(C=C2C(C)=C(CC(=O)O)C3=C2C=CC(F)=C3)C=C1,LFWHFZJPXXOYNR-MFOYZWKCSA-N,,0.97,
Sulindac,CC1=C(CC(=O)O)C2=CC(F)=CC=C2C1=CC1=CC=C(S(C)=O)C=C1,"InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-",Sulindac sulfone,CC1=C(CC(=O)O)C2=C(C=CC(F)=C2)C1=CC1=CC=C(S(C)(=O)=O)C=C1,MVGSNCBCUWPVDA-UHFFFAOYSA-N,,0.98,
Ethionamide,CCC1=NC=CC(C(N)=S)=C1,"InChI=1S/C8H10N2S/c1-2-7-5-6(8(9)11)3-4-10-7/h3-5H,2H2,1H3,(H2,9,11)",Ethionamide sulphoxide,CCC1=NC=CC(C(N)=S=O)=C1,QDQQNGZRIJPDGA-UHFFFAOYSA-N,,0.87,
Amodiaquine,CCN(CC)CC1=C(O)C=CC(NC2=CC=NC3=CC(Cl)=CC=C23)=C1,"InChI=1S/C20H22ClN3O/c1-3-24(4-2)13-14-11-16(6-8-20(14)25)23-18-9-10-22-19-12-15(21)5-7-17(18)19/h5-12,25H,3-4,13H2,1-2H3,(H,22,23)",desethylamodiaquine,CCNCC1=C(O)C=CC(NC2=CC=NC3=CC(Cl)=CC=C23)=C1,VRXFDHAGFYWGHT-UHFFFAOYSA-N,Cytochrome P450 2C8,0.96,
Furazolidone,O=C1OCCN1N=CC1=CC=C([N+](=O)[O-])O1,"InChI=1S/C8H7N3O5/c12-8-10(3-4-15-8)9-5-6-1-2-7(16-6)11(13)14/h1-2,5H,3-4H2/b9-5+",3-amino-2-oxazolidone,NN1CCOC1=O,KYCJNIUHWNJNCT-UHFFFAOYSA-N,,0.21,
Rifabutin,COC1C=COC2(C)OC3=C(C2=O)C2=C(C(=O)C(=C4NC5(CCN(CC(C)C)CC5)N=C42)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C(O)=C3C,"InChI=1S/C46H62N4O11/c1-22(2)21-50-18-16-46(17-19-50)48-34-31-32-39(54)28(8)42-33(31)43(56)45(10,61-42)59-20-15-30(58-11)25(5)41(60-29(9)51)27(7)38(53)26(6)37(52)23(3)13-12-14-24(4)44(57)47-36(40(32)55)35(34)49-46/h12-15,20,22-23,25-27,30,37-38,41,49,52-54H,16-19,21H2,1-11H3,(H,47,57)/b13-12+,20-15+,24-14-/t23-,25+,26+,27+,30-,37-,38+,41+,45-/m0/s1",27-O-demethylrifabutin,CC(=O)OC1C(C)C(O)C=COC2(C)OC3=C(C2=O)C2=C(C(=O)C(=C4NC5(CCN(CC(C)C)CC5)N=C42)N=C(O)C(C)=CC=CC(C)C(O)C(C)C(O)C1C)C(O)=C3C,BZRNSFHHZZYSST-VBSJQSPRSA-N,Cytochrome P450 3A4,0.95,
Rifabutin,COC1C=COC2(C)OC3=C(C2=O)C2=C(C(=O)C(=C4NC5(CCN(CC(C)C)CC5)N=C42)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C(O)=C3C,"InChI=1S/C46H62N4O11/c1-22(2)21-50-18-16-46(17-19-50)48-34-31-32-39(54)28(8)42-33(31)43(56)45(10,61-42)59-20-15-30(58-11)25(5)41(60-29(9)51)27(7)38(53)26(6)37(52)23(3)13-12-14-24(4)44(57)47-36(40(32)55)35(34)49-46/h12-15,20,22-23,25-27,30,37-38,41,49,52-54H,16-19,21H2,1-11H3,(H,47,57)/b13-12+,20-15+,24-14-/t23-,25+,26+,27+,30-,37-,38+,41+,45-/m0/s1",25-O-deacetylrifabutin,COC1C=COC2(C)OC3=C(C2=O)C2=C(C(=O)C(=C4NC5(CCN(CC(C)C)CC5)N=C42)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(O)C1C)C(O)=C3C,SCGFWNINBXENQT-FMPFFZOVSA-N,,0.99,
Paramethadione,CCC1(C)OC(=O)N(C)C1=O,"InChI=1S/C7H11NO3/c1-4-7(2)5(9)8(3)6(10)11-7/h4H2,1-3H3","5-ethyl-5-methyl-2,4-oxazolidinedione",CCC1(C)OC(=O)N=C1O,MGHNWMRNFGYJKE-UHFFFAOYSA-N,Cytochrome P450 2C9,0.2,
Imatinib,CC1=C(NC2=NC=CC(C3=CN=CC=C3)=N2)C=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1,"InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)",AFN911,CN1CCN(CC2=CC=C(C(=O)NC3=CC(NC4=NC=CC(C5=CN=CC=C5)=N4)C(CO)C=C3)C=C2)CC1,JBSTUPHUZMAVFU-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 1A1, Cytochrome P450 1B1, Cytochrome P450 4F3",0.55,
Imatinib,CC1=C(NC2=NC=CC(C3=CN=CC=C3)=N2)C=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1,"InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)",Piperidine N-oxide imatinib,CC1=C(NC2=[NH+]C=CC(C3=C[N-][CH]C=C3)=N2)C=C(NC(=O)C2=CC=C(CN3CC[N+](C)([O-])CC3)C=C2)C=C1,XCNZJTPSXKIWMO-UHFFFAOYSA-N,"Dimethylaniline monooxygenase [N-oxide-forming] 3, Cytochrome P450 3A4",0.58,
Imatinib,CC1=C(NC2=NC=CC(C3=CN=CC=C3)=N2)C=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1,"InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)",Pyridine N-oxide imatinib,CC1=C(NC2=NC=CC(C3=C[N+]([O-])=CC=C3)=N2)C=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1,QEQWNPDNPZKKNH-UHFFFAOYSA-N,"Dimethylaniline monooxygenase [N-oxide-forming] 3, Cytochrome P450 3A4",0.94,
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",Dihydrotestosterone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,NVKAWKQGWWIWPM-ABEVXSGRSA-N,3-oxo-5-alpha-steroid 4-dehydrogenase 2,0.51,
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",5-alpha-Dihydrotestosterone glucuronide,CC12CCC(=O)CC1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,CLQMBSSRTBUNDV-CPKOJWPQSA-N,,0.32,
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,Cytochrome P450 19A1,0.31,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,,0.78,
Androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Cytochrome P450 19A1,0.31,
Dihydrotestosterone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,NVKAWKQGWWIWPM-ABEVXSGRSA-N,5-alpha-Dihydrotestosterone glucuronide,CC12CCC(=O)CC1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,CLQMBSSRTBUNDV-CPKOJWPQSA-N,,0.33,
Dihydrotestosterone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,NVKAWKQGWWIWPM-ABEVXSGRSA-N,5a-Dihydrotestosterone sulfate,CC12CCC(=O)CC1CCC1C2CCC2(C)C(OS(=O)(=O)O)CCC12,KYVPWJSGFKNNLD-ABEVXSGRSA-N,,0.62,
Dihydrotestosterone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,NVKAWKQGWWIWPM-ABEVXSGRSA-N,"5alpha-androstane-3alpha,17beta-diol",CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2O,"InChI=1S/C19H32O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-17,20-21H,3-11H2,1-2H3/t12-,13+,14-,15-,16-,17-,18-,19-/m0/s1",,0.77,
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,,0.78,
Niacin,O=C(O)C1=CN=CC=C1,"InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)",Niacinamide,NC(=O)C1=CC=CN=C1,,,0.47,
Niacin,O=C(O)C1=CN=CC=C1,"InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)",Trigonelline,C[N+]1=CC=CC(C(=O)[O-])=C1,,,0.7,
Clorazepic acid,O=C(O)C1N=C(C2=CC=CC=C2)C2=C(C=CC(Cl)=C2)NC1=O,"InChI=1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,14H,(H,18,20)(H,21,22)",Nordazepam,O=C1CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N1,"InChI=1S/C15H11ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)",Cytochrome P450 3A4,0.8,
Nordazepam,O=C1CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N1,"InChI=1S/C15H11ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)",Oxazepam,O=C1NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=NC1O,ADIMAYPTOBDMTL-UHFFFAOYSA-N,,0.87,
Nordazepam,O=C1CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N1,"InChI=1S/C15H11ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)",p-Hydroxynordiazepam,O=C1CN=C(C2=CC=C(O)C=C2)C2=CC(Cl)=CC=C2N1,WVHIBVZUJQMFON-UHFFFAOYSA-N,,0.95,
Guanabenz,NC(N)=NN=CC1=C(Cl)C=CC=C1Cl,"InChI=1S/C8H8Cl2N4/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12/h1-4H,(H4,11,12,14)/b13-4+",Guanoxabenz,N=C(NO)NN=CC1=C(Cl)C=CC=C1Cl,"InChI=1S/C8H8Cl2N4O/c9-6-2-1-3-7(10)5(6)4-12-13-8(11)14-15/h1-4,15H,(H3,11,13,14)/b12-4+",Cytochrome P450 1A2,0.66,
Clofarabine,NC1=C2N=CN(C3OC(CO)C(O)C3F)C2=NC(Cl)=N1,"InChI=1S/C10H11ClFN5O3/c11-10-15-7(13)5-8(16-10)17(2-14-5)9-4(12)6(19)3(1-18)20-9/h2-4,6,9,18-19H,1H2,(H2,13,15,16)/t3-,4+,6-,9-/m1/s1",clofarabind-5'-monophosphate,NC1=C2N=CN(C3OC(COP(=O)(O)O)C(O)C3F)C2=NC(Cl)=N1,JEJRVFQHFJDNJN-CQOARYKOSA-N,Deoxycytidine kinase,0.94,
Prednisone,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,"InChI=1S/C21H26O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-15,18,22,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1",Prednisolone,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,OIGNJSKKLXVSLS-VWUMJDOOSA-N,Cytochrome P450 3A4,0.83,
Astemizole,COC1=CC=C(CCN2CCC(NC3=NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,"InChI=1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)",Tecastemizole,FC1=CC=C(CN2C(NC3CCNCC3)=NC3=CC=CC=C32)C=C1,"InChI=1S/C19H21FN4/c20-15-7-5-14(6-8-15)13-24-18-4-2-1-3-17(18)23-19(24)22-16-9-11-21-12-10-16/h1-8,16,21H,9-13H2,(H,22,23)",Cytochrome P450 3A4,0.85,
Astemizole,COC1=CC=C(CCN2CCC(NC3=NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,"InChI=1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)",desmethylastemizole,OC1=CC=C(CCN2CCC(NC3=NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,LAGYWHSFHIMTPE-UHFFFAOYSA-N,Cytochrome P450 3A4,0.98,
Adenosine,NC1=C2N=CN(C3OC(CO)C(O)C3O)C2=NC=N1,"InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",Adenosine monophosphate,NC1=C2N=CN(C3OC(COP(=O)(O)O)C(O)C3O)C2=NC=N1,UDMBCSSLTHHNCD-KQYNXXCUSA-N,Adenosine kinase,0.93,
Adenosine,NC1=C2N=CN(C3OC(CO)C(O)C3O)C2=NC=N1,"InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",Inosine,O=C1N=CNC2=C1N=CN2C1OC(CO)C(O)C1O,UGQMRVRMYYASKQ-KQYNXXCUSA-N,Adenosine deaminase,0.82,
Inosine,O=C1N=CNC2=C1N=CN2C1OC(CO)C(O)C1O,UGQMRVRMYYASKQ-KQYNXXCUSA-N,Hypoxanthine,O=C1N=CNC2=C1NC=N2,FDGQSTZJBFJUBT-UHFFFAOYSA-N,Purine nucleoside phosphorylase,0.28,
Xanthine,O=C1NC(=O)C2=C(N=CN2)N1,LRFVTYWOQMYALW-UHFFFAOYSA-N,Uric acid,O=C1NC(=O)C2=C(N1)NC(=O)N2,LEHOTFFKMJEONL-UHFFFAOYSA-N,Xanthine dehydrogenase/oxidase,0.92,
Simvastatin,CCC(C)(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,"InChI=1S/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1",simvastatin hydroxy acid,CCC(C)(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC(O)CC(O)CC(=O)O)C21,XWLXKKNPFMNSFA-HGQWONQESA-N,Cytochrome P450 3A4,0.93,
Mebendazole,COC(=O)NC1=NC2=C(C=C(C(=O)C3=CC=CC=C3)C=C2)N1,"InChI=1S/C16H13N3O3/c1-22-16(21)19-15-17-12-8-7-11(9-13(12)18-15)14(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,17,18,19,21)",2-amino-5-benzoylbenzimidazole,N=C1NC2=C(C=C(C(=O)C3=CC=CC=C3)C=C2)N1,GPMHHSJZGVOEFS-UHFFFAOYSA-N,,0.66,
Leucovorin,NC1=NC2=C(C(=O)N1)N(C=O)C(CNC1=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C1)CN2,"InChI=1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32)/t12?,13-/m0/s1",5-Methyltetrahydrofolate,CN1C2=C(N=C(N)NC2=O)NCC1CNC1=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C1,ZNOVTXRBGFNYRX-ZGTCLIOFSA-N,,0.95,
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1",Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,JKKFKPJIXZFSSB-CBZIJGRNSA-N,,0.83,
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1",Estrone glucuronide,CC12CCC3C4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4CCC3C1CCC2=O,FJAZVHYPASAQKM-JBAURARKSA-N,,0.55,
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1",4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,Cytochrome P450 3A4,0.85,
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1",2-Hydroxyestrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)[O-])C(O)=C4)CCC3C1CCC2=O,DTMWSKSAMRZGQH-PEDDLLMLSA-M,,0.76,
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1",4-Hydroxyestrone sulfate,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(OS(=O)(=O)O)C=C4,QIJNCQNMZUTUIF-KQWCVQSUSA-N,,0.69,
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1",2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4",0.96,
Trazodone,O=C1N(CCCN2CCN(C3=CC(Cl)=CC=C3)CC2)N=C2C=CC=CN12,"InChI=1S/C19H22ClN5O/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25/h1-3,5-7,9,15H,4,8,10-14H2",m-chlorophenylpiperazine (m-CPP) ,ClC1=CC=CC(N2CCNCC2)=C1,VHFVKMTVMIZMIK-UHFFFAOYSA-N,Cytochrome P450 3A4,0.28,
Trazodone,O=C1N(CCCN2CCN(C3=CC(Cl)=CC=C3)CC2)N=C2C=CC=CN12,"InChI=1S/C19H22ClN5O/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25/h1-3,5-7,9,15H,4,8,10-14H2",triazolopyridinone epoxide,O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C2C3OC3C=CN21,QFERKVDPWYTEPE-UHFFFAOYSA-N,,0.47,
Trazodone,O=C1N(CCCN2CCN(C3=CC(Cl)=CC=C3)CC2)N=C2C=CC=CN12,"InChI=1S/C19H22ClN5O/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25/h1-3,5-7,9,15H,4,8,10-14H2",4'-hydroxytrazodone ,O=C1N(CCCN2CCN(C3=CC(Cl)=C(O)C=C3)CC2)N=C2C=CC=CN12,FNUZSRSXQFIOPL-UHFFFAOYSA-N,,0.95,
Verapamil,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,"InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3",Verapamil metabolite D-617,CNCCCC(C#N)(C1=CC(OC)=C(OC)C=C1)C(C)C,WLOBUUJURNEQCL-UHFFFAOYSA-N,Cytochrome P450 2C8,0.88,
Verapamil,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,"InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3",Norverapamil,COC1=C(OC)C=C(CCNCCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,UPKQNCPKPOLASS-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 1A2",0.95,
O-Desmethylverapamil (D-702),COC1=C(O)C=C(CCN(C)CCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,OAAPYTCHFIIVON-UHFFFAOYSA-N,Verapamil metabolite D-620,COC1=C(OC)C=C(C(C#N)(CCCN)C(C)C)C=C1,UCWOSFAANAZHKR-UHFFFAOYSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4",0.86,
Verapamil metabolite D-617,CNCCCC(C#N)(C1=CC(OC)=C(OC)C=C1)C(C)C,WLOBUUJURNEQCL-UHFFFAOYSA-N,Verapamil metabolite D-620,COC1=C(OC)C=C(C(C#N)(CCCN)C(C)C)C=C1,UCWOSFAANAZHKR-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.98,
Verapamil metabolite D-617,CNCCCC(C#N)(C1=CC(OC)=C(OC)C=C1)C(C)C,WLOBUUJURNEQCL-UHFFFAOYSA-N,Verapamil metabolite PR-25,CNCCCC(C#N)(C1=CC(OC)=C(O)C=C1)C(C)C,VNRFDZGJCSCHFU-UHFFFAOYSA-N,,0.98,
Norverapamil,COC1=C(OC)C=C(CCNCCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,UPKQNCPKPOLASS-UHFFFAOYSA-N,Verapamil metabolite D-715 (PR-22),COC1=C(O)C=C(C(C#N)(CCCNCCC2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,VAUMWVGUBVPENJ-UHFFFAOYSA-N,Cytochrome P450 2C8,0.99,
Norverapamil,COC1=C(OC)C=C(CCNCCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,UPKQNCPKPOLASS-UHFFFAOYSA-N,Verapamil metabolite D-620,COC1=C(OC)C=C(C(C#N)(CCCN)C(C)C)C=C1,UCWOSFAANAZHKR-UHFFFAOYSA-N,Cytochrome P450 2C8,0.9,
Epinephrine,CNCC(O)C1=CC(O)=C(O)C=C1,"InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1",Epinephrine sulfate,CNCC(O)C1=CC(O)=C(OS(=O)(=O)O)C=C1,AELFRHHZGTVYGJ-QMMMGPOBSA-N,,0.66,
Epinephrine,CNCC(O)C1=CC(O)=C(O)C=C1,"InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1",Metanephrine,CNCC(O)C1=CC(OC)=C(O)C=C1,,Catechol O-methyltransferase,0.82,
Epinephrine,CNCC(O)C1=CC(O)=C(O)C=C1,"InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1",Epinephrine glucuronide,CNCC(O)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C(O)=C1,BLTFFSZSAZRUSC-FYRJOLOESA-N,UDP-glucuronosyltransferase 1-3,0.33,
Chlorpropamide,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,"InChI=1S/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14)",2-Hydroxychlorpropamide,CCCN=C(O)NS(=O)(=O)C1=C(O)C=C(Cl)C=C1,QRXRPQPWKRLTQX-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.4,
Chlorpropamide,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,"InChI=1S/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14)",3-Hydroxychlorpropamide,CCCN=C(O)NS(=O)(=O)C1=CC(O)=C(Cl)C=C1,RXFPYNAVFFDUJE-UHFFFAOYSA-N,,0.41,
Chlorpropamide,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,"InChI=1S/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14)",4-Chlorobenzenesulfonylurea,NC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,AZEPYUPSYWCRBG-UHFFFAOYSA-N,,0.8,
Aprepitant,CC(OC1OCCN(CC2=NNC(=O)N2)C1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,"InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1","(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine",CC(OC1OCCNC1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,AFBDSAJOMZYQAI-CNOZUTPLSA-N,Cytochrome P450 3A4,0.74,
Tamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,"InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-",Tamoxifen N-oxide,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[O-])C=C1)C1=CC=CC=C1,YAASNACECBQAFW-QPLCGJKRSA-N,"Dimethylaniline monooxygenase [N-oxide-forming] 1, Dimethylaniline monooxygenase [N-oxide-forming] 3",0.95,
4-hydroxytamoxifen sulfate,CCC(=C(C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OS(=O)(=O)O)C=C1)C1=CC=CC=C1,CFSXIBDXCWVFJR-QPLCGJKRSA-N,Endoxifen (4-hydroxy-N-desmethyltamoxifen),CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,MHJBZVSGOZTKRH-IZHYLOQSSA-N,"Sulfotransferase 1A1, Estrogen sulfotransferase",0.82,
Endoxifen (4-hydroxy-N-desmethyltamoxifen),CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,MHJBZVSGOZTKRH-IZHYLOQSSA-N,4-hydroxytamoxifen sulfate,CCC(=C(C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OS(=O)(=O)O)C=C1)C1=CC=CC=C1,CFSXIBDXCWVFJR-QPLCGJKRSA-N,"Sulfotransferase 1A1, Estrogen sulfotransferase",0.82,
Losartan,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,"InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28)",Losartan carboxaldehyde,CCCCC1=NC(Cl)=C(C=O)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,FQZSMTSTFMNWQF-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.86,
Losartan,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,"InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28)",Losartan N2-glucuronide,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN(C3OC(C(=O)O)C(O)C(O)C3O)N=N2)C=C1,NGFMQMUIOUSHGR-RTCYWULBSA-N,"UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 1-10, UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 2B17",0.68,
Losartan,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,"InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28)",Losartan carboxylic acid,CCCCC1=NC(Cl)=C(C(=O)O)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,ZEUXAIYYDDCIRX-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 3A5",0.9,
Losartan carboxaldehyde,CCCCC1=NC(Cl)=C(C=O)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,FQZSMTSTFMNWQF-UHFFFAOYSA-N,Losartan carboxylic acid,CCCCC1=NC(Cl)=C(C(=O)O)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,ZEUXAIYYDDCIRX-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.9,
Warfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3",S-7-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC(O)=CC=C2C1=O,BQSUFDMOXLLKQK-HNNXBMFYSA-N,Cytochrome P450 2C9,0.66,
Warfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3",S-6-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC(O)=C2)OC1=O,IQWPEJBUOJQPDE-AWEZNQCLSA-N,Cytochrome P450 2C9,0.96,
Warfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3",S-4'-Hydroxywarfarin,CC(=O)CC(C1=CC=C(O)C=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,RRZWAMPDGRWRPF-OAHLLOKOSA-N,"Cytochrome P450 2C18, Cytochrome P450 2C19",0.98,
Warfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3",R-10(S)-Hydroxywarfarin,CC(=O)C(O)C(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,BPZSPAZBZFZZBN-NVXWUHKLSA-N,Cytochrome P450 3A4,0.89,
Warfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3",R-8-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(OC1=O)C(O)=CC=C2,BHBOXPNWDGYJNB-CQSZACIVSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C19",0.93,
Warfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3",R-7-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=C(O)C=C2)OC1=O,SKFYEJMLNMTTJA-OAHLLOKOSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C8",0.99,
Midazolam,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N21,"InChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3",1-hydroxymidazolam,OCC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N21,QHSMEGADRFZVNE-UHFFFAOYSA-N,Cytochrome P450 3A4,0.95,
Midazolam,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N21,"InChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3",4-hydroxymidazolam,CC1=NC=C2C(O)N=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N21,ZYISITHKPKHPKG-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.91,
Mycophenolate mofetil,COC1=C(CC=C(C)CCC(=O)OCCN2CCOCC2)C(O)=C2C(=O)OCC2=C1C,"InChI=1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+",Mycophenolic acid,COC1=C(CC=C(C)CCC(=O)O)C(O)=C2C(=O)OCC2=C1C,"InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+","Liver carboxylesterase 1, Carboxylic ester hydrolase",0.93,
Mycophenolate mofetil,COC1=C(CC=C(C)CCC(=O)OCCN2CCOCC2)C(O)=C2C(=O)OCC2=C1C,"InChI=1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+",Mycophenolic acid glucuronide,COC1=C(CC=C(C)CCC(=O)O)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C2C(=O)OCC2=C1C,BYFGTSAYQQIUCN-WTKPLQERSA-N,"UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-8, UDP-glucuronosyltransferase 1-7, UDP-glucuronosyltransferase 1-10",0.66,
Flurazepam,CCN(CC)CCN1C(=O)CN=C(C2=CC=CC=C2F)C2=C1C=CC(Cl)=C2,"InChI=1S/C21H23ClFN3O/c1-3-25(4-2)11-12-26-19-10-9-15(22)13-17(19)21(24-14-20(26)27)16-7-5-6-8-18(16)23/h5-10,13H,3-4,11-12,14H2,1-2H3",Hydroxyethylflurazepam,CCN(CCO)CCN1C(=O)CN=C(C2=CC=CC=C2F)C2=CC(Cl)=CC=C21,IRYBKIZHCXMFFO-UHFFFAOYSA-N,,0.98,
Flurazepam,CCN(CC)CCN1C(=O)CN=C(C2=CC=CC=C2F)C2=C1C=CC(Cl)=C2,"InChI=1S/C21H23ClFN3O/c1-3-25(4-2)11-12-26-19-10-9-15(22)13-17(19)21(24-14-20(26)27)16-7-5-6-8-18(16)23/h5-10,13H,3-4,11-12,14H2,1-2H3",Norflurazepam,O=C1CN=C(C2=C(F)C=CC=C2)C2=C(C=CC(Cl)=C2)N1,UVCOILFBWYKHHB-UHFFFAOYSA-N,,0.83,
Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1CC2=CC(OC)=C(OC)C=C2CC1C(=O)O,"InChI=1S/C27H34N2O7/c1-5-36-27(33)21(12-11-18-9-7-6-8-10-18)28-17(2)25(30)29-16-20-15-24(35-4)23(34-3)14-19(20)13-22(29)26(31)32/h6-10,14-15,17,21-22,28H,5,11-13,16H2,1-4H3,(H,31,32)/t17-,21-,22-/m0/s1",Moexiprilat,COC1=C(OC)C=C2CN(C(=O)C(C)NC(CCC3=CC=CC=C3)C(=O)O)C(C(=O)O)CC2=C1,CMPAGYDKASJORH-YSSFQJQWSA-N,,0.95,
Furosemide,NS(=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(C(=O)O)=C1,"InChI=1S/C12H11ClN2O5S/c13-9-5-10(15-6-7-2-1-3-20-7)8(12(16)17)4-11(9)21(14,18)19/h1-5,15H,6H2,(H,16,17)(H2,14,18,19)",4-chloro-5-sulfamoylanthranilic acid,NC1=CC(Cl)=C(S(N)(=O)=O)C=C1C(=O)O,QQLJBZFXGDHSRU-UHFFFAOYSA-N,,0.75,
Nitrofurantoin,O=C1CN(N=CC2=CC=C([N+](=O)[O-])O2)C(=O)N1,"InChI=1S/C8H6N4O5/c13-6-4-11(8(14)10-6)9-3-5-1-2-7(17-5)12(15)16/h1-3H,4H2,(H,10,13,14)/b9-3+",Aminofurantoin,NC1=CC=C(C=NN2CC(O)=NC2=O)O1,KLJOOBXQOIHZQM-UHFFFAOYSA-N,,0.48,
Nicergoline,COC12CC(COC(=O)C3=CN=CC(Br)=C3)CN(C)C1CC1=CN(C)C3=CC=CC2=C13,"InChI=1S/C24H26BrN3O3/c1-27-13-17-8-21-24(30-3,19-5-4-6-20(27)22(17)19)9-15(12-28(21)2)14-31-23(29)16-7-18(25)11-26-10-16/h4-7,10-11,13,15,21H,8-9,12,14H2,1-3H3/t15-,21-,24+/m1/s1","10-alpha-methoxy-9,10-dihydrolysergol",COC12CC(CO)CN(C)C1CC1=CNC3=CC=CC2=C13,JGQZSBLQHCTAJF-NFXPUDJFSA-N,Cytochrome P450 2D6,0.88,
Naltrexone,O=C1CCC2(O)C3CC4=C5C(=C(O)C=C4)OC1C52CCN3CC1CC1,"InChI=1S/C20H23NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,15,18,22,24H,1-2,5-10H2/t15-,18+,19+,20-/m1/s1",6-beta-naltrexol,OC1=C2OC3C(O)CCC4(O)C5CC(=C2C34CCN5CC2CC2)C=C1,JLVNEHKORQFVQJ-UHFFFAOYSA-N,,0.93,
Delavirdine,CC(C)NC1=C(N2CCN(C(=O)C3=CC4=C(C=CC(NS(C)(=O)=O)=C4)N3)CC2)N=CC=C1,"InChI=1S/C22H28N6O3S/c1-15(2)24-19-5-4-8-23-21(19)27-9-11-28(12-10-27)22(29)20-14-16-13-17(26-32(3,30)31)6-7-18(16)25-20/h4-8,13-15,24-26H,9-12H2,1-3H3",N-desalkyl delavirdine,CS(=O)(=O)NC1=CC=C2NC(C(=O)N3CCN(C4=C(N)C=CC=N4)CC3)=CC2=C1,MTEFFPTUUPAKOV-UHFFFAOYSA-N,Cytochrome P450 3A4,0.93,
Lamivudine,NC1=NC(=O)N(C2CSC(CO)O2)C=C1,"InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1",Lamivudine sulfoxide,NC1=NC(=O)N(C2CS(=O)C(CO)O2)C=C1,LJMQAXFNQNADRZ-FYZWQCAOSA-N,Sulfotransferase 1A1,0.87,
Lamivudine,NC1=NC(=O)N(C2CSC(CO)O2)C=C1,"InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1",Lamivudine-monophosphate,NC1=NC(=O)N(C2CSC(COP(=O)(O)O)O2)C=C1,WUMZLKDCOINBEA-UHFFFAOYSA-N,,0.9,
Lamivudine,NC1=NC(=O)N(C2CSC(CO)O2)C=C1,"InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1",Lamivudine-triphosphate,NC1=NC(=O)N(C2CSC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)C=C1,YLEQMGZZMCJKCN-UHFFFAOYSA-N,,0.78,
Flurbiprofen,CC(C(=O)O)C1=CC(F)=C(C2=CC=CC=C2)C=C1,"InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)",4'-Hydroxyflurbiprofen,CC(C(=O)O)C1=CC(F)=C(C2=CC=C(O)C=C2)C=C1,GTSMMBJBNJDFRA-UHFFFAOYSA-N,Cytochrome P450 2C9,0.92,
Flurbiprofen,CC(C(=O)O)C1=CC(F)=C(C2=CC=CC=C2)C=C1,"InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)",Flurbiprofen glucuronide,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC(F)=C(C2=CC=CC=C2)C=C1,PLPQBSOCUVSKTP-QGCNQZRGSA-N,"UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 2B4",0.46,
Adefovir dipivoxil,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C21)OCOC(=O)C(C)(C)C,"InChI=1S/C20H32N5O8P/c1-19(2,3)17(26)30-11-32-34(28,33-12-31-18(27)20(4,5)6)13-29-8-7-25-10-24-14-15(21)22-9-23-16(14)25/h9-10H,7-8,11-13H2,1-6H3,(H2,21,22,23)",Adefovir,NC1=C2N=CN(CCOCP(=O)(O)O)C2=NC=N1,SUPKOOSCJHTBAH-UHFFFAOYSA-N,,0.81,
Adefovir,NC1=C2N=CN(CCOCP(=O)(O)O)C2=NC=N1,SUPKOOSCJHTBAH-UHFFFAOYSA-N,Adefovir monophosphate,NC1=C2N=CN(CCOCP(=O)(O)OP(=O)(O)O)C2=NC=N1,VQIHLCFUFNQXPS-UHFFFAOYSA-N,"Adenylate kinase isoenzyme 1, Adenylate kinase 2, mitochondrial",0.87,
Adefovir monophosphate,NC1=C2N=CN(CCOCP(=O)(O)OP(=O)(O)O)C2=NC=N1,VQIHLCFUFNQXPS-UHFFFAOYSA-N,Adefovir Diphosphate,NC1=C2N=CN(CCOCP(=O)(O)OP(=O)(O)OP(=O)(O)O)C2=NC=N1,MELHEUHXJKQZNC-UHFFFAOYSA-N,"Nucleoside diphosphate kinase A, Nucleoside diphosphate kinase B",0.91,
Procaine,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1,"InChI=1S/C13H20N2O2/c1-3-15(4-2)9-10-17-13(16)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3",para-aminobenzoic acid,NC1=CC=C(C(=O)O)C=C1,ALYNCZNDIQEVRV-UHFFFAOYSA-N,Cholinesterase,0.57,
Nateglinide,CC(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,"InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1",Nateglinide metabolite M2/M3,CC(CO)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,GMHTWYIGIMINLF-OKEQZYBDSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.96,
Nateglinide,CC(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,"InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1",Nateglinide metabolite M1,CC(C)(O)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,IUMHIIXPABZGRF-YTPLPTRZSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.91,
Nateglinide,CC(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,"InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1",Nateglinide metabolite M7,C=C(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,QKNIFXOGUWQRIF-YJEKIOLLSA-N,,0.92,
Nateglinide,CC(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,"InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1",Nateglinide glucuronide and isomers (M4/M5/M6),CC(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)OC2OC(C(=O)O)C(O)C(O)C2O)CC1,YTIRWNSTJVSCRW-VJQMJTOBSA-N,UDP-glucuronosyltransferases (UGTs),0.48,
Nateglinide metabolite M1,CC(C)(O)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,IUMHIIXPABZGRF-YTPLPTRZSA-N,Nateglinide metabolite M11/M12,CC(O)(CO)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,IQRZZFUXRZWAPZ-XZZQLLPFSA-N,,0.96,
Nateglinide metabolite M7,C=C(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,QKNIFXOGUWQRIF-YJEKIOLLSA-N,Nateglinide metabolite M11/M12,CC(O)(CO)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,IQRZZFUXRZWAPZ-XZZQLLPFSA-N,,0.81,
Risperidone,CC1=C(CCN2CCC(C3=NOC4=C3C=CC(F)=C4)CC2)C(=O)N2CCCCC2=N1,"InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3",9-hydroxyrisperidone,CC1=C(CCN2CCC(C3=NOC4=C3C=CC(F)=C4)CC2)C(=O)N2CCCC(O)C2=N1,PMXMIIMHBWHSKN-UHFFFAOYSA-N,Cytochrome P450 2D6,0.94,
Esomeprazole,COC1=CC2=C(C=C1)NC(S(=O)CC1=NC=C(C)C(OC)=C1C)=N2,"InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)/t24-/m0/s1",Active Metabolite of Esomeprazole,COC1=CC2=C(C=C1)N=C1N2SCC2=C(C)C(OC)=C(C)C=[N+]12,NNKKOITVFGCNKQ-UHFFFAOYSA-N,,0.52,
Esomeprazole,COC1=CC2=C(C=C1)NC(S(=O)CC1=NC=C(C)C(OC)=C1C)=N2,"InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)/t24-/m0/s1",Omeprazole sulfone,COC1=CC2=C(C=C1)N=C(S(=O)(=O)CC1=C(C)C(OC)=C(C)C=N1)N2,IXEQEYRTSRFZEO-UHFFFAOYSA-N,Cytochrome P450 3A4,0.94,
Esomeprazole,COC1=CC2=C(C=C1)NC(S(=O)CC1=NC=C(C)C(OC)=C1C)=N2,"InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)/t24-/m0/s1",5-hydroxyesomeprazole,COC1=CC2=C(C=C1)N=C(S(=O)CC1=NC=C(CO)C(OC)=C1C)N2,CMZHQFXXAAIBKE-UHFFFAOYSA-N,Cytochrome P450 2C19,0.94,
Hydrocortisone,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,"InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",Cortisone,CC12CCC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,"InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-15,18,22,26H,3-8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1","Corticosteroid 11-beta-dehydrogenase isozyme 1, Corticosteroid 11-beta-dehydrogenase isozyme 2",0.83,
Cortisone,CC12CCC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,"InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-15,18,22,26H,3-8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1",Tetrahydrocortisone,CC12CCC(O)CC1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,,,0.66,
Cortisone,CC12CCC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,"InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-15,18,22,26H,3-8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1",Dihydrocortisol,CC12CCC(=O)CC1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,,,0.6,
Mannitol,OCC(O)C(O)C(O)C(O)CO,"InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4-,5-,6-/m1/s1",Glycogen,OCC1OC(OCC2OC(OC3C(CO)OC(O)C(O)C3O)C(O)C(O)C2OC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O,BYSGBSNPRWKUQH-UJDJLXLFSA-N,,0.23,
Zileuton,CC(C1=CC2=CC=CC=C2S1)N(O)C(N)=O,"InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)",Hydroxyzileuton,CC(C1=CC2=C(C=C(O)C=C2)S1)N(O)C(=N)O,ZQQVPNNYZLDMMO-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 1A2",0.63,
Zileuton,CC(C1=CC2=CC=CC=C2S1)N(O)C(N)=O,"InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)",Zileuton sulfoxide,CC(C1=CC2=CC=CC=C2S1=O)N(O)C(=N)O,KWEAXQJUQDQMNY-UHFFFAOYSA-N,Cytochrome P450 3A4,0.23,
Zileuton,CC(C1=CC2=CC=CC=C2S1)N(O)C(N)=O,"InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)",Dehydroxyzyleuton,CC(NC(=N)O)C1=CC2=CC=CC=C2S1,CKVDCQYUEYONIA-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.62,
Zileuton,CC(C1=CC2=CC=CC=C2S1)N(O)C(N)=O,"InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)",Zileuton O-glucuronide,CC(C1=CC2=CC=CC=C2S1)N(OC1OC(C(=O)O)C(O)C(O)C1O)C(=N)O,CYYKQHWQVGZJRJ-UPZRFPAJSA-N,UDP-glucuronosyltransferase 1-9,0.43,
Dehydroxyzyleuton,CC(NC(=N)O)C1=CC2=CC=CC=C2S1,CKVDCQYUEYONIA-UHFFFAOYSA-N,Dehydroxyzileuton sulfoxide,CC(NC(N)=O)C1=CC2=CC=CC=C2S1=O,KGUIRZVMBWMQQZ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.19,
Ethotoin,CCN1C(=O)NC(C2=CC=CC=C2)C1=O,"InChI=1S/C11H12N2O2/c1-2-13-10(14)9(12-11(13)15)8-6-4-3-5-7-8/h3-7,9H,2H2,1H3,(H,12,15)",p-Hydroxyl-ethotoin,CCN1C(=O)NC(C2=CC=C(O)C=C2)C1=O,UUBDNHDPPHJUHB-UHFFFAOYSA-N,,0.93,
4-Hydroxyretinoic acid,CC(C=CC1=C(C)C(O)CCC1(C)C)=CC=CC(C)=CC(=O)O,KGUMXGDKXYTTEY-FRCNGJHJSA-N,4-Oxoretinoic acid,CC(C=CC1=C(C)C(=O)CCC1(C)C)=CC=CC(C)=CC(=O)O,GGCUJPCCTQNTJF-FRCNGJHJSA-N,"Cytochrome P450 3A7, Cytochrome P450 2C18, Cytochrome P450 4A11, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2A6, Cytochrome P450 26A1",0.61,
"5,6-Epoxyretinoic acid",CC(C=CC12OC1(C)CCCC2(C)C)=CC=CC(C)=CC(=O)O,KEEHJLBAOLGBJZ-WEDZBJJJSA-N,"rac-5,6-Epoxy-retinoyl-beta-D-glucuronide",CC(C=CC12OC1(C)CCCC2(C)C)=CC=CC(C)=CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,,0.59,
2-Oxoclopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N1CCC2SC(=O)C=C2C1,JBSAZVIMJUOBNB-WUJWULDRSA-N,Active Metabolite of Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N1CCC(S)=C(CC(=O)O)C1,CXPJTQJWJQRBOF-HNNXBMFYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6, Cytochrome P450 2C9, Cytochrome P450 2C19",0.72,
Irinotecan,CCC1=C2CN3C(=CC4=C(COC(=O)C4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(N4CCCCC4)CC3)C=C12,"InChI=1S/C33H38N4O6/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3/t33-/m0/s1",SN-38,CCC1=C2C=C(O)C=CC2=NC2=C1CN1C2=CC2=C(COC(=O)C2(O)CC)C1=O,FJHBVJOVLFPMQE-QFIPXVFZSA-N,"Cholinesterase, Liver carboxylesterase 1, Cocaine esterase",0.96,
Mometasone,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(O)C(=O)CCl,"InChI=1S/C22H28Cl2O4/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,24)17(26)10-20(16,3)22(12,28)18(27)11-23/h6-7,9,12,15-17,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1",6-beta-hydroxy-mometasone furoate,CC1CC2C3C(O)CC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)C1=CC=CO1)C(=O)CCl,NVZADOUZVHKHSK-PWHXNIGKSA-N,,0.72,
Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=C(CC(=O)O)C=C2,"InChI=1S/C21H23NO3/c1-22(2)11-5-8-18-17-7-4-3-6-16(17)14-25-20-10-9-15(12-19(18)20)13-21(23)24/h3-4,6-10,12H,5,11,13-14H2,1-2H3,(H,23,24)/b18-8-",N-desmethyl olopatadine,CNCCC=C1C2=CC=CC=C2COC2=C1C=C(CC(=O)O)C=C2,VQMJUHOJPCPUAM-IDUWFGFVSA-N,Cytochrome P450 3A4,0.99,
Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=C(CC(=O)O)C=C2,"InChI=1S/C21H23NO3/c1-22(2)11-5-8-18-17-7-4-3-6-16(17)14-25-20-10-9-15(12-19(18)20)13-21(23)24/h3-4,6-10,12H,5,11,13-14H2,1-2H3,(H,23,24)/b18-8-",Olopatadine N-oxide,C[N+](C)([O-])CCC=C1C2=CC=CC=C2COC2=C1C=C(CC(=O)O)C=C2,TXKZPVWYFNGMCP-LSCVHKIXSA-N,"Dimethylaniline monooxygenase [N-oxide-forming] 1, Dimethylaniline monooxygenase [N-oxide-forming] 3",0.98,
Malathion,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,"InChI=1S/C10H19O6PS2/c1-5-15-9(11)7-8(10(12)16-6-2)19-17(18,13-3)14-4/h8H,5-7H2,1-4H3",Malathion dicarboxylic acid,COP(=S)(OC)SC(CC(=O)O)C(=O)O,NIUNKPWHNGMQRE-UHFFFAOYSA-N,,0.75,
Malathion,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,"InChI=1S/C10H19O6PS2/c1-5-15-9(11)7-8(10(12)16-6-2)19-17(18,13-3)14-4/h8H,5-7H2,1-4H3",Malathion monocarboxylic acid,CCOC(=O)C(CC(=O)O)SP(=S)(OC)OC,FARGSBYVTRDSKX-UHFFFAOYSA-N,,0.95,
Etoposide,COC1=C(O)C(OC)=CC(C2C3=CC4=C(C=C3C(OC3OC5COC(C)OC5C(O)C3O)C3COC(=O)C23)OCO4)=C1,"InChI=1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1",Etoposide glucuronide,COC1=CC(C2C3=C(C=C4OCOC4=C3)C(OC3OC4COC(C)OC4C(O)C3O)C3COC(=O)C23)=CC(OC)=C1OC1OC(C(=O)O)C(O)C(O)C1O,URCVASXWNJQAEH-UHFFFAOYSA-N,UDP-glucuronosyltransferase 1-1,0.91,
Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,"InChI=1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19)",(R)-MHD,NC(=O)N1C2=C(C=CC=C2)CC(O)C2=CC=CC=C21,BMPDWHIDQYTSHX-AWEZNQCLSA-N,"Aldo-keto reductase family 1 member C1, Aldo-keto reductase family 1 member C2, Aldo-keto reductase family 1 member C3, Aldo-keto reductase family 1 member C4",0.64,
Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,"InChI=1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19)",(S)-MHD,NC(=O)N1C2=CC=CC=C2CC(O)C2=C1C=CC=C2,,"Aldo-keto reductase family 1 member C1, Aldo-keto reductase family 1 member C2, Aldo-keto reductase family 1 member C3, Aldo-keto reductase family 1 member C4, Carbonyl reductase [NADPH] 1, Carbonyl reductase [NADPH] 3",0.64,
Nalidixic acid,CCN1C=C(C(=O)O)C(=O)C2=C1N=C(C)C=C2,"InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17)",Hydroxynalidixic acid,CCN1C=C(C(=O)O)C(=O)C2=CC=C(CO)N=C21,FRJDYPGZHOEEKU-UHFFFAOYSA-N,,0.96,
Phenelzine,NNCCC1=CC=CC=C1,"InChI=1S/C8H12N2/c9-10-7-6-8-4-2-1-3-5-8/h1-5,10H,6-7,9H2",Phenylacetic acid,O=C(O)CC1=CC=CC=C1,"InChI=1S/C8H8O2/c9-8(10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,9,10)",,0.4,
Phenelzine,NNCCC1=CC=CC=C1,"InChI=1S/C8H12N2/c9-10-7-6-8-4-2-1-3-5-8/h1-5,10H,6-7,9H2",Phenethylamine,NCCC1=CC=CC=C1,"InChI=1S/C8H11N/c9-7-6-8-4-2-1-3-5-8/h1-5H,6-7,9H2",,0.82,
Phenethylamine,NCCC1=CC=CC=C1,"InChI=1S/C8H11N/c9-7-6-8-4-2-1-3-5-8/h1-5H,6-7,9H2",Phenylacetic acid,O=C(O)CC1=CC=CC=C1,"InChI=1S/C8H8O2/c9-8(10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,9,10)",,0.46,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",Estradiol-17beta 3-sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2O,QZIGLSSUDXBTLJ-QGPAGSFOSA-N,UDP-glucuronosyltransferases (UGTs),0.83,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",2-Methoxyestrone 3-glucuronide,COC1=C(OC2OC(O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(=O)CCC34)C2=C1,CLTGLDLWQUZPJU-OOJOVCNMSA-N,UDP-glucuronosyltransferases (UGTs),0.51,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,"Cytochrome P450 1B1, Cytochrome P450 3A5",0.68,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",17-beta-Estradiol-3-glucuronide,CC12CCC3C4=C(C=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4)CCC3C1CCC2O,MUOHJTRCBBDUOW-BFXFFQJBSA-N,UDP-glucuronosyltransferases (UGTs),0.55,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",2-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide),COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(O)CCC34)C2=C1,LLCPFVIBUZJITJ-GVEMAFOVSA-N,,0.52,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",17-beta-Estradiol glucuronide,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,MTKNDAQYHASLID-RNFKDHMMSA-N,,0.61,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide),CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,VRMSCBRLZUCJBX-QXYWQCSFSA-N,UDP-glucuronosyltransferases (UGTs),0.56,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 1A1",0.75,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",4-Hydroxyestradiol,CC12CCC3C4=C(CCC3C1CCC2O)C(O)=C(O)C=C4,,Cytochrome P450 1B1,0.85,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1","17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,,0.73,
"17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Cytochrome P450 1A2,0.61,
4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,4-Hydroxyestradiol,CC12CCC3C4=C(CCC3C1CCC2O)C(O)=C(O)C=C4,,,0.82,
2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,2-hydroxyestradiol,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2O,DILDHNKDVHLEQB-XSSYPUMDSA-N,Catechol O-methyltransferase,0.79,
Naproxen,COC1=CC2=C(C=C1)C=C(C(C)C(=O)O)C=C2,"InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1",O-Desmethylnaproxen,CC(C(=O)O)C1=CC2=CC=C(O)C=C2C=C1,XWJUDDGELKXYNO-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C8, Cytochrome P450 1A2",0.91,
Naproxen,COC1=CC2=C(C=C1)C=C(C(C)C(=O)O)C=C2,"InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1",Naproxen O-glucuronide,COC1=CC=C2C=C(C(C)C(=O)OC3OC(C(=O)O)C(C)C(C)C3C)C=CC2=C1,JPEWXHCASWOSRA-LQLJUYLHSA-N,,0.41,
O-Desmethylnaproxen,CC(C(=O)O)C1=CC2=CC=C(O)C=C2C=C1,XWJUDDGELKXYNO-UHFFFAOYSA-N,O-Desmethylnaproxen sulfate,CC(C(=O)O)C1=CC2=C(C=C1)C=C(OS(=O)(=O)O)C=C2,BNKMSCMOWGCUOF-UHFFFAOYSA-N,"Sulfotransferase 1A1, Estrogen sulfotransferase, Sulfotransferase family cytosolic 1B member 1",0.74,
O-Desmethylnaproxen,CC(C(=O)O)C1=CC2=CC=C(O)C=C2C=C1,XWJUDDGELKXYNO-UHFFFAOYSA-N,O-Desmethylnaproxen acyl glucuronide,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC2=C(C=C1)C=C(O)C=C2,WKYUVCYFVJKWHF-FVNSOWSRSA-N,"UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 1-6, UDP-glucuronosyltransferase 1-7, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-10, UDP-glucuronosyltransferase 2B7",0.35,
O-Desmethylnaproxen,CC(C(=O)O)C1=CC2=CC=C(O)C=C2C=C1,XWJUDDGELKXYNO-UHFFFAOYSA-N,O-Desmethylnaproxen O-glucuronide,CC(C(=O)O)C1=CC2=C(C=C1)C=C(OC1OC(C(=O)O)C(O)C(O)C1O)C=C2,BFGOTVVWSNGSME-FVNSOWSRSA-N,"UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-7, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-10",0.34,
Primidone,CCC1(C2=CC=CC=C2)C(=O)NCNC1=O,"InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16)",Phenobarbital,CCC1(C2=CC=CC=C2)C(=O)NC(=O)NC1=O,DDBREPKUVSBGFI-UHFFFAOYSA-N,Cytochrome P450 2C19,0.88,
Sulfasalazine,O=C(O)C1=CC(N=NC2=CC=C(S(=O)(=O)NC3=NC=CC=C3)C=C2)=CC=C1O,"InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+",Mesalazine,NC1=CC(C(=O)O)=C(O)C=C1,"InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)",,0.4,
Sulfasalazine,O=C(O)C1=CC(N=NC2=CC=C(S(=O)(=O)NC3=NC=CC=C3)C=C2)=CC=C1O,"InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+",Sulfapyridine,NC1=CC=C(S(=O)(=O)NC2=CC=CC=N2)C=C1,"InChI=1S/C11H11N3O2S/c12-9-4-6-10(7-5-9)17(15,16)14-11-3-1-2-8-13-11/h1-8H,12H2,(H,13,14)",,0.61,
Candesartan cilexetil,CCOC1=NC2=C(C(C(=O)OC(C)OC(=O)OC3CCCCC3)=CC=C2)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,"InChI=1S/C33H34N6O6/c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,35,36,37,38)",Candesartan,CCOC1=NC2=CC=CC(C(=O)O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,"InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)",,0.88,
Tazarotene,CCOC(=O)C1=CN=C(C#CC2=CC3=C(C=C2)SCCC3(C)C)C=C1,"InChI=1S/C21H21NO2S/c1-4-24-20(23)16-7-9-17(22-14-16)8-5-15-6-10-19-18(13-15)21(2,3)11-12-25-19/h6-7,9-10,13-14H,4,11-12H2,1-3H3",Tazarotenic acid,CC1(C)CCSC2=C1C=C(C#CC1=NC=C(C(=O)O)C=C1)C=C2,IQIBKLWBVJPOQO-UHFFFAOYSA-N,,0.93,
Alfentanil,CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCN2N=NN(CC)C2=O)CC1,"InChI=1S/C21H32N6O3/c1-4-19(28)27(18-9-7-6-8-10-18)21(17-30-3)11-13-24(14-12-21)15-16-26-20(29)25(5-2)22-23-26/h6-10H,4-5,11-17H2,1-3H3",AMX,CC1=NN(C2=CC(S(=O)(=O)O)=CC=C2)C(=O)C1N=NC1=C(S(=O)(=O)O)C=C(Cl)C(Cl)=C1,UOJXCGAWGJWRNV-FMQUCBEESA-N,Cytochrome P450 3A4,0.36,
Pentoxifylline,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C13H18N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8H,4-7H2,1-3H3",Lisofylline,CC(O)CCCCN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C13H20N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8-9,18H,4-7H2,1-3H3/t9-/m1/s1",,0.97,
Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,"InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)",Indapamide metabolite M5,CC1=CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,LWCDXWWLUHMMJI-UHFFFAOYSA-N,Cytochrome P450 3A4,0.49,
Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,"InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)",Indapamide metabolite M1,CC1CC2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,ARPVNNMMMDXBBF-UHFFFAOYSA-N,Cytochrome P450 3A4,0.94,
Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,"InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)",Indapamide epoxide intermediate,CC1CC2=C(C=CC3OC23)N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,ZDRCVKKLZHUQLV-UHFFFAOYSA-N,Cytochrome P450 3A4,0.5,
Indapamide metabolite M5,CC1=CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,LWCDXWWLUHMMJI-UHFFFAOYSA-N,Indapamide metabolite M4,CC1C(=O)C2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,WTWDWHYDLVHLPL-UHFFFAOYSA-N,Cytochrome P450 3A4,0.48,
Indapamide metabolite M1,CC1CC2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,ARPVNNMMMDXBBF-UHFFFAOYSA-N,Indapamide metabolite M3,CC1=CC2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,NYONMYACEVMMGW-UHFFFAOYSA-N,Cytochrome P450 3A4,0.5,
Indapamide epoxide intermediate,CC1CC2=C(C=CC3OC23)N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,ZDRCVKKLZHUQLV-UHFFFAOYSA-N,Indapamide metabolite M6,CC1CC2=C(C=CC(O)C2O)N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,CZPZKXRBEJAROA-UHFFFAOYSA-N,Epoxide hydrolase 1,0.93,
Indapamide metabolite M4,CC1C(=O)C2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,WTWDWHYDLVHLPL-UHFFFAOYSA-N,Indapamide metabolite M2,CC1C(=O)C2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,AHVOGCBKNVSCRL-UHFFFAOYSA-N,Cytochrome P450 3A4,0.94,
Indapamide metabolite M3,CC1=CC2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,NYONMYACEVMMGW-UHFFFAOYSA-N,Indapamide metabolite M2,CC1C(=O)C2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,AHVOGCBKNVSCRL-UHFFFAOYSA-N,Cytochrome P450 3A4,0.49,
Meloxicam,CC1=CN=C(NC(=O)C2=C(O)C3=C(C=CC=C3)S(=O)(=O)N2C)S1,"InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)",5'-hydroxymethyl meloxicam,CN1C(C(O)=NC2=NC=C(CO)S2)=C(O)C2=CC=CC=C2S1(=O)=O,LOOSAJMIEADILV-UHFFFAOYSA-N,,0.69,
5'-hydroxymethyl meloxicam,CN1C(C(O)=NC2=NC=C(CO)S2)=C(O)C2=CC=CC=C2S1(=O)=O,LOOSAJMIEADILV-UHFFFAOYSA-N,5'-carboxy meloxicam,CN1C(C(O)=NC2=NC=C(C(=O)O)S2)=C(O)C2=CC=CC=C2S1(=O)=O,MTQQFYLGAZXHTB-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9",0.98,
Orciprenaline,CC(C)NCC(O)C1=CC(O)=CC(O)=C1,"InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8/h3-5,7,11-15H,6H2,1-2H3",Orciprenaline-3-O-sulfate,CC(C)NCC(O)C1=CC(O)=CC(OS(=O)(=O)O)=C1,IJWHPUWEGCYHMQ-UHFFFAOYSA-N,,0.65,
Propofol glucuronide,CC(C)C1=CC=CC(C(C)C)=C1OC1OC(C(=O)O)C(O)C(O)C1O,JZSJIASBMOIIKI-RUKPJNHUSA-N,1-Quinol glucuronide,CC(C)C1=CC(O)=CC(C(C)C)=C1OC1OC(C(=O)O)C(O)C(O)C1O,OCSNDZGMSQTRGL-RUKPJNHUSA-N,,0.96,
Diazepam,CN1C(=O)CN=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,"InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3",desmethyldiazepam,O=C1CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N1,AKPLHCDWDRPJGD-UHFFFAOYSA-N,,0.87,
Diazepam,CN1C(=O)CN=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,"InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3",Temazepam,CN1C(=O)C(O)N=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,"InChI=1S/C16H13ClN2O2/c1-19-13-8-7-11(17)9-12(13)14(18-15(20)16(19)21)10-5-3-2-4-6-10/h2-9,15,20H,1H3","Prostaglandin G/H synthase 1, Cytochrome P450 2C19",0.87,
Diazepam,CN1C(=O)CN=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,"InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3",Oxazepam,O=C1NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=NC1O,ADIMAYPTOBDMTL-UHFFFAOYSA-N,Cytochrome P450 1A2,0.78,
Nordazepam,O=C1CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N1,"InChI=1S/C15H11ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)",Nordiazepam O-glucuronide,O=C(O)C1OC(OC2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N2)C(O)C(O)C1O,HIENWGUIYHGOPI-QHKDLCCSSA-N,,0.54,
Oxazepam,O=C1NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=NC1O,"InChI=1S/C15H11ClN2O2/c16-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)18-15(20)14(19)17-12/h1-8,15,20H,(H,17,19)",Oxazepam glucuronide,O=C(O)C1OC(OC2N=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N=C2O)C(O)C(O)C1O,FIKQKGFUBZQEBL-IFBJMGMISA-N,"UDP-glucuronosyltransferase 2B15, UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 1-9",0.47,
Methylphenobarbital,CCC1(C2=CC=CC=C2)C(=O)NC(=O)N(C)C1=O,"InChI=1S/C13H14N2O3/c1-3-13(9-7-5-4-6-8-9)10(16)14-12(18)15(2)11(13)17/h4-8H,3H2,1-2H3,(H,14,16,18)",Phenobarbital,CCC1(C2=CC=CC=C2)C(=O)NC(=O)NC1=O,DDBREPKUVSBGFI-UHFFFAOYSA-N,,0.84,
Terbinafine,CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,"InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+",Terbinafine dihydrodiol derivative (1),CN(CC=CC#CC(C)(C)C)CC1=CC(O)=C(O)C2=CC=CC=C12,BSCJZDRHKPMNFX-WEVVVXLNSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C9, Cytochrome P450 2B6",0.66,
Terbinafine,CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,"InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+",Terbinafine dihydrodiol derivative (2),CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=C(O)C(O)=CC=C12,OZUIZHMLRLTKOH-FNORWQNLSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C9, Cytochrome P450 2B6",0.71,
Hydroxyterbinafine,CN(CC=CC#CC(C)(C)CO)CC1=CC=CC2=CC=CC=C12,GPEJUKJZTGFNKY-XBXARRHUSA-N,Carboxyterbinafine,CN(CC=CC#CC(C)(C)C(=O)O)CC1=CC=CC2=CC=CC=C12,DSPCPJFHUUUMEV-XBXARRHUSA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19",0.89,
Hydroxyterbinafine,CN(CC=CC#CC(C)(C)CO)CC1=CC=CC2=CC=CC=C12,GPEJUKJZTGFNKY-XBXARRHUSA-N,N-Desmethylhydroxyterbinafine,CC(C)(C#CC=CCNCC1=CC=CC2=CC=CC=C12)CO,CKGLMMKXUSSSAA-XVNBXDOJSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6, Cytochrome P450 1A2, Cytochrome P450 2C9, Cytochrome P450 2C8, Cytochrome P450 2C19",0.89,
N-Desmethylterbinafine,CC(C)(C)C#CC=CCNCC1=CC=CC2=CC=CC=C12,IZJZLXQHMWUCIC-XBXARRHUSA-N,N-Desmethylhydroxyterbinafine,CC(C)(C#CC=CCNCC1=CC=CC2=CC=CC=C12)CO,CKGLMMKXUSSSAA-XVNBXDOJSA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19",0.92,
1-Naphthaldehyde,O=CC1=CC=CC2=CC=CC=C12,SQAINHDHICKHLX-UHFFFAOYSA-N,1-Naphthoic acid,O=C(O)C1=C2C=CC=CC2=CC=C1,LNETULKMXZVUST-UHFFFAOYSA-N,,0.7,
N-Desmethylterbinafine,CC(C)(C)C#CC=CCNCC1=CC=CC2=CC=CC=C12,IZJZLXQHMWUCIC-XBXARRHUSA-N,N-Desmethylterbinafine dihydrodiol derivative (1),CC(C)(C)C#CC=CCNCC1=CC(O)=C(O)C2=CC=CC=C12,PQMBQNSIJJFKTL-XBXARRHUSA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C9",0.63,
N-Desmethylterbinafine,CC(C)(C)C#CC=CCNCC1=CC=CC2=CC=CC=C12,IZJZLXQHMWUCIC-XBXARRHUSA-N,N-Desmethylterbinafine dihydrodiol derivative (2),CC(C)(C)C#CC=CCNCC1=CC=CC2=C(O)C(O)=CC=C12,QNITXIUZLIXMAL-GQCTYLIASA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C9",0.68,
Terbinafine dihydrodiol derivative (1),CN(CC=CC#CC(C)(C)C)CC1=CC(O)=C(O)C2=CC=CC=C12,BSCJZDRHKPMNFX-WEVVVXLNSA-N,N-Desmethylterbinafine dihydrodiol derivative (1),CC(C)(C)C#CC=CCNCC1=CC(O)=C(O)C2=CC=CC=C12,PQMBQNSIJJFKTL-XBXARRHUSA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4",0.92,
Terbinafine dihydrodiol derivative (2),CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=C(O)C(O)=CC=C12,OZUIZHMLRLTKOH-FNORWQNLSA-N,N-Desmethylterbinafine dihydrodiol derivative (2),CC(C)(C)C#CC=CCNCC1=CC=CC2=C(O)C(O)=CC=C12,QNITXIUZLIXMAL-GQCTYLIASA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4",0.92,
Benzphetamine,CC(CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,"InChI=1S/C17H21N/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17/h3-12,15H,13-14H2,1-2H3/t15-/m0/s1",Amphetamine,CC(N)CC1=CC=CC=C1,KWTSXDURSIMDCE-UHFFFAOYSA-N,,0.47,
Benzphetamine,CC(CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,"InChI=1S/C17H21N/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17/h3-12,15H,13-14H2,1-2H3/t15-/m0/s1",Methamphetamine,CNC(C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,,0.56,
Alprenolol,C=CCC1=CC=CC=C1OCC(O)CNC(C)C,"InChI=1S/C15H23NO2/c1-4-7-13-8-5-6-9-15(13)18-11-14(17)10-16-12(2)3/h4-6,8-9,12,14,16-17H,1,7,10-11H2,2-3H3",4-hydroxy-alprenolol,C=CCC1=CC(O)=CC=C1OCC(O)CNC(C)C,HNXRWPIZRBNFDD-UHFFFAOYSA-N,,0.9,
Suprofen,CC(C(=O)O)C1=CC=C(C(=O)C2=CC=CS2)C=C1,"InChI=1S/C14H12O3S/c1-9(14(16)17)10-4-6-11(7-5-10)13(15)12-3-2-8-18-12/h2-9H,1H3,(H,16,17)",Suprofen glucuronide,CC(C(=O)OC(=O)C1OC(O)C(O)C(O)C1O)C1=CC=C(C(=O)C2=CC=CS2)C=C1,JSDNVZNTHLHVBN-MMWQRLKXSA-N,"UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 2B7",0.5,
Guaifenesin,COC1=CC=CC=C1OCC(O)CO,"InChI=1S/C10H14O4/c1-13-9-4-2-3-5-10(9)14-7-8(12)6-11/h2-5,8,11-12H,6-7H2,1H3",beta-(2-methoxyphenoxy)-lactic acid,COC1=CC=CC=C1OCC(O)C(=O)O,MXVBBOLVTSAHEX-UHFFFAOYSA-N,,0.83,
Quinapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1CC2=CC=CC=C2CC1C(=O)O,"InChI=1S/C25H30N2O5/c1-3-32-25(31)21(14-13-18-9-5-4-6-10-18)26-17(2)23(28)27-16-20-12-8-7-11-19(20)15-22(27)24(29)30/h4-12,17,21-22,26H,3,13-16H2,1-2H3,(H,29,30)/t17-,21-,22-/m0/s1",Quinaprilat,CC(NC(CCC1=CC=CC=C1)C(=O)O)C(=O)N1CC2=C(C=CC=C2)CC1C(=O)O,FLSLEGPOVLMJMN-YSSFQJQWSA-N,Liver carboxylesterase 1,0.94,
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,"InChI=1S/C17H12Cl2N4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3",4-hydroxytriazolam,CC1=NN=C2C(O)N=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,YUQRFPYHTPARRM-UHFFFAOYSA-N,Cytochrome P450 3A4,0.89,
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,"InChI=1S/C17H12Cl2N4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3",1'-hydroxytriazolam,OCC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,BHUYWUDMVCLHND-UHFFFAOYSA-N,Cytochrome P450 3A4,0.94,
Didanosine,O=C1N=CNC2=C1N=CN2C1CCC(CO)O1,"InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m0/s1",Uric acid,O=C1NC(=O)C2=C(N1)NC(=O)N2,LEHOTFFKMJEONL-UHFFFAOYSA-N,,0.35,
Didanosine,O=C1N=CNC2=C1N=CN2C1CCC(CO)O1,"InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m0/s1",Xanthine,O=C1NC(=O)C2=C(N=CN2)N1,LRFVTYWOQMYALW-UHFFFAOYSA-N,,0.35,
Didanosine,O=C1N=CNC2=C1N=CN2C1CCC(CO)O1,"InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m0/s1",Hypoxanthine,O=C1N=CNC2=C1NC=N2,FDGQSTZJBFJUBT-UHFFFAOYSA-N,,0.33,
Cocaine,COC(=O)C1C(OC(=O)C2=CC=CC=C2)CC2CCC1N2C,"InChI=1S/C17H21NO4/c1-18-12-8-9-13(18)15(17(20)21-2)14(10-12)22-16(19)11-6-4-3-5-7-11/h3-7,12-15H,8-10H2,1-2H3/t12-,13+,14-,15+/m0/s1",norcocaine,COC(=O)C1C2CCC(CC1C(=O)OC1=CC=CC=C1)N2,RERBBBLSJAMJFJ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.47,
Cocaine,COC(=O)C1C(OC(=O)C2=CC=CC=C2)CC2CCC1N2C,"InChI=1S/C17H21NO4/c1-18-12-8-9-13(18)15(17(20)21-2)14(10-12)22-16(19)11-6-4-3-5-7-11/h3-7,12-15H,8-10H2,1-2H3/t12-,13+,14-,15+/m0/s1",Benzoylecgonine,CN1C2CCC1C(C(=O)O)C(OC(=O)C1=CC=CC=C1)C2,"InChI=1S/C16H19NO4/c1-17-11-7-8-12(17)14(15(18)19)13(9-11)21-16(20)10-5-3-2-4-6-10/h2-6,11-14H,7-9H2,1H3,(H,18,19)/t11-,12+,13-,14+/m0/s1",,0.96,
Cocaine,COC(=O)C1C(OC(=O)C2=CC=CC=C2)CC2CCC1N2C,"InChI=1S/C17H21NO4/c1-18-12-8-9-13(18)15(17(20)21-2)14(10-12)22-16(19)11-6-4-3-5-7-11/h3-7,12-15H,8-10H2,1-2H3/t12-,13+,14-,15+/m0/s1",Cocaethylene,CCOC(=O)C1C(OC(=O)C2=CC=CC=C2)CC2CCC1N2C,NMPOSNRHZIWLLL-UHFFFAOYSA-N,,0.97,
Zonisamide,NS(=O)(=O)CC1=NOC2=CC=CC=C12,"InChI=1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12)",2-sulfamoylacetylphenol,CCC1(O)CC2CN(CCC3=C(NC4=CC=CC=C34)C(C(=O)OC)(C3=C(OC)C=C4C(=C3)C35CCN6CC=CC(CC)(C(O)C(O)(C(=O)OC)C3N4C)C65)C2)C1,NDMPLJNOPCLANR-CYJJREDESA-N,Cytochrome P450 3A4,0.25,
Zonisamide,NS(=O)(=O)CC1=NOC2=CC=CC=C12,"InChI=1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12)",N-acetyl zonisamide,CC(=O)NS(=O)(=O)CC1=NOC2=C1C=CC=C2,HXFUTAFSEXINIW-UHFFFAOYSA-N,,0.82,
Repaglinide,CCOC1=C(C(=O)O)C=CC(CC(=O)NC(CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1,"InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1",hydroxyrepaglinide,CCOC1=C(C(=O)O)C=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O)C2)=C1,OBMAZJVHPAVADF-UHFFFAOYSA-N,Cytochrome P450 2C8,0.69,
Repaglinide,CCOC1=C(C(=O)O)C=CC(CC(=O)NC(CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1,"InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1",repaglinide aromatic amine,CCOC1=C(C(=O)O)C=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N)=C1,OSCVKZCOJUTUFD-UHFFFAOYSA-N,Cytochrome P450 3A4,0.57,
Almotriptan,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N1CCCC1)C=C2,"InChI=1S/C17H25N3O2S/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3",N-desmethylalmotriptan,CNCCC1=CNC2=C1C=C(CS(=O)(=O)N1CCCC1)C=C2,IREINZNGILEJRP-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2D6, Cytochrome P450 1A2, Cytochrome P450 2C19, Cytochrome P450 2E1, Cytochrome P450 2C8",0.99,
Ketotifen,CN1CCC(=C2C3=CC=CC=C3CC(=O)C3=C2C=CS3)CC1,"InChI=1S/C19H19NOS/c1-20-9-6-13(7-10-20)18-15-5-3-2-4-14(15)12-17(21)19-16(18)8-11-22-19/h2-5,8,11H,6-7,9-10,12H2,1H3",Ketotifen-N-glucuronide,C[N+]1(C2OC(C(=O)[O-])C(O)C(O)C2O)CCC(=C2C3=C(C=CC=C3)CC(=O)C3=C2C=CS3)CC1,WLTPAELNPGRIGG-AQTBWJFISA-N,"UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 1-4, UDP-glucuronosyltransferase 2B10",0.73,
Ketotifen,CN1CCC(=C2C3=CC=CC=C3CC(=O)C3=C2C=CS3)CC1,"InChI=1S/C19H19NOS/c1-20-9-6-13(7-10-20)18-15-5-3-2-4-14(15)12-17(21)19-16(18)8-11-22-19/h2-5,8,11H,6-7,9-10,12H2,1H3",10-alpha-hydroxyl Ketotifen,CN1CCC(=C2C3=CC=CC=C3CC(O)C3=C2C=CS3)CC1,TZHJFZBFWVCFAA-UHFFFAOYSA-N,,0.76,
Ketotifen,CN1CCC(=C2C3=CC=CC=C3CC(=O)C3=C2C=CS3)CC1,"InChI=1S/C19H19NOS/c1-20-9-6-13(7-10-20)18-15-5-3-2-4-14(15)12-17(21)19-16(18)8-11-22-19/h2-5,8,11H,6-7,9-10,12H2,1H3",Nor-ketotifen,O=C1CC2=CC=CC=C2C(=C2CCNCC2)C2=C1SC=C2,IYSYPCSSDZBWHN-UHFFFAOYSA-N,,0.99,
Levosimendan,CC1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1,"InChI=1S/C14H12N6O/c1-9-6-13(21)19-20-14(9)10-2-4-11(5-3-10)17-18-12(7-15)8-16/h2-5,9,17H,6H2,1H3,(H,19,21)/t9-/m1/s1",OR-1855,CC1CC(=O)NN=C1C1=CC=C(N)C=C1,GDMRFHZLKNYRRO-SSDOTTSWSA-N,,0.86,
Levosimendan,CC1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1,"InChI=1S/C14H12N6O/c1-9-6-13(21)19-20-14(9)10-2-4-11(5-3-10)17-18-12(7-15)8-16/h2-5,9,17H,6H2,1H3,(H,19,21)/t9-/m1/s1",OR-1896,CC(=O)NC1=CC=C(C2=NNC(=O)CC2C)C=C1,GDZXNMWZXLDEKG-MRVPVSSYSA-N,,0.78,
Salmeterol,OCC1=C(O)C=CC(C(O)CNCCCCCCOCCCCC2=CC=CC=C2)=C1,"InChI=1S/C25H37NO4/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2",alpha-hydroxysalmeterol,OCC1=C(O)C=CC(C(O)CNCCCCCCOCCCC(O)C2=CC=CC=C2)=C1,PGRMEHUQIPZHKM-UHFFFAOYSA-N,Cytochrome P450 3A4,0.94,
Acetylsalicylic acid,CC(=O)OC1=CC=CC=C1C(=O)O,"InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)",Gentisic acid,O=C(O)C1=C(O)C=CC(O)=C1,,Cytochrome P450 2C9,0.5,
Acetylsalicylic acid,CC(=O)OC1=CC=CC=C1C(=O)O,"InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)",Salicyluric acid,O=C(O)CNC(=O)C1=C(O)C=CC=C1,,Medium-chain fatty-acid--CoA ligase,0.3,
Phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C18H16O3/c1-2-13(12-8-4-3-5-9-12)16-17(19)14-10-6-7-11-15(14)21-18(16)20/h3-11,13,19H,2H2,1H3",4'-Hydroxy-R-phenprocoumon,CCC(C1=CC=C(O)C=C1)C1=C(O)C2=CC=CC=C2OC1=O,ZPNYHQZRGWFLST-CYBMUJFWSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C8",0.98,
Phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C18H16O3/c1-2-13(12-8-4-3-5-9-12)16-17(19)14-10-6-7-11-15(14)21-18(16)20/h3-11,13,19H,2H2,1H3",8-Hydroxy-R-phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=C(OC1=O)C(O)=CC=C2,DKNXIPNBVAVYAP-GFCCVEGCSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.92,
Phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C18H16O3/c1-2-13(12-8-4-3-5-9-12)16-17(19)14-10-6-7-11-15(14)21-18(16)20/h3-11,13,19H,2H2,1H3",7-Hydroxy-R-phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=C(C=C(O)C=C2)OC1=O,HBAPGROFUGJSGR-CYBMUJFWSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.98,
Felbamate,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,"InChI=1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)","2-Phenyl-1,3-propanediol monocarbamate",N=C(O)OCC(CO)C1=CC=CC=C1,JQVQIZWJBLGVRW-UHFFFAOYSA-N,Cytochrome P450 2C19,0.55,
Felbamate,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,"InChI=1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)",p-Hydroxyfelbamate,NC(=O)OCC(COC(N)=O)C1=CC=C(O)C=C1,PXBZEVLDFAKFLV-UHFFFAOYSA-N,"Cytochrome P450 3A7, Cytochrome P450 2E1",0.84,
Felbamate,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,"InChI=1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)",2-Hydroxyfelbamate,NC(=O)OCC(O)(COC(N)=O)C1=CC=CC=C1,VTXNIAJKDLEHGX-UHFFFAOYSA-N,"Cytochrome P450 3A7, Cytochrome P450 2E1",0.66,
"2-Phenyl-1,3-propanediol monocarbamate",N=C(O)OCC(CO)C1=CC=CC=C1,JQVQIZWJBLGVRW-UHFFFAOYSA-N,3-Carbamoyl-2-phenylpropionaldehyde,N=C(O)OCC(C=O)C1=CC=CC=C1,XUCMSYZLYLONTH-UHFFFAOYSA-N,Alcohol dehydrogenase 1A,0.71,
3-Carbamoyl-2-phenylpropionaldehyde,N=C(O)OCC(C=O)C1=CC=CC=C1,XUCMSYZLYLONTH-UHFFFAOYSA-N,Atropaldehyde,C=C(C=O)C1=CC=CC=C1,ZFBRJUBOJXNIQM-UHFFFAOYSA-N,,0.29,
3-Carbamoyl-2-phenylpropionaldehyde,N=C(O)OCC(C=O)C1=CC=CC=C1,XUCMSYZLYLONTH-UHFFFAOYSA-N,"4-Hydroxy-5-phenyltetrahydro-1,3-oxazin-2-one",OC1=NC(O)C(C2=CC=CC=C2)CO1,XZZMJRBYVRSAOS-UHFFFAOYSA-N,,0.41,
3-Carbamoyl-2-phenylpropionaldehyde,N=C(O)OCC(C=O)C1=CC=CC=C1,XUCMSYZLYLONTH-UHFFFAOYSA-N,3-Carbamoyl-2-phenylpropionic acid,N=C(O)OCC(C(=O)O)C1=CC=CC=C1,AYRIVCKWIAUVOO-UHFFFAOYSA-N,"Aldehyde dehydrogenase, dimeric NADP-preferring",0.81,
"4-Hydroxy-5-phenyltetrahydro-1,3-oxazin-2-one",OC1=NC(O)C(C2=CC=CC=C2)CO1,XZZMJRBYVRSAOS-UHFFFAOYSA-N,"5-Phenyl-1,3-oxazinane-2,4-dione",O=C1N=C(O)C(C2=CC=CC=C2)CO1,YPIQXPKZXKWWSZ-UHFFFAOYSA-N,Alcohol dehydrogenase 1A,0.37,
"5-Phenyl-1,3-oxazinane-2,4-dione",O=C1N=C(O)C(C2=CC=CC=C2)CO1,YPIQXPKZXKWWSZ-UHFFFAOYSA-N,3-Carbamoyl-2-phenylpropionic acid,N=C(O)OCC(C(=O)O)C1=CC=CC=C1,AYRIVCKWIAUVOO-UHFFFAOYSA-N,,0.34,
Hydrocodone,COC1=C2OC3C(=O)CCC4C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-12,17H,4-5,7-9H2,1-2H3/t11-,12+,17-,18-/m0/s1",Hydromorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3C1C5,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2,4,10-11,16,19H,3,5-8H2,1H3/t10-,11+,16-,17-/m0/s1","Cytochrome P450 2D6, Cytochrome P450 2B6, Cytochrome P450 2C19",0.99,
Hydrocodone,COC1=C2OC3C(=O)CCC4C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-12,17H,4-5,7-9H2,1-2H3/t11-,12+,17-,18-/m0/s1",norhydrocodone,COC1=C2OC3C(=O)CCC4C5CC(=C2C34CCN5)C=C1,JGORUXKMRLIJSV-ZWUPXRALSA-N,Cytochrome P450 3A4,0.98,
Zaleplon,CCN(C(C)=O)C1=CC=CC(C2=CC=NC3=C(C#N)C=NN23)=C1,"InChI=1S/C17H15N5O/c1-3-21(12(2)23)15-6-4-5-13(9-15)16-7-8-19-17-14(10-18)11-20-22(16)17/h4-9,11H,3H2,1-2H3",desethylzaleplon,CCNC1=CC=CC(C2=CC=NC3=C(C#N)C=NN23)=C1,QIBDHPGCTQWVTR-UHFFFAOYSA-N,Cytochrome P450 3A4,0.93,
Methyldopa,CC(N)(CC1=CC=C(O)C(O)=C1)C(=O)O,"InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1",Alpha-methyldopamine,CC(N)CC1=CC(O)=C(O)C=C1,KSRGADMGIRTXAF-UHFFFAOYSA-N,Aromatic-L-amino-acid decarboxylase,0.66,
Methyldopa,CC(N)(CC1=CC=C(O)C(O)=C1)C(=O)O,"InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1","3,4-Dihydroxyphenylacetone",CC(=O)CC1=CC(O)=C(O)C=C1,JQXBETDGCMQLMK-UHFFFAOYSA-N,,0.51,
Methyldopa,CC(N)(CC1=CC=C(O)C(O)=C1)C(=O)O,"InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1",3-O-methyl-alpha-methyldopa,COC1=C(O)C=CC(CC(N)C(=O)O)=C1,PFDUUKDQEHURQC-ZETCQYMHSA-N,Catechol O-methyltransferase,0.74,
3-O-methyl-alpha-methyldopa,COC1=C(O)C=CC(CC(N)C(=O)O)=C1,PFDUUKDQEHURQC-ZETCQYMHSA-N,3-O-methyl-alpha-methyldopa sulfate,COC1=CC=C(CC(C)(N)C(=O)O)C=C1OS(=O)(=O)O,NKCGFFAMYYALPZ-NSHDSACASA-N,Sulfotransferase,0.56,
Ethinylestradiol,C#CC1(O)CCC2C3CCC4=C(C=CC(O)=C4)C3CCC21C,"InChI=1S/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16-,17-,18+,19+,20+/m1/s1",2-hydroxyethinylestradiol,C#CC1(O)CCC2C3CCC4=CC(O)=C(O)C=C4C3CCC21C,KQJCDKMHNQVWDV-GJRSTEQNSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 1A2, Cytochrome P450 3A5",0.96,
"N,N-Didesmethyldiphenhydramine",NCCOC(C1=CC=CC=C1)C1=CC=CC=C1,NFJFUDGBWGXTHS-UHFFFAOYSA-N,Diphenylmethoxyacetic acid,O=C(O)COC(C1=CC=CC=C1)C1=CC=CC=C1,KWGQOJWITMQEOT-UHFFFAOYSA-N,,0.77,
Dopamine,NCCC1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",6-Hydroxydopamine,NCCC1=C(O)C=C(O)C(O)=C1,DIVDFFZHCJEHGG-UHFFFAOYSA-N,,0.73,
Dopamine,NCCC1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",Dopamine 4-sulfate,NCCC1=CC(O)=C(OS(=O)(=O)O)C=C1,DEKNNWJXAQTLFA-UHFFFAOYSA-N,,0.54,
Dopamine,NCCC1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",Dopamine 3-O-sulfate,NCCC1=CC(OS(=O)(=O)O)=C(O)C=C1,NZKRYJGNYPYXJZ-UHFFFAOYSA-N,,0.5,
Dopamine,NCCC1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",Dopamine glucuronide,NCCC1=CC(O)=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,CQASRCDNLNMIJY-BYNIDDHOSA-N,,0.22,
Azathioprine,CN1C=NC([N+](=O)[O-])=C1SC1=NC=NC2=C1NC=N2,"InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)",6-Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,"Glutathione S-transferase Mu 1, Glutathione S-transferase A1, Glutathione S-transferase A2",0.23,
6-Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,6-thiouric acid,OC1=NC2=C(N=C(O)N2)C(S)=N1,SXHQUGJSTGOXMD-UHFFFAOYSA-N,Xanthine dehydrogenase/oxidase,0.36,
6-Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,6-Thiosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,WMRIOGFRJLQENF-UUOKFMHZSA-N,Hypoxanthine-guanine phosphoribosyltransferase,0.19,
6-Thiosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,WMRIOGFRJLQENF-UUOKFMHZSA-N,6-thioxanthylic acid,O=P(O)(O)C(O)C1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,GRTRLPZIJODDLV-BQGLTYQTSA-N,"Inosine-5'-monophosphate dehydrogenase 1, Inosine-5'-monophosphate dehydrogenase 2",0.83,
Doxorubicinol,COC1=CC=CC2=C1C(=O)C1=C(C2=O)C(O)=C2CC(O)(C(O)CO)CC(OC3CC(N)C(O)C(C)O3)C2=C1O,NKZRZOVSJNSBFR-FEMMEMONSA-N,Doxorubicinol deoxaglycone,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(CC(O)(C(O)CO)CC3)C(O)=C1C2=O,IGJIPNOEJDYNRR-QUXALOBESA-N,"NADPH--cytochrome P450 reductase, Xanthine dehydrogenase/oxidase, NAD(P)H dehydrogenase [quinone] 1",0.73,
Doxorubicinol,COC1=CC=CC2=C1C(=O)C1=C(C2=O)C(O)=C2CC(O)(C(O)CO)CC(OC3CC(N)C(O)C(C)O3)C2=C1O,NKZRZOVSJNSBFR-FEMMEMONSA-N,Doxorubicine hydroxyaglycone,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(CC(O)(C(=O)CO)CC3O)C(O)=C1C2=O,IBZGBXXTIGCACK-CWKPULSASA-N,,0.78,
Frovatriptan,CNC1CCC2=C(C1)C1=C(C=CC(C(N)=O)=C1)N2,"InChI=1S/C14H17N3O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18)/t9-/m1/s1",desmethyl frovatriptan,N=C(O)C1=CC=C2NC3=C(CC(N)CC3)C2=C1,FPYHQGKIVXULKF-DDWIOCJRSA-N,,0.8,
Frovatriptan,CNC1CCC2=C(C1)C1=C(C=CC(C(N)=O)=C1)N2,"InChI=1S/C14H17N3O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18)/t9-/m1/s1",Hydroxylated N-acetyl desmethyl frovatriptan,CC(=O)NC1CCC2NC3=C(O)C=C(C(N)=O)C=C3C2C1,CDCOGHQILPZANE-UHFFFAOYSA-N,,0.37,
Frovatriptan,CNC1CCC2=C(C1)C1=C(C=CC(C(N)=O)=C1)N2,"InChI=1S/C14H17N3O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18)/t9-/m1/s1",N-acetyl desmethyl frovatriptan,CC(=O)NC1CCC2NC3=CC=C(C(N)=O)C=C3C2C1,CQIAKQMSTPQBAU-UHFFFAOYSA-N,,0.37,
Salbutamol,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,"InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3",Salbutamol 4-O-sulfate,CC(C)(C)NCC(O)C1=CC=C(OS(=O)(=O)O)C(CO)=C1,FPMLHYFHLRTRMB-UHFFFAOYSA-N,,0.68,
Ketoprofen,CC(C(=O)O)C1=CC(C(=O)C2=CC=CC=C2)=CC=C1,"InChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)",Ketoprofen glucuronide,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC(C(=O)C2=CC=CC=C2)=CC=C1,PBTXSZZKPHBHMA-LYFYOZKASA-N,,0.43,
Metyrapone,CC(C)(C(=O)C1=CN=CC=C1)C1=CC=CN=C1,"InChI=1S/C14H14N2O/c1-14(2,12-6-4-8-16-10-12)13(17)11-5-3-7-15-9-11/h3-10H,1-2H3",Metyrapol,CC(C)(C1=CN=CC=C1)C(O)C1=CN=CC=C1,DDFNHFXLQJLFSX-UHFFFAOYSA-N,,0.5,
Cinacalcet,CC(NCCCC1=CC(C(F)(F)F)=CC=C1)C1=CC=CC2=CC=CC=C12,"InChI=1S/C22H22F3N/c1-16(20-13-5-10-18-9-2-3-12-21(18)20)26-14-6-8-17-7-4-11-19(15-17)22(23,24)25/h2-5,7,9-13,15-16,26H,6,8,14H2,1H3/t16-/m1/s1",Hydrocinnamic acid,O=C(O)CCC1=CC=CC=C1,XMIIGOLPHOKFCH-UHFFFAOYSA-N,,0.19,
Cinacalcet,CC(NCCCC1=CC(C(F)(F)F)=CC=C1)C1=CC=CC2=CC=CC=C12,"InChI=1S/C22H22F3N/c1-16(20-13-5-10-18-9-2-3-12-21(18)20)26-14-6-8-17-7-4-11-19(15-17)22(23,24)25/h2-5,7,9-13,15-16,26H,6,8,14H2,1H3/t16-/m1/s1",hydroxy-hydrocinnamic acid,O=C(O)CCC1=CC=CC(O)=C1,QVWAEZJXDYOKEH-UHFFFAOYSA-N,,0.18,
Balsalazide,O=C(O)CCNC(=O)C1=CC=C(N=NC2=CC=C(O)C(C(=O)O)=C2)C=C1,"InChI=1S/C17H15N3O6/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23/h1-6,9,21H,7-8H2,(H,18,24)(H,22,23)(H,25,26)/b20-19+",5-aminosalicylic acid,NC1=CC(C(=O)O)=C(O)C=C1,KBOPZPXVLCULAV-UHFFFAOYSA-N,NADPH azoreductase,0.54,
Balsalazide,O=C(O)CCNC(=O)C1=CC=C(N=NC2=CC=C(O)C(C(=O)O)=C2)C=C1,"InChI=1S/C17H15N3O6/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23/h1-6,9,21H,7-8H2,(H,18,24)(H,22,23)(H,25,26)/b20-19+",4-aminobenzoyl-(beta)-alanine,NC1=CC=C(C(=O)NCCC(=O)O)C=C1,VHAXWROFYVPXMZ-UHFFFAOYSA-N,,0.5,
Sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1,"InChI=1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)",5-Hydroxysulfamethoxazole,NC1=CC=C(S(=O)(=O)NC2=NOC(CO)=C2)C=C1,CECJOLRUXWTJHV-UHFFFAOYSA-N,,0.91,
Sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1,"InChI=1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)",N-acetylsulfamethoxazole,CC(=O)NC1=CC=C(S(=O)(=O)NC2=NOC(C)=C2)C=C1,GXPIUNZCALHVBA-UHFFFAOYSA-N,"Arylamine N-acetyltransferase 1, Arylamine N-acetyltransferase 2",0.88,
5-Hydroxysulfamethoxazole,NC1=CC=C(S(=O)(=O)NC2=NOC(CO)=C2)C=C1,CECJOLRUXWTJHV-UHFFFAOYSA-N,N4-Acetyl-5-OH-sulfamethoxazole,CC(=O)NC1=CC=C(S(=O)(=O)NC2=NOC(CO)=C2)C=C1,YKWZTWOYFWCVKH-UHFFFAOYSA-N,"Arylamine N-acetyltransferase 1, Arylamine N-acetyltransferase 2",0.89,
N-acetylsulfamethoxazole,CC(=O)NC1=CC=C(S(=O)(=O)NC2=NOC(C)=C2)C=C1,GXPIUNZCALHVBA-UHFFFAOYSA-N,N4-Acetyl-5-OH-sulfamethoxazole,CC(=O)NC1=CC=C(S(=O)(=O)NC2=NOC(CO)=C2)C=C1,YKWZTWOYFWCVKH-UHFFFAOYSA-N,,0.92,
Sulfamethoxazole N4-hydroxylamine,CC1=CC(NS(=O)(=O)C2=CC=C(NO)C=C2)=NO1,MJAMPGKHIZXVFJ-UHFFFAOYSA-N,Nitroso-sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N=O)C=C2)=NO1,GHNQGDUYHCZZPT-UHFFFAOYSA-N,,0.92,
Glyburide,COC1=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCCCC3)C=C2)C=C(Cl)C=C1,"InChI=1S/C23H28ClN3O5S/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18/h7-12,15,18H,2-6,13-14H2,1H3,(H,25,28)(H2,26,27,29)",3-trans-Hydroxycyclohexyl glyburide,COC1=C(C(O)=NCCC2=CC=C(S(=O)(=O)NC(O)=NC3CCCC(O)C3)C=C2)C=C(Cl)C=C1,,"Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A7, Cytochrome P450 3A5",0.48,
Isosorbide mononitrate,O=[N+]([O-])OC1COC2C(O)COC12,"InChI=1S/C6H9NO6/c8-3-1-11-6-4(13-7(9)10)2-12-5(3)6/h3-6,8H,1-2H2/t3-,4+,5+,6+/m0/s1",Isosorbide,OC1COC2C(O)COC12,"InChI=1S/C6H10O4/c7-3-1-9-6-4(8)2-10-5(3)6/h3-8H,1-2H2/t3-,4+,5-,6-/m1/s1",,0.52,
Phylloquinone,CC(=CCC1=C(C)C(=O)C2=C(C=CC=C2)C1=O)CCCC(C)CCCC(C)CCCC(C)C,"InChI=1S/C31H46O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,18-20,22-24H,9-17,21H2,1-6H3/b25-20+/t23-,24-/m1/s1",Menatetrenone,CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCC1=C(C)C(=O)C2=CC=CC=C2C1=O,"InChI=1S/C31H40O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,12,14,16,18-20H,9-11,13,15,17,21H2,1-6H3/b23-14+,24-16+,25-20+",UbiA prenyltransferase domain-containing protein 1,0.96,
Felodipine,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=C(Cl)C(Cl)=CC=C1,"InChI=1S/C18H19Cl2NO4/c1-5-25-18(23)14-10(3)21-9(2)13(17(22)24-4)15(14)11-7-6-8-12(19)16(11)20/h6-8,15,21H,5H2,1-4H3",dehydrofelodipine,CCOC(=O)C1=C(C)N=C(C)C(C(=O)OC)=C1C1=C(Cl)C(Cl)=CC=C1,REQRUBNOOIAHMG-UHFFFAOYSA-N,Cytochrome P450 3A4,0.33,
Mycophenolic acid,COC1=C(CC=C(C)CCC(=O)O)C(O)=C2C(=O)OCC2=C1C,"InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+",6-O-desmethyl-mycophenolic acid,CC(=CCC1=C(O)C(C)=C2COC(=O)C2=C1O)CCC(=O)O,MHSRNZSBNXFMLF-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4, Cytochrome P450 3A5",0.91,
Mycophenolic acid,COC1=C(CC=C(C)CCC(=O)O)C(O)=C2C(=O)OCC2=C1C,"InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+",Mycophenolic acid-7-O-glucuronide,COC1=C(CC=C(C)CCC(=O)O)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C2C(=O)OCC2=C1C,BYFGTSAYQQIUCN-WTKPLQERSA-N,"UDP-glucuronosyltransferase 1-8, UDP-glucuronosyltransferase 1-10, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-7, UDP-glucuronosyltransferase 1-1",0.65,
Mycophenolic acid,COC1=C(CC=C(C)CCC(=O)O)C(O)=C2C(=O)OCC2=C1C,"InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+",Mycophenolic acid-acyl glucuronide,COC1=C(C)C2=C(C(=O)OC2)C(O)=C1CC=C(C)CCC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,QBMSTEZXAMABFF-UEARNRKISA-N,UDP-glucuronosyltransferase 2B7,0.72,
Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,"InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)",SR 49498,CCCCC(O)=NC1(C(O)=NCC2=CC=C(C3=CC=CC=C3C3=NNN=N3)C=C2)CCCC1,PAKGYCNZUGIDHV-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.5,
Irbesartan derivative M4,CC(O)CCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,YASLDPAAWWZGIP-UHFFFAOYSA-N,Irbesartan derivative M1,CC(O)CCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,LIDZWACDVHJFLD-UHFFFAOYSA-N,Cytochrome P450 2C9,0.94,
Irbesartan derivative M4,CC(O)CCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,YASLDPAAWWZGIP-UHFFFAOYSA-N,Irbesartan derivative M6,CC(=O)CCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,MIGTZGLTQNODIS-UHFFFAOYSA-N,,0.97,
Irbesartan derivative M1,CC(O)CCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,LIDZWACDVHJFLD-UHFFFAOYSA-N,Irbesartan derivative M2,CC(=O)CCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,VYPCFUKCQSQGKN-UHFFFAOYSA-N,,0.98,
Irbesartan derivative M6,CC(=O)CCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,MIGTZGLTQNODIS-UHFFFAOYSA-N,Irbesartan derivative M2,CC(=O)CCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,VYPCFUKCQSQGKN-UHFFFAOYSA-N,,0.93,
Mercaptopurine,S=C1N=CNC2=C1NC=N2,"InChI=1S/C5H4N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)",6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,Hypoxanthine-guanine phosphoribosyltransferase,0.19,
Mercaptopurine,S=C1N=CNC2=C1NC=N2,"InChI=1S/C5H4N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)",8-hydroxythioguanine,OC1=NC2=C(N1)C(=S)N=CN2,OIZCDCVIFRRJFF-UHFFFAOYSA-N,Aldehyde oxidase,0.73,
6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,Thioxanthine monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,WMRIOGFRJLQENF-UUOKFMHZSA-N,GMP synthase [glutamine-hydrolyzing],0.93,
6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,Methyl-thioinosine 5'-monophospate,CSC1=NC=NC2=C1N=CN2C1OC(COP(=O)(O)O)C(O)C1O,BMYFUCYXRGTQQL-IOSLPCCCSA-N,Thiopurine S-methyltransferase,0.96,
6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,6-Mercaptopurine riboside,OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,NKGPJODWTZCHGF-KQYNXXCUSA-N,,0.93,
Thioxanthine monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,WMRIOGFRJLQENF-UUOKFMHZSA-N,Thioguanosine monophosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)O)C(O)C1O)C=N2,BPZXYEUJBFHASJ-UUOKFMHZSA-N,GMP synthase [glutamine-hydrolyzing],0.79,
6-Mercaptopurine riboside,OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,NKGPJODWTZCHGF-KQYNXXCUSA-N,6-Methylmercaptopurine-riboside,CSC1=NC=NC2=C1N=CN2C1OC(CO)C(O)C1O,ZDRFDHHANOYUTE-IOSLPCCCSA-N,Thiopurine S-methyltransferase,0.96,
6-Methylmercaptopurine-riboside,CSC1=NC=NC2=C1N=CN2C1OC(CO)C(O)C1O,ZDRFDHHANOYUTE-IOSLPCCCSA-N,Methyl-thioinosine 5'-monophospate,CSC1=NC=NC2=C1N=CN2C1OC(COP(=O)(O)O)C(O)C1O,BMYFUCYXRGTQQL-IOSLPCCCSA-N,Adenosine kinase,0.93,
Procainamide,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,"InChI=1S/C13H21N3O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17)",N-Acetyl-3-hydroxyprocainamide,CCN(CC)CCN=C(O)C1=CC(O)=C(N=C(C)O)C=C1,REELIONXYPAEGO-UHFFFAOYSA-N,Cytochrome P450 2D6,0.22,
Tolterodine,CC1=CC(C(CCN(C(C)C)C(C)C)C2=CC=CC=C2)=C(O)C=C1,"InChI=1S/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,20,24H,13-14H2,1-5H3/t20-/m1/s1",N-Dealkylated tolterodine,CC1=CC(C(CCNC(C)C)C2=CC=CC=C2)=C(O)C=C1,CPLYUIYTJCFQJD-KRWDZBQOSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4",0.95,
Tolterodine,CC1=CC(C(CCN(C(C)C)C(C)C)C2=CC=CC=C2)=C(O)C=C1,"InChI=1S/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,20,24H,13-14H2,1-5H3/t20-/m1/s1",5-Hydroxymethyl tolterodine,CC(C)N(CCC(C1=CC=CC=C1)C1=C(O)C=CC(CO)=C1)C(C)C,DUXZAXCGJSBGDW-FQEVSTJZSA-N,Cytochrome P450 2D6,0.92,
N-Dealkylated tolterodine,CC1=CC(C(CCNC(C)C)C2=CC=CC=C2)=C(O)C=C1,CPLYUIYTJCFQJD-KRWDZBQOSA-N,N-Dealkylated 5-hydroxymethyl tolterodine,CC(C)NCCC(C1=CC=CC=C1)C1=C(O)C=CC(CO)=C1,CCZYBOXFQXWQIF-QGZVFWFLSA-N,,0.91,
5-Hydroxymethyl tolterodine,CC(C)N(CCC(C1=CC=CC=C1)C1=C(O)C=CC(CO)=C1)C(C)C,DUXZAXCGJSBGDW-FQEVSTJZSA-N,N-Dealkylated 5-hydroxymethyl tolterodine,CC(C)NCCC(C1=CC=CC=C1)C1=C(O)C=CC(CO)=C1,CCZYBOXFQXWQIF-QGZVFWFLSA-N,,0.95,
5-Hydroxymethyl tolterodine,CC(C)N(CCC(C1=CC=CC=C1)C1=C(O)C=CC(CO)=C1)C(C)C,DUXZAXCGJSBGDW-FQEVSTJZSA-N,5-Carboxylic acid tolterodine,CC(C)N(CCC(C1=CC=CC=C1)C1=C(O)C=CC(C(=O)O)=C1)C(C)C,NKTNTJFTBRPQIZ-LJQANCHMSA-N,,0.9,
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)","cis, trans-5'-Hydroxythalidomide",O=C1NC(=O)C(N2C(=O)C3=CC=CC=C3C2=O)CC1O,HHTOWVWIVBSOKC-UHFFFAOYSA-N,Cytochrome P450 2C19,0.88,
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",Thalidomide arene oxide,O=C1N=C(O)CCC1N1C(=O)C2=CC3OC3C=C2C1=O,MNALUCRLHVMELD-UHFFFAOYSA-N,"Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 2C19, Cytochrome P450 2E1",0.35,
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",4-phthalimidoglutaramic acid,NC(=O)C(CCC(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,CUBMYGDAHSAJPJ-UHFFFAOYSA-N,,0.84,
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",2-phthalimidoglutaramic acid,NC(=O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,JMKLVQRQCLMCIN-UHFFFAOYSA-N,,0.73,
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",alpha-(o-carboxybenzamido)glutarimide,O=C1CCC(NC(=O)C2=C(C(=O)O)C=CC=C2)C(=O)N1,QTUSGYNZYGYXIN-UHFFFAOYSA-N,,0.7,
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",5-Hydroxythalidomide,O=C1CCC(N2C(=O)C3=C(C=C(O)C=C3)C2=O)C(=O)N1,LJBQRRQTZUJWRC-UHFFFAOYSA-N,Cytochrome P450 2C19,0.9,
alpha-(o-carboxybenzamido)glutarimide,O=C1CCC(NC(=O)C2=C(C(=O)O)C=CC=C2)C(=O)N1,QTUSGYNZYGYXIN-UHFFFAOYSA-N,2-(o-carboxybenzamido)glutaramic acid,NC(=O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,ZIMWCUUEMGFXNW-UHFFFAOYSA-N,,0.73,
Thalidomide arene oxide,O=C1N=C(O)CCC1N1C(=O)C2=CC3OC3C=C2C1=O,MNALUCRLHVMELD-UHFFFAOYSA-N,5-Hydroxythalidomide,O=C1CCC(N2C(=O)C3=C(C=C(O)C=C3)C2=O)C(=O)N1,LJBQRRQTZUJWRC-UHFFFAOYSA-N,,0.35,
2-phthalimidoglutaramic acid,NC(=O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,JMKLVQRQCLMCIN-UHFFFAOYSA-N,2-phthalimidoglutaric acid,O=C(O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,FEFFSKLJNYRHQN-UHFFFAOYSA-N,,0.93,
5-Hydroxythalidomide,O=C1CCC(N2C(=O)C3=C(C=C(O)C=C3)C2=O)C(=O)N1,LJBQRRQTZUJWRC-UHFFFAOYSA-N,"5,6-dihydroxythalidomide",O=C1CCC(N2C(=O)C3=CC(O)=C(O)C=C3C2=O)C(=O)N1,JBCNYDFXFUMCRO-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 2C9, Cytochrome P450 1A1",0.98,
4-phthalimidoglutaramic acid,NC(=O)C(CCC(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,CUBMYGDAHSAJPJ-UHFFFAOYSA-N,2-phthalimidoglutaric acid,O=C(O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,FEFFSKLJNYRHQN-UHFFFAOYSA-N,,0.81,
4-phthalimidoglutaramic acid,NC(=O)C(CCC(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,CUBMYGDAHSAJPJ-UHFFFAOYSA-N,4-(o-carboxybenzamido)glutaramic acid,NC(=O)C(CCC(=O)O)NC(=O)C1=C(C(=O)O)C=CC=C1,JOAOKNHCUKCBBE-UHFFFAOYSA-N,,0.69,
2-phthalimidoglutaramic acid,NC(=O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,JMKLVQRQCLMCIN-UHFFFAOYSA-N,2-(o-carboxybenzamido)glutaramic acid,NC(=O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,ZIMWCUUEMGFXNW-UHFFFAOYSA-N,,0.69,
alpha-(o-carboxybenzamido)glutarimide,O=C1CCC(NC(=O)C2=C(C(=O)O)C=CC=C2)C(=O)N1,QTUSGYNZYGYXIN-UHFFFAOYSA-N,Phthalic Acid,O=C(O)C1=CC=CC=C1C(=O)O,"InChI=1S/C8H6O4/c9-7(10)5-3-1-2-4-6(5)8(11)12/h1-4H,(H,9,10)(H,11,12)",,0.29,
2-(o-carboxybenzamido)glutaramic acid,NC(=O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,ZIMWCUUEMGFXNW-UHFFFAOYSA-N,L-Glutamine,NC(=O)CCC(N)C(=O)O,"InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1",,0.2,
2-(o-carboxybenzamido)glutaramic acid,NC(=O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,ZIMWCUUEMGFXNW-UHFFFAOYSA-N,Phthalic Acid,O=C(O)C1=CC=CC=C1C(=O)O,"InChI=1S/C8H6O4/c9-7(10)5-3-1-2-4-6(5)8(11)12/h1-4H,(H,9,10)(H,11,12)",,0.31,
4-(o-carboxybenzamido)glutaramic acid,NC(=O)C(CCC(=O)O)NC(=O)C1=C(C(=O)O)C=CC=C1,JOAOKNHCUKCBBE-UHFFFAOYSA-N,Isoglutamine,NC(=O)C(N)CCC(=O)O,"InChI=1S/C5H10N2O3/c6-3(5(7)10)1-2-4(8)9/h3H,1-2,6H2,(H2,7,10)(H,8,9)/t3-/m0/s1",,0.2,
4-(o-carboxybenzamido)glutaramic acid,NC(=O)C(CCC(=O)O)NC(=O)C1=C(C(=O)O)C=CC=C1,JOAOKNHCUKCBBE-UHFFFAOYSA-N,Phthalic Acid,O=C(O)C1=CC=CC=C1C(=O)O,"InChI=1S/C8H6O4/c9-7(10)5-3-1-2-4-6(5)8(11)12/h1-4H,(H,9,10)(H,11,12)",,0.31,
2-(o-carboxybenzamido)glutaramic acid,NC(=O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,ZIMWCUUEMGFXNW-UHFFFAOYSA-N,2-(o-carboxybenzamido)glutaric acid,O=C(O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,QIWKCQDJZPRXNS-UHFFFAOYSA-N,,0.92,
2-phthalimidoglutaric acid,O=C(O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,FEFFSKLJNYRHQN-UHFFFAOYSA-N,2-(o-carboxybenzamido)glutaric acid,O=C(O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,QIWKCQDJZPRXNS-UHFFFAOYSA-N,,0.68,
4-(o-carboxybenzamido)glutaramic acid,NC(=O)C(CCC(=O)O)NC(=O)C1=C(C(=O)O)C=CC=C1,JOAOKNHCUKCBBE-UHFFFAOYSA-N,2-(o-carboxybenzamido)glutaric acid,O=C(O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,QIWKCQDJZPRXNS-UHFFFAOYSA-N,,0.81,
2-(o-carboxybenzamido)glutaric acid,O=C(O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,QIWKCQDJZPRXNS-UHFFFAOYSA-N,Glutamic acid,NC(CCC(=O)O)C(=O)O,"InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1",,0.18,
2-(o-carboxybenzamido)glutaric acid,O=C(O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,QIWKCQDJZPRXNS-UHFFFAOYSA-N,Phthalic Acid,O=C(O)C1=CC=CC=C1C(=O)O,"InChI=1S/C8H6O4/c9-7(10)5-3-1-2-4-6(5)8(11)12/h1-4H,(H,9,10)(H,11,12)",,0.32,
Ibuprofen,CC(C)CC1=CC=C(C(C)C(=O)O)C=C1,"InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)",1-hydroxyibuprofen,CC(C(=O)O)C1=CC=C(C(O)C(C)C)C=C1,RMOQYHYFRKTDRI-UHFFFAOYSA-N,,0.78,
3-Hydroxyibuprofen,CC(CO)CC1=CC=C(C(C)C(=O)O)C=C1,HFAIHLSDLUYLQA-UHFFFAOYSA-N,Carboxy-ibuprofen,CC(CC1=CC=C(C(C)C(=O)O)C=C1)C(=O)O,DIVLBIVDYADZPL-UHFFFAOYSA-N,Cytochrome P450 2C9,0.9,
Benzylpenicillin,CC1(C)SC2C(NC(=O)CC3=CC=CC=C3)C(=O)N2C1C(=O)O,"InChI=1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1",6-aminopenicillanic acid,CC1(C)SC2C(N)C(=O)N2C1C(=O)O,NGHVIOIJCVXTGV-ALEPSDHESA-N,,0.85,
Benzylpenicillin,CC1(C)SC2C(NC(=O)CC3=CC=CC=C3)C(=O)N2C1C(=O)O,"InChI=1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1",Penicilloic acid,CC1(C)SC(C(NC(=O)CC2=CC=CC=C2)C(=O)O)NC1C(=O)O,HCYWNSXLUZRKJX-UHFFFAOYSA-N,,0.71,
Melatonin,COC1=CC2=C(C=C1)NC=C2CCNC(C)=O,"InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)",6-Hydroxymelatonin,COC1=C(O)C=C2NC=C(CCN=C(C)O)C2=C1,OMYMRCXOJJZYKE-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 1A1, Cytochrome P450 2C19",0.75,
Melatonin,COC1=CC2=C(C=C1)NC=C2CCNC(C)=O,"InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)",5-Methoxytryptamine,COC1=CC2=C(C=C1)NC=C2CCN,JTEJPPKMYBDEMY-UHFFFAOYSA-N,,0.91,
Melatonin,COC1=CC2=C(C=C1)NC=C2CCNC(C)=O,"InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)",N-Acetyl-5-hydroxytryptamine,CC(=O)NCCC1=CNC2=C1C=C(O)C=C2,MVAWJSIDNICKHF-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 1A2",0.92,
6-Hydroxymelatonin,COC1=C(O)C=C2NC=C(CCN=C(C)O)C2=C1,OMYMRCXOJJZYKE-UHFFFAOYSA-N,6-Hydroxymelatonin sulfate,COC1=C(OS(=O)(=O)O)C=C2NC=C(CCN=C(C)O)C2=C1,QQEILXDLZRLTME-UHFFFAOYSA-N,,0.81,
N-Acetyl-5-hydroxytryptamine,CC(=O)NCCC1=CNC2=C1C=C(O)C=C2,MVAWJSIDNICKHF-UHFFFAOYSA-N,N-Acetyl-5-hydroxytryptamine sulfate,CC(=O)NCCC1=CNC2=C1C=C(OS(=O)(=O)O)C=C2,UCAJZNVFRVLULS-UHFFFAOYSA-N,,0.83,
N-Acetyl-5-hydroxytryptamine,CC(=O)NCCC1=CNC2=C1C=C(O)C=C2,MVAWJSIDNICKHF-UHFFFAOYSA-N,N-Acetyl-5-hydroxytryptamine glucuronide,CC(=O)NCCC1=CNC2=C1C=C(OC1OC(C(=O)O)C(O)C(O)C1O)C=C2,DRKQFNYKSNWOTC-PDHYLSHYSA-N,UDP-glucuronosyltransferases (UGTs),0.5,
6-Hydroxymelatonin,COC1=C(O)C=C2NC=C(CCN=C(C)O)C2=C1,OMYMRCXOJJZYKE-UHFFFAOYSA-N,6-Hydroxymelatonin glucuronide,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)NC=C2CCNC(C)=O,BIRHYNBRXCOXLU-OOHXRKOZSA-N,UDP-glucuronosyltransferases (UGTs),0.53,
5-Methoxytryptamine,COC1=CC2=C(C=C1)NC=C2CCN,JTEJPPKMYBDEMY-UHFFFAOYSA-N,Pinoline,COC1=CC2=C(C=C1)NC1=C2CCNC1,QYMDEOQLJUUNOF-UHFFFAOYSA-N,,0.67,
5-Methoxytryptamine,COC1=CC2=C(C=C1)NC=C2CCN,JTEJPPKMYBDEMY-UHFFFAOYSA-N,Bufotenine,CN(C)CCC1=CNC2=C1C=C(O)C=C2,VTTONGPRPXSUTJ-UHFFFAOYSA-N,,0.86,
Bufotenine,CN(C)CCC1=CNC2=C1C=C(O)C=C2,VTTONGPRPXSUTJ-UHFFFAOYSA-N,"N,N-Dimethyltryptamine",CN(C)CCC1=CNC2=CC=CC=C12,DMULVCHRPCFFGV-UHFFFAOYSA-N,,0.81,
Glipizide,CC1=NC=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCCCC3)C=C2)N=C1,"InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28)",3-cis-Hydroxyglipizide,CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCCC(O)C3)C=C2)C=N1,GZLIUWBDTXQVBY-ZYMOGRSISA-N,,0.94,
Glipizide,CC1=NC=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCCCC3)C=C2)N=C1,"InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28)",4-trans-Hydroxyglipizide,CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(O)CC3)C=C2)C=N1,WPQWQJBFAJEUHS-FITNRVMRSA-N,Cytochrome P450 2C9,0.97,
Atorvastatin,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC=C2)=C(C2=CC=C(F)C=C2)N1CCC(O)CC(O)CC(=O)O,"InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1",ortho-hydroxyatorvastatin,CC(C)C1=C(C(O)=NC2=CC=CC=C2O)C(C2=CC=CC=C2)=C(C2=CC=C(F)C=C2)N1CCC(O)CC(O)CC(=O)O,CZBPKFICAYVHHM-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.78,
Emedastine,CCOCCN1C(N2CCCN(C)CC2)=NC2=CC=CC=C21,"InChI=1S/C17H26N4O/c1-3-22-14-13-21-16-8-5-4-7-15(16)18-17(21)20-10-6-9-19(2)11-12-20/h4-5,7-8H,3,6,9-14H2,1-2H3",5-hydroxyemedastine,CCOCCN1C(N2CCCN(C)CC2)=NC2=C1C=CC(O)=C2,JNLXTCQXMDMAOC-UHFFFAOYSA-N,,0.92,
Emedastine,CCOCCN1C(N2CCCN(C)CC2)=NC2=CC=CC=C21,"InChI=1S/C17H26N4O/c1-3-22-14-13-21-16-8-5-4-7-15(16)18-17(21)20-10-6-9-19(2)11-12-20/h4-5,7-8H,3,6,9-14H2,1-2H3",6-hydroxyemedastine,CCOCCN1C(N2CCCN(C)CC2)=NC2=C1C=C(O)C=C2,YDYQGSLFCJVMNN-UHFFFAOYSA-N,,0.9,
Benzocaine,CCOC(=O)C1=CC=C(N)C=C1,"InChI=1S/C9H11NO2/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6H,2,10H2,1H3",Aminobenzoic acid,NC1=CC=C(C(=O)O)C=C1,"InChI=1S/C7H7NO2/c8-6-3-1-5(2-4-6)7(9)10/h1-4H,8H2,(H,9,10)",,0.74,
Hesperetin,COC1=C(O)C=C(C2CC(=O)C3=C(O)C=C(O)C=C3O2)C=C1,"InChI=1S/C16H14O6/c1-21-13-3-2-8(4-10(13)18)14-7-12(20)16-11(19)5-9(17)6-15(16)22-14/h2-6,14,17-19H,7H2,1H3/t14-/m0/s1",eriodictyol,O=C1CC(C2=CC(O)=C(O)C=C2)OC2=C1C(O)=CC(O)=C2,SBHXYTNGIZCORC-ZDUSSCGKSA-N,Cytochrome P450 1A2,0.98,
Leflunomide,CC1=C(C(=O)NC2=CC=C(C(F)(F)F)C=C2)C=NO1,"InChI=1S/C12H9F3N2O2/c1-7-10(6-16-19-7)11(18)17-9-4-2-8(3-5-9)12(13,14)15/h2-6H,1H3,(H,17,18)",A771726,CC(O)=C(C#N)C(=O)NC1=CC=C(C(F)(F)F)C=C1,UTNUDOFZCWSZMS-JXMROGBWSA-N,Cytochrome P450 1A2,0.31,
Rosuvastatin,CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C2=CC=C(F)C=C2)=C1C=CC(O)CC(O)CC(=O)O,"InChI=1S/C22H28FN3O6S/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32/h5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30)/b10-9+/t16-,17-/m1/s1",N-Desmethylrosuvastatin,CC(C)C1=C(C=CC(O)CC(O)CC(=O)O)C(C2=CC=C(F)C=C2)=NC(NS(C)(=O)=O)=N1,,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.93,
Rosuvastatin,CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C2=CC=C(F)C=C2)=C1C=CC(O)CC(O)CC(=O)O,"InChI=1S/C22H28FN3O6S/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32/h5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30)/b10-9+/t16-,17-/m1/s1",Rosuvastatin 5 S-lactone,CC(C)C1=C(C=CC2CC(O)CC(=O)O2)C(C2=CC=C(F)C=C2)=NC(N(C)S(C)(=O)=O)=N1,,Cytochrome P450 2C9,0.94,
Sertraline,CNC1CCC(C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C21,"InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/t12-,17-/m0/s1",norsertraline,NC1CCC(C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C21,SRPXSILJHWNFMK-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2D6, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2B6",0.91,
Nifedipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+](=O)[O-],"InChI=1S/C17H18N2O6/c1-9-13(16(20)24-3)15(14(10(2)18-9)17(21)25-4)11-7-5-6-8-12(11)19(22)23/h5-8,15,18H,1-4H3",dehydronifedipine,COC(=O)C1=C(C2=CC=CC=C2[N+](=O)[O-])C(C(=O)OC)=C(C)N=C1C,UMQHJQGNGLQJPF-UHFFFAOYSA-N,Cytochrome P450 3A4,0.35,
Amiodarone,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(C=CC=C2)O1,"InChI=1S/C25H29I2NO3/c1-4-7-11-22-23(18-10-8-9-12-21(18)31-22)24(29)17-15-19(26)25(20(27)16-17)30-14-13-28(5-2)6-3/h8-10,12,15-16H,4-7,11,13-14H2,1-3H3",Desethylamiodarone,CCCCC1=C(C(=O)C2=CC(I)=C(OCCNCC)C(I)=C2)C2=CC=CC=C2O1,VXOKDLACQICQFA-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 1A2, Cytochrome P450 2D6, Cytochrome P450 2C8, Cytochrome P450 3A4",0.99,
Gliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)C=C1,"InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)/t12-,13+",7--Hydroxygliclazide,CC1=CC=C(S(=O)(=O)NC(O)=NN2CC3CC(O)CC3C2)C=C1,JMHDCYDSYHLATB-ITGUQSILSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2C18, Cytochrome P450 2C8",0.51,
Gliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)C=C1,"InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)/t12-,13+",6--Hydroxygliclazide,CC1=CC=C(S(=O)(=O)NC(O)=NN2CC3CCC(O)C3C2)C=C1,VUUZEWXIRFGRFE-IACUBPJLSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2C18, Cytochrome P450 2C8",0.48,
Gliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)C=C1,"InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)/t12-,13+",Methylhydroxygliclazide,O=S(=O)(NC(O)=NN1CC2CCCC2C1)C1=CC=C(CO)C=C1,IHCHVBQHVIUSTM-BETUJISGSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2C18",0.54,
Gliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)C=C1,"InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)/t12-,13+",7--Hydroxygliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CC(O)CC3C2)C=C1,JMHDCYDSYHLATB-CLLJXQQHSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2C18, Cytochrome P450 2C8",0.9,
Gliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)C=C1,"InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)/t12-,13+",6--Hydroxygliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CCC(O)C3C2)C=C1,VUUZEWXIRFGRFE-YUTCNCBUSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2C18, Cytochrome P450 2C8",0.82,
Methylhydroxygliclazide,O=S(=O)(NC(O)=NN1CC2CCCC2C1)C1=CC=C(CO)C=C1,IHCHVBQHVIUSTM-BETUJISGSA-N,Carboxygliclazide,O=C(NN1CC2CCCC2C1)NS(=O)(=O)C1=CC=C(C(=O)O)C=C1,DSNDPTBTZSQWJS-TXEJJXNPSA-N,,0.56,
Tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1,"InChI=1S/C12H18N2O3S/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15)",4-Hydroxy tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(CO)C=C1,SJRHYONYKZIRPM-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 2C9",0.93,
Rabeprazole,COCCCOC1=C(C)C(CS(=O)C2=NC3=CC=CC=C3N2)=NC=C1,"InChI=1S/C18H21N3O3S/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18/h3-4,6-9H,5,10-12H2,1-2H3,(H,20,21)",Active Metabolite of Rabeprazole,COCCCOC1=C(C)C=[N+]2C3=NC4=C(C=CC=C4)N3SCC2=C1,HGSXCFCOXJLVEZ-UHFFFAOYSA-N,,0.45,
Proguanil,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1,"InChI=1S/C11H16ClN5/c1-7(2)15-10(13)17-11(14)16-9-5-3-8(12)4-6-9/h3-7H,1-2H3,(H5,13,14,15,16,17)",cycloguanil,CC1(C)N=C(N)N=C(N)N1C1=CC=C(Cl)C=C1,QMNFFXRFOJIOKZ-UHFFFAOYSA-N,Cytochrome P450 2C19,0.31,
Pioglitazone,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,"InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)",Pioglitazone metabolite M-I,O=C1NC(=O)C(CC2=CC=C(O)C=C2)S1,NKOHRVBBQISBSB-UHFFFAOYSA-N,,0.67,
Pioglitazone,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,"InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)",Pioglitazone metabolite M-II,CCC1=CN=C(C(O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,RMTFRGFLVHAYCI-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4",0.89,
Pioglitazone,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,"InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)",Pioglitazone metabolite M-VI,O=C1NC(=O)C(CC2=CC=C(OCCC3=NC=C(C(=O)O)C=C3)C=C2)S1,SLOBZACXYXBLIT-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4",0.87,
Pioglitazone,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,"InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)",Pioglitazone metabolite M-V,O=C(O)CC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,OIQJTMMAMWFMQR-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4",0.94,
Pioglitazone,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,"InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)",Pioglitazone metabolite M-IV,CC(O)C1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,OXVFDZYQLGRLCD-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4",0.93,
Pioglitazone metabolite M-II,CCC1=CN=C(C(O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,RMTFRGFLVHAYCI-UHFFFAOYSA-N,Mitoglitazone,CCC1=CN=C(C(=O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,IRNJSRAGRIZIHD-UHFFFAOYSA-N,,0.8,
Pioglitazone metabolite M-II,CCC1=CN=C(C(O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,RMTFRGFLVHAYCI-UHFFFAOYSA-N,Pioglitazone metabolite M-XI,CC(O)C1=CN=C(C(O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,YYDPBNAZWVLEQF-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4",0.97,
Pioglitazone metabolite M-V,O=C(O)CC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,OIQJTMMAMWFMQR-UHFFFAOYSA-N,Pioglitazone metabolite M-VI,O=C1NC(=O)C(CC2=CC=C(OCCC3=NC=C(C(=O)O)C=C3)C=C2)S1,SLOBZACXYXBLIT-UHFFFAOYSA-N,,0.83,
Pioglitazone metabolite M-IV,CC(O)C1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,OXVFDZYQLGRLCD-UHFFFAOYSA-N,Pioglitazone metabolite M-III,CC(=O)C1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,JMLKLMFMQRAJNI-UHFFFAOYSA-N,,0.87,
Pioglitazone metabolite M-IV,CC(O)C1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,OXVFDZYQLGRLCD-UHFFFAOYSA-N,Pioglitazone metabolite M-XI,CC(O)C1=CN=C(C(O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,YYDPBNAZWVLEQF-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4",0.92,
Carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,"InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3",8-Hydroxycarbazolylcarvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=C(N2)C(O)=CC=C1,GPPVNZVFGNMPNR-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 1A1",0.91,
Carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,"InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3",4'-Hydroxyphenylcarvedilol,COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC(O)=C1,ZCJHEORDHXCJNB-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 2E1, Cytochrome P450 2C9, Cytochrome P450 3A4",0.94,
Carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,"InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3",5'-Hydroxyphenylcarvedilol,COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=C(O)C=C1,PVUVZUBTCLBJMT-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 2C9, Cytochrome P450 3A4",0.93,
Carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,"InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3",1-Hydroxyphenylcarvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=C(O)C2=C1C1=CC=CC=C1N2,UQJJKVKQRTUYJW-UHFFFAOYSA-N,"Prostaglandin G/H synthase 1, Cytochrome P450 2D6, Cytochrome P450 1A2, Cytochrome P450 1A1",0.89,
Sulfinpyrazone,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,"InChI=1S/C23H20N2O3S/c26-22-21(16-17-29(28)20-14-8-3-9-15-20)23(27)25(19-12-6-2-7-13-19)24(22)18-10-4-1-5-11-18/h1-15,21H,16-17H2",Sulfinpyrazone sulfide,O=C1C(CCSC2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,PLGXGMUJUXKCDD-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.93,
Cefapirin,CC(=O)OCC1=C(C(=O)O)N2C(=O)C(NC(=O)CSC3=CC=NC=C3)C2SC1,"InChI=1S/C17H17N3O6S2/c1-9(21)26-6-10-7-28-16-13(15(23)20(16)14(10)17(24)25)19-12(22)8-27-11-2-4-18-5-3-11/h2-5,13,16H,6-8H2,1H3,(H,19,22)(H,24,25)/t13-,16-/m1/s1",Desacetylcephapirin,O=C(CSC1=CC=NC=C1)NC1C(=O)N2C(C(=O)O)=C(CO)CSC12,IOFHZPVEQXTSQW-UHFFFAOYSA-N,,0.95,
Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=CC=C12,"InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3",Doxepin N-oxide,C[N+](C)([O-])CCC=C1C2=C(C=CC=C2)COC2=C1C=CC=C2,QJCSDPQQGVJGQY-GZTJUZNOSA-N,,0.97,
Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=CC=C12,"InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3",(E)-2-hydroxydoxepin,CN(C)CCC=C1C2=C(C=CC=C2)COC2=CC=C(O)C=C12,GRQPGTWGEQWMMM-IUXPMGMMSA-N,Cytochrome P450 2D6,0.93,
N-desmethyldoxepin,CNCCC=C1C2=CC=CC=C2COC2=CC=CC=C12,HVKCEFHNSNZIHO-YBEGLDIGSA-N,Didesmethyl doxepin,NCCC=C1C2=CC=CC=C2COC2=CC=CC=C12,HLUSHBJOSPBFOC-OQLLNIDSSA-N,,0.99,
Doxepin N-oxide,C[N+](C)([O-])CCC=C1C2=C(C=CC=C2)COC2=C1C=CC=C2,QJCSDPQQGVJGQY-GZTJUZNOSA-N,Doxepin N-oxide glucuronide,C[N+](C)(CCC=C1C2=C(C=CC=C2)COC2=C1C=CC=C2)OC1OC(C(=O)O)C(O)C(O)C1O,NLZMYODDTAMNJM-GOSZAKIASA-O,,0.65,
(E)-2-hydroxydoxepin,CN(C)CCC=C1C2=C(C=CC=C2)COC2=CC=C(O)C=C12,GRQPGTWGEQWMMM-IUXPMGMMSA-N,Hydroxydoxepin glucuronide,CN(C)CCC=C1C2=C(C=CC=C2)COC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C12,RECOUBTVNVWWDB-IUXPMGMMSA-N,,0.64,
N-desmethyldoxepin,CNCCC=C1C2=CC=CC=C2COC2=CC=CC=C12,HVKCEFHNSNZIHO-YBEGLDIGSA-N,Hydroxydesmethyl doxepin,CNCCC=C1C2=C(C=CC=C2)COC2=C1C=C(O)C=C2,LUWRONBNZDYVBL-APSNUPSMSA-N,Cytochrome P450 2D6,0.93,
(E)-2-hydroxydoxepin,CN(C)CCC=C1C2=C(C=CC=C2)COC2=CC=C(O)C=C12,GRQPGTWGEQWMMM-IUXPMGMMSA-N,(E)-2-hydroxy-N-desmethyldoxepin,CNCCC=C1C2=C(C=CC=C2)COC2=C1C=C(O)C=C2,LUWRONBNZDYVBL-FRKPEAEDSA-N,,0.99,
Hydroxydesmethyl doxepin,CNCCC=C1C2=C(C=CC=C2)COC2=C1C=C(O)C=C2,LUWRONBNZDYVBL-APSNUPSMSA-N,Hydroxydesmethyl doxepin glucuronide,CN(C)CCC=C1C2=C(C=CC=C2)COC2=C1C=C(OC1OC(C(=O)O)C(O)C(O)C1O)C=C2,RECOUBTVNVWWDB-CAOOACKPSA-N,,0.64,
Nefazodone,CCC1=NN(CCCN2CCN(C3=CC(Cl)=CC=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,"InChI=1S/C25H32ClN5O2/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22/h3-6,8-11,20H,2,7,12-19H2,1H3",hydroxynefazodone,CC(O)C1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,VKGQYGXMUUBRBD-UHFFFAOYSA-N,Cytochrome P450 3A4,0.91,
Nefazodone,CCC1=NN(CCCN2CCN(C3=CC(Cl)=CC=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,"InChI=1S/C25H32ClN5O2/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22/h3-6,8-11,20H,2,7,12-19H2,1H3",m-Chlorophenylpiperazine,ClC1=CC(N2CCNCC2)=CC=C1,"InChI=1S/C10H13ClN2/c11-9-2-1-3-10(8-9)13-6-4-12-5-7-13/h1-3,8,12H,4-7H2",Cytochrome P450 3A4,0.26,
2-hydroxydesipramine,CNCCCN1C2=CC=CC=C2CCC2=CC(O)=CC=C21,NVJBOLMRGMDGLD-UHFFFAOYSA-N,2-hydroxy-desipramine glucuronide,CNCCCN1C2=CC=CC=C2CCC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C21,XJHAOJJEVSPMBA-QMDPOKHVSA-N,,0.56,
Gemifloxacin,CON=C1CN(C2=NC3=C(C=C2F)C(=O)C(C(=O)O)=CN3C2CC2)CC1CN,"InChI=1S/C18H20FN5O4/c1-28-22-14-8-23(6-9(14)5-20)17-13(19)4-11-15(25)12(18(26)27)7-24(10-2-3-10)16(11)21-17/h4,7,9-10H,2-3,5-6,8,20H2,1H3,(H,26,27)/b22-14+",N-acetyl gemifloxacin,CON=C1CN(C2=NC3=C(C=C2F)C(=O)C(C(=O)O)=CN3C2CC2)CC1NC(C)=O,ZLRGFKRHAFQIIT-HZHRSRAPSA-N,,0.89,
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,"InChI=1S/C13H18ClNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,15H,1-4H3",S-Hydroxybupropion,CC(NC(C)(C)CO)C(=O)C1=CC(Cl)=CC=C1,AKOAEVOSDHIVFX-SECBINFHSA-N,"Cytochrome P450 2B6, Cytochrome P450 2E1, Cytochrome P450 3A4, Cytochrome P450 2C19",0.92,
Procarbazine,CNNCC1=CC=C(C(=O)NC(C)C)C=C1,"InChI=1S/C12H19N3O/c1-9(2)15-12(16)11-6-4-10(5-7-11)8-14-13-3/h4-7,9,13-14H,8H2,1-3H3,(H,15,16)",N-isopropylterephthalamic acid,CC(C)NC(=O)C1=CC=C(C(=O)O)C=C1,PRCGIFCKPACTDG-UHFFFAOYSA-N,,0.73,
Orphenadrine,CC1=CC=CC=C1C(OCCN(C)C)C1=CC=CC=C1,"InChI=1S/C18H23NO/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16/h4-12,18H,13-14H2,1-3H3",N-demethyl orphenadrine,CNCCOC(C1=CC=CC=C1)C1=CC=CC=C1C,PNYKGCPSFKLFKA-UHFFFAOYSA-N,,0.97,
Orphenadrine,CC1=CC=CC=C1C(OCCN(C)C)C1=CC=CC=C1,"InChI=1S/C18H23NO/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16/h4-12,18H,13-14H2,1-3H3","N,N-didemethyl orphenadrine",CC1=C(C(OCCN)C2=CC=CC=C2)C=CC=C1,BJVWYJOLTICWGB-UHFFFAOYSA-N,,0.94,
Phenobarbital,CCC1(C2=CC=CC=C2)C(=O)NC(=O)NC1=O,"InChI=1S/C12H12N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h3-7H,2H2,1H3,(H2,13,14,15,16,17)",p-Hydroxyphenobarbital,CCC1(C2=CC=C(O)C=C2)C(=O)NC(=O)NC1=O,IEPXMKJNWPXDBP-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.94,
p-Hydroxyphenobarbital,CCC1(C2=CC=C(O)C=C2)C(=O)NC(=O)NC1=O,IEPXMKJNWPXDBP-UHFFFAOYSA-N,Phenobarbital O-sulfate,CCC1(C2=CC=C(OS(=O)(=O)O)C=C2)C(=O)NC(=O)NC1=O,SBVMQBDFNZJWGL-UHFFFAOYSA-N,,0.88,
p-Hydroxyphenobarbital,CCC1(C2=CC=C(O)C=C2)C(=O)NC(=O)NC1=O,IEPXMKJNWPXDBP-UHFFFAOYSA-N,Phenobarbital O-glucuronide,CCC1(C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C(=O)NC(=O)NC1=O,RQTUXVFRLKPUJG-ZAOAHOKWSA-N,,0.59,
4-Hydroxyifosfamide,O=P1(NCCCl)OCCC(O)N1CCCl,JHUJMHKRHQPBRG-UHFFFAOYSA-N,4-Ketoifosfamide,O=C1CCOP(=O)(NCCCl)N1CCCl,PEZLCTIXHCOEOG-UHFFFAOYSA-N,,0.56,
4-Hydroxyifosfamide,O=P1(NCCCl)OCCC(O)N1CCCl,JHUJMHKRHQPBRG-UHFFFAOYSA-N,aldoifosfamide,O=CCCOP(=O)(NCCCl)NCCCl,IPTJZZUYNOWWHM-UHFFFAOYSA-N,,0.32,
4-Hydroxyifosfamide,O=P1(NCCCl)OCCC(O)N1CCCl,JHUJMHKRHQPBRG-UHFFFAOYSA-N,4-Thioifosfamide,NC(CCC(=O)NC(CSC1CCOP(=O)(NCCCl)N1CCCl)C(=O)NCC(=O)O)C(=O)O,UINSPYHKZALITP-XNZWOTSQSA-N,,0.42,
aldoifosfamide,O=CCCOP(=O)(NCCCl)NCCCl,IPTJZZUYNOWWHM-UHFFFAOYSA-N,Alcoifosfamide,O=P(NCCCl)(NCCCl)OCCCO,JOAQXFLTMDRBOD-UHFFFAOYSA-N,,0.86,
aldoifosfamide,O=CCCOP(=O)(NCCCl)NCCCl,IPTJZZUYNOWWHM-UHFFFAOYSA-N,Carboxylifosfamide,O=C(O)CCOP(=O)(NCCCl)NCCCl,DNDBVHDNSYHKLI-UHFFFAOYSA-N,Retinal dehydrogenase 1,0.89,
aldoifosfamide,O=CCCOP(=O)(NCCCl)NCCCl,IPTJZZUYNOWWHM-UHFFFAOYSA-N,Isophosphamide mustard,O=P(O)(NCCCl)NCCCl,BKCJZNIZRWYHBN-UHFFFAOYSA-N,,0.5,
Isophosphamide mustard,O=P(O)(NCCCl)NCCCl,BKCJZNIZRWYHBN-UHFFFAOYSA-N,Ifosforamide Aziridinium,O=P(O)(NCCCl)[NH+]1CC1,NAFVGKNCETZZFN-UHFFFAOYSA-O,,0.65,
Propafenone,CCCNCC(O)COC1=C(C(=O)CCC2=CC=CC=C2)C=CC=C1,"InChI=1S/C21H27NO3/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17/h3-11,18,22-23H,2,12-16H2,1H3",N-desalkylpropafenone,NCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1,HIGKMVIPYOFHBP-UHFFFAOYSA-N,Cytochrome P450 1A2,0.94,
Propafenone,CCCNCC(O)COC1=C(C(=O)CCC2=CC=CC=C2)C=CC=C1,"InChI=1S/C21H27NO3/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17/h3-11,18,22-23H,2,12-16H2,1H3",5-hydroxypropafenone,CCCNCC(O)COC1=C(C(=O)CCC2=CC=CC=C2)C=C(O)C=C1,LUTWDNUXHDYZRA-UHFFFAOYSA-N,Cytochrome P450 2D6,0.9,
Domperidone,O=C1NC2=CC=CC=C2N1CCCN1CCC(N2C(=O)NC3=C2C=CC(Cl)=C3)CC1,"InChI=1S/C22H24ClN5O2/c23-15-6-7-20-18(14-15)25-22(30)28(20)16-8-12-26(13-9-16)10-3-11-27-19-5-2-1-4-17(19)24-21(27)29/h1-2,4-7,14,16H,3,8-13H2,(H,24,29)(H,25,30)","5-Chloro-1,3-dihydro-1-(4-piperidinyl)-2H-benzimidazol-2-one",OC1=NC2=C(C=CC(Cl)=C2)N1C1CCNCC1,DOAYWDKFDPSTSV-UHFFFAOYSA-N,Cytochrome P450 3A4,0.7,
Desflurane,FC(F)OC(F)C(F)(F)F,"InChI=1S/C3H2F6O/c4-1(3(7,8)9)10-2(5)6/h1-2H",trifluoroacetic acid,O=C(O)C(F)(F)F,DTQVDTLACAAQTR-UHFFFAOYSA-N,Cytochrome P450 2E1,0.24,
Oxymorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3(O)C1C5,"InChI=1S/C17H19NO4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,12,15,19,21H,4-8H2,1H3/t12-,15+,16+,17-/m1/s1",noroxycodone,COC1=C2OC3C(=O)CCC4(O)C5CC(=C2C34CCN5)C=C1,RIKMCJUNPCRFMW-ISWURRPUSA-N,Cytochrome P450 3A4,0.98,
Oxymorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3(O)C1C5,"InChI=1S/C17H19NO4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,12,15,19,21H,4-8H2,1H3/t12-,15+,16+,17-/m1/s1",alpha-noroxycodol,COC1=C2OC3C(O)CCC4(O)C5CC(=C2C34CCN5)C=C1,KFWOOLJUSYSBAD-NZQXGWJPSA-N,Cytochrome P450 3A4,0.91,
Oxymorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3(O)C1C5,"InChI=1S/C17H19NO4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,12,15,19,21H,4-8H2,1H3/t12-,15+,16+,17-/m1/s1",alpha-oxycodol,COC1=C2OC3C(O)CCC4(O)C5CC(=C2C34CCN5C)C=C1,LHTAJTFGGUDLRH-FHHXKLHRSA-N,Cytochrome P450 2D6,0.93,
Flecainide,O=C(NCC1CCCCN1)C1=C(OCC(F)(F)F)C=CC(OCC(F)(F)F)=C1,"InChI=1S/C17H20F6N2O3/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26)",Meta-O-dealkylated flecainide,O=C(NCC1CCCCN1)C1=CC(O)=CC=C1OCC(F)(F)F,FVJPPEWHZCSTAC-UHFFFAOYSA-N,,0.96,
Captopril,CC(CS)C(=O)N1CCCC1C(=O)O,"InChI=1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7+/m1/s1",captopril-cysteine disulfide,CC(CSSCC(N)C(=O)O)C(=O)N1CCCC1C(=O)O,NEEBNBLVYKFVTK-VGMNWLOBSA-N,,0.81,
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,"InChI=1S/C16H11ClN4/c17-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)18-9-15-20-19-10-21(14)15/h1-8,10H,9H2",4-hydroxy-estazolam,OC1N=C(C2=CC=CC=C2)C2=C(C=CC(Cl)=C2)N2C=NN=C12,LJIJJCXFWLORDQ-UHFFFAOYSA-N,,0.88,
Finasteride,CC(C)(C)NC(=O)C1CCC2C3CCC4NC(=O)C=CC4(C)C3CCC12C,"InChI=1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1",omega-hydroxyfinasteride,CC(C)(O)N=C(O)C1CCC2C3CCC4N=C(O)C=CC4(C)C3CCC12C,LVMYOUOJYSDZSC-UHFFFAOYSA-N,Cytochrome P450 3A4,0.39,
Halofantrine,CCCCN(CCCC)CCC(O)C1=C2C=CC(C(F)(F)F)=CC2=C2C=C(Cl)C=C(Cl)C2=C1,"InChI=1S/C26H30Cl2F3NO/c1-3-5-10-32(11-6-4-2)12-9-25(33)23-16-22-21(14-18(27)15-24(22)28)20-13-17(26(29,30)31)7-8-19(20)23/h7-8,13-16,25,33H,3-6,9-12H2,1-2H3",N-debutylhalofantrine,CCCCNCCC(O)C1=C2C=CC(C(F)(F)F)=CC2=C2C=C(Cl)C=C(Cl)C2=C1,FYHCHSNOXWVJJT-UHFFFAOYSA-N,Cytochrome P450 3A4,0.96,
Dantrolene,O=C1CN(N=CC2=CC=C(C3=CC=C([N+](=O)[O-])C=C3)O2)C(=O)N1,"InChI=1S/C14H10N4O5/c19-13-8-17(14(20)16-13)15-7-11-5-6-12(23-11)9-1-3-10(4-2-9)18(21)22/h1-7H,8H2,(H,16,19,20)/b15-7+",5-hydroxydantrolene,O=C1N=C(O)C(O)N1N=CC1=CC=C(C2=CC=C([N+](=O)[O-])C=C2)O1,PGORTQZSSAZLCK-VIZOYTHASA-N,,0.65,
Ketamine,CNC1(C2=CC=CC=C2Cl)CCCCC1=O,"InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3",Norketamine,NC1(C2=C(Cl)C=CC=C2)CCCCC1=O,BEQZHFIKTBVCAU-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2B6, Cytochrome P450 3A4",0.84,
Ketamine,CNC1(C2=CC=CC=C2Cl)CCCCC1=O,"InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3",6-Hydroxyketamine,CNC1(C2=CC=CC=C2Cl)CCCC(O)C1=O,WAXHSFGMMWDOAE-UHFFFAOYSA-N,,0.83,
Ketamine,CNC1(C2=CC=CC=C2Cl)CCCCC1=O,"InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3",5-Hydroxyketamine,CNC1(C2=CC=CC=C2Cl)CCC(O)CC1=O,GJRAGJDIUMHOLU-UHFFFAOYSA-N,,0.89,
Ketamine,CNC1(C2=CC=CC=C2Cl)CCCCC1=O,"InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3",4-Hydroxyketamine,CNC1(C2=CC=CC=C2Cl)CC(O)CCC1=O,RHZRNGQIDYHQPV-UHFFFAOYSA-N,,0.85,
Norketamine,NC1(C2=C(Cl)C=CC=C2)CCCCC1=O,BEQZHFIKTBVCAU-UHFFFAOYSA-N,4-Hydroxynorketamine,NC1(C2=CC=CC=C2Cl)CC(O)CCC1=O,SNESGYGKISOJIN-UHFFFAOYSA-N,,0.84,
Norketamine,NC1(C2=C(Cl)C=CC=C2)CCCCC1=O,BEQZHFIKTBVCAU-UHFFFAOYSA-N,5-Hydroxynorketamine,NC1(C2=CC=CC=C2Cl)CCC(O)CC1=O,JNIMTHZVAYLUSL-UHFFFAOYSA-N,,0.87,
Norketamine,NC1(C2=C(Cl)C=CC=C2)CCCCC1=O,BEQZHFIKTBVCAU-UHFFFAOYSA-N,,NC1(C2=CC=CC=C2Cl)CCCC(O)C1=O,CFBVGSWSOJBYGC-UHFFFAOYSA-N,,0.81,
6-Hydroxyketamine,CNC1(C2=CC=CC=C2Cl)CCCC(O)C1=O,WAXHSFGMMWDOAE-UHFFFAOYSA-N,6-Hydroxynorketamine,NC1(C2=CC=CC=C2Cl)CCCC(O)C1=O,CFBVGSWSOJBYGC-UHFFFAOYSA-N,,0.86,
5-Hydroxyketamine,CNC1(C2=CC=CC=C2Cl)CCC(O)CC1=O,GJRAGJDIUMHOLU-UHFFFAOYSA-N,5-Hydroxynorketamine,NC1(C2=CC=CC=C2Cl)CCC(O)CC1=O,JNIMTHZVAYLUSL-UHFFFAOYSA-N,,0.86,
4-Hydroxyketamine,CNC1(C2=CC=CC=C2Cl)CC(O)CCC1=O,RHZRNGQIDYHQPV-UHFFFAOYSA-N,4-Hydroxynorketamine,NC1(C2=CC=CC=C2Cl)CC(O)CCC1=O,SNESGYGKISOJIN-UHFFFAOYSA-N,,0.86,
Paclitaxel,CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(NC(=O)C3=CC=CC=C3)C3=CC=CC=C3)C(C)=C1C2(C)C,"InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1","6, 3'-p-dihydroxypaclitaxel",CC(=O)OC1C(=O)C2(C)C(O)C(O)C3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(NC(=O)C3=CC=CC=C3)C3=CC=C(O)C=C3)C(C)=C1C2(O)O,VCMRTKHRFJRAJE-UHFFFAOYSA-N,Cytochrome P450 3A4,0.91,
Saquinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(O)C(CC1=CC=CC=C1)NC(=O)C(CC(N)=O)NC(=O)C1=NC2=C(C=CC=C2)C=C1,"InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1",M2 di-hydroxylated metabolite,CN=C(O)C(O)C1=CC2=C(C=CN2C2CCN(CCC3=CC=CC=C3F)CC2)C(O)=C1,KMSSEFLPBNDJAH-UHFFFAOYSA-N,Cytochrome P450 3A4,0.41,
Levodopa,NC(CC1=CC(O)=C(O)C=C1)C(=O)O,"InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1",Dopamine,NCCC1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",Aromatic-L-amino-acid decarboxylase,0.63,
Dopamine,NCCC1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",3-Methoxytyramine,COC1=C(O)C=CC(CCN)=C1,,Catechol O-methyltransferase,0.76,
Dopamine,NCCC1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",Norepinephrine,NCC(O)C1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1",Dopamine beta-hydroxylase,0.69,
Sevoflurane,FCOC(C(F)(F)F)C(F)(F)F,"InChI=1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2",Hexafluoroisopropanol,OC(C(F)(F)F)C(F)(F)F,BYEAHWXPCBROCE-UHFFFAOYSA-N,Cytochrome P450 2E1,0.59,
Epoprostenol,CCCCCC(O)C=CC1C(O)CC2OC(=CCCCC(=O)O)CC21,"InChI=1S/C20H32O5/c1-2-3-4-7-14(21)10-11-16-17-12-15(8-5-6-9-20(23)24)25-19(17)13-18(16)22/h8,10-11,14,16-19,21-22H,2-7,9,12-13H2,1H3,(H,23,24)/b11-10+,15-8-/t14-,16+,17+,18+,19-/m0/s1","6,15-Diketo-13,14-dihydro-PGF1-alpha",CCCCCC(=O)C=CC1C(O)CC(O)C1CC(=O)CCCCC(=O)O,VKPWUQVGTPVEMU-QVPQFPIISA-N,,0.47,
Epoprostenol,CCCCCC(O)C=CC1C(O)CC2OC(=CCCCC(=O)O)CC21,"InChI=1S/C20H32O5/c1-2-3-4-7-14(21)10-11-16-17-12-15(8-5-6-9-20(23)24)25-19(17)13-18(16)22/h8,10-11,14,16-19,21-22H,2-7,9,12-13H2,1H3,(H,23,24)/b11-10+,15-8-/t14-,16+,17+,18+,19-/m0/s1",6-Keto-PGF1-alpha,CCCCCC(O)C=CC1C(O)CC(O)C1CC(=O)CCCCC(=O)O,KFGOFTHODYBSGM-ZUNNJUQCSA-N,,0.52,
Gemfibrozil,CC1=CC(OCCCC(C)(C)C(=O)O)=C(C)C=C1,"InChI=1S/C15H22O3/c1-11-6-7-12(2)13(10-11)18-9-5-8-15(3,4)14(16)17/h6-7,10H,5,8-9H2,1-4H3,(H,16,17)",Gemfibrozil 1-beta-glucuronide,CC1=CC(OCCCC(C)(C)C(=O)OC2OC(C(=O)O)C(O)C(O)C2O)=C(C)C=C1,CJMNXSKEVNPQOK-UHFFFAOYSA-N,"UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 2B4, UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 2B17",0.41,
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,"InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3",8-hydroxyclomipramine,CN(C)CCCN1C2=CC=C(O)C=C2CCC2=CC=C(Cl)C=C21,PVKACZKLKCTAHR-UHFFFAOYSA-N,Cytochrome P450 2D6,0.89,
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,"InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3",clomipramine N-oxide,C[N+](C)([O-])CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,ARNOTLDVJSFYBP-UHFFFAOYSA-N,,0.97,
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,"InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3",2-hydroxyclomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(O)=C(Cl)C=C21,QXZNSJJZRXNDJQ-UHFFFAOYSA-N,Cytochrome P450 2D6,0.85,
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,"InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3",Desmethylclomipramine,CNCCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,VPIXQGUBUKFLRF-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C19, Cytochrome P450 3A4",0.99,
Desmethylclomipramine,CNCCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,VPIXQGUBUKFLRF-UHFFFAOYSA-N,didesmethylclomipramine,NCCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,LHDZEFLZJRLKPT-UHFFFAOYSA-N,Cytochrome P450 1A2,0.99,
2-hydroxyclomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(O)=C(Cl)C=C21,QXZNSJJZRXNDJQ-UHFFFAOYSA-N,2-hydroxydesmethyl clomipramine,CNCCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C(O)=C2,BTEFPKOBUHDJSN-UHFFFAOYSA-N,Cytochrome P450 2D6,0.99,
2-hydroxyclomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(O)=C(Cl)C=C21,QXZNSJJZRXNDJQ-UHFFFAOYSA-N,2-hydroxyclomipramine glucuronide,CN(C)CCCN1C2=C(C=C(O)C(Cl)=C2)CCC2=C1C=CC=C2OC1OC(C(=O)O)C(O)C(O)C1O,FHDAIUXAPWZOKI-LYVDORBWSA-N,,0.56,
8-hydroxyclomipramine,CN(C)CCCN1C2=CC=C(O)C=C2CCC2=CC=C(Cl)C=C21,PVKACZKLKCTAHR-UHFFFAOYSA-N,8-hydroxyclomipramine glucuronide,CN(C)CCCN1C2=C(C=CC(Cl)=C2)CCC2=C1C=CC(O)=C2OC1OC(C(=O)O)C(O)C(O)C1O,UQBOPEJATBRQRS-MDYSUIJBSA-N,,0.53,
8-hydroxyclomipramine,CN(C)CCCN1C2=CC=C(O)C=C2CCC2=CC=C(Cl)C=C21,PVKACZKLKCTAHR-UHFFFAOYSA-N,8-hydroxydesmethyl clomipramine,CNCCCN1C2=CC=C(O)C=C2CCC2=CC=C(Cl)C=C21,MRLCQGACIDFFSH-UHFFFAOYSA-N,,0.99,
2-hydroxydesmethyl clomipramine,CNCCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C(O)=C2,BTEFPKOBUHDJSN-UHFFFAOYSA-N,2-hydroxydesmethyl clomipramine glucuronide,CNCCCN1C2=C(C=C(O)C(Cl)=C2)CCC2=C1C=CC=C2OC1OC(C(=O)O)C(O)C(O)C1O,FFAZHDSFJXPRMI-QMDPOKHVSA-N,,0.56,
Isocarboxazid,CC1=CC(C(=O)NNCC2=CC=CC=C2)=NO1,"InChI=1S/C12H13N3O2/c1-9-7-11(15-17-9)12(16)14-13-8-10-5-3-2-4-6-10/h2-7,13H,8H2,1H3,(H,14,16)",Hippuric acid,O=C(O)CNC(=O)C1=CC=CC=C1,QIAFMBKCNZACKA-UHFFFAOYSA-N,,0.19,
Olsalazine,O=C(O)C1=CC(N=NC2=CC=C(O)C(C(=O)O)=C2)=CC=C1O,"InChI=1S/C14H10N2O6/c17-11-3-1-7(5-9(11)13(19)20)15-16-8-2-4-12(18)10(6-8)14(21)22/h1-6,17-18H,(H,19,20)(H,21,22)/b16-15+",Mesalazine,NC1=CC(C(=O)O)=C(O)C=C1,"InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)",,0.77,
Olsalazine,O=C(O)C1=CC(N=NC2=CC=C(O)C(C(=O)O)=C2)=CC=C1O,"InChI=1S/C14H10N2O6/c17-11-3-1-7(5-9(11)13(19)20)15-16-8-2-4-12(18)10(6-8)14(21)22/h1-6,17-18H,(H,19,20)(H,21,22)/b16-15+",Olsalazine-O-sulfate,O=C(O)C1=C(O)C=CC(N=NC2=CC(C(=O)O)=C(OS(=O)(=O)O)C=C2)=C1,VMGXLRXDXJZSTP-UHFFFAOYSA-N,,0.67,
Mesalazine,NC1=CC(C(=O)O)=C(O)C=C1,"InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)",N-acetyl-5-aminosalicylic acid,CC(=O)NC1=CC=C(O)C(C(=O)O)=C1,,,0.72,
Lisdexamfetamine,CC(CC1=CC=CC=C1)NC(=O)C(N)CCCCN,"InChI=1S/C15H25N3O/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19)/t12-,14-/m0/s1",Dextroamphetamine,CC(N)CC1=CC=CC=C1,"InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1",,0.36,
Lisdexamfetamine,CC(CC1=CC=CC=C1)NC(=O)C(N)CCCCN,"InChI=1S/C15H25N3O/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19)/t12-,14-/m0/s1",Lysine,NCCCCC(N)C(=O)O,"InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/t5-/m0/s1",,0.17,
Hydralazine,NNC1=NN=CC2=CC=CC=C12,"InChI=1S/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)",Hydralazine acetone hydrazone,CC(C)=NNC1=NN=CC2=C1C=CC=C2,AKFJXINWDQGPHO-UHFFFAOYSA-N,,0.8,
Hydralazine,NNC1=NN=CC2=CC=CC=C12,"InChI=1S/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)",Hydralazine pyruvate hydrazone,CC(=NNC1=NN=CC2=CC=CC=C12)C(=O)O,CXGHHASVNBBLOU-NTUHNPAUSA-N,,0.67,
Nelarabine,COC1=NC(N)=NC2=C1N=CN2C1OC(CO)C(O)C1O,"InChI=1S/C11H15N5O5/c1-20-9-5-8(14-11(12)15-9)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15)/t4-,6-,7+,10-/m1/s1",9--D-arabinofuranosylguanine,NC1=NC2=C(N=[C]N2C2OC(CO)C(O)C2O)C(=O)N1,QFXYYZOMRMBRPL-FJFJXFQQSA-N,Adenosine deaminase,0.81,
9--D-arabinofuranosylguanine,NC1=NC2=C(N=[C]N2C2OC(CO)C(O)C2O)C(=O)N1,QFXYYZOMRMBRPL-FJFJXFQQSA-N,Guanine,NC1=NC(=O)C2=C(N=CN2)N1,"InChI=1S/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",,0.36,
Guanine,NC1=NC(=O)C2=C(N=CN2)N1,"InChI=1S/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",Xanthine,O=C1NC(=O)C2=C(N=CN2)N1,LRFVTYWOQMYALW-UHFFFAOYSA-N,Guanine deaminase,0.61,
4'-hydroxylumiracoxib (M23),CC1=CC(CC(=O)O)=C(NC2=C(Cl)C=C(O)C=C2F)C=C1,LUNFHOZKXHTOLG-UHFFFAOYSA-N,4'-Carboxylumiracoxib glucuronide (M22),CC1=CC=C(NC2=C(Cl)C=C(O)C=C2F)C(CC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)=C1,SEZLIFDZXOQYCW-DAZJWRSOSA-N,UDP-glucuronosyltransferases (UGTs),0.62,
4'-hydroxylumiracoxib (M23),CC1=CC(CC(=O)O)=C(NC2=C(Cl)C=C(O)C=C2F)C=C1,LUNFHOZKXHTOLG-UHFFFAOYSA-N,Lumiracoxib metabolite M25,CC1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(O)C=C1F,RVWXBXJNQUDTIJ-UHFFFAOYSA-N,,0.61,
4'-hydroxylumiracoxib (M23),CC1=CC(CC(=O)O)=C(NC2=C(Cl)C=C(O)C=C2F)C=C1,LUNFHOZKXHTOLG-UHFFFAOYSA-N,Lumiracoxib metabolite M9,O=C(O)CC1=CC(CO)=CC=C1NC1=C(Cl)C=C(O)C=C1F,CTTBSLWMGLKKJO-UHFFFAOYSA-N,,0.96,
Lumiracoxib metabolite M25,CC1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(O)C=C1F,RVWXBXJNQUDTIJ-UHFFFAOYSA-N,Lumiracoxib metabolite M25 glucuronide (M20),CC1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1F,SETAFJOLASRPRK-DAZJWRSOSA-N,UDP-glucuronosyltransferases (UGTs),0.73,
Lumiracoxib metabolite M9,O=C(O)CC1=CC(CO)=CC=C1NC1=C(Cl)C=C(O)C=C1F,CTTBSLWMGLKKJO-UHFFFAOYSA-N,4'-Hydroxy-5-carboxylumiracoxib (M5),O=C(O)CC1=CC(C(=O)O)=CC=C1NC1=C(Cl)C=C(O)C=C1F,MNDQIDSPYXYALX-UHFFFAOYSA-N,,0.93,
4'-Hydroxy-5-carboxylumiracoxib (M5),O=C(O)CC1=CC(C(=O)O)=CC=C1NC1=C(Cl)C=C(O)C=C1F,MNDQIDSPYXYALX-UHFFFAOYSA-N,Lumiracoxib metabolite M2,O=C(O)CC1=CC(C(=O)O)=CC=C1NC1=C(Cl)C=C(OS(=O)(=O)O)C=C1F,NDKGEYRNJBCHHS-UHFFFAOYSA-N,Sulfotransferase,0.88,
4'-Hydroxy-5-carboxylumiracoxib (M5),O=C(O)CC1=CC(C(=O)O)=CC=C1NC1=C(Cl)C=C(O)C=C1F,MNDQIDSPYXYALX-UHFFFAOYSA-N,Lumiracoxib metabolite M8,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(O)C=C1F,LFXDWINKKUWAOT-UHFFFAOYSA-N,,0.65,
Lumiracoxib metabolite M15,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=CC=C1F,CYWNCAUMMWNHKA-UHFFFAOYSA-N,Lumiracoxib metabolite M8,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(O)C=C1F,LFXDWINKKUWAOT-UHFFFAOYSA-N,,0.94,
Lumiracoxib metabolite M8,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(O)C=C1F,LFXDWINKKUWAOT-UHFFFAOYSA-N,Lumiracoxib metabolite M4/M6,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(OS(=O)(=O)O)C=C1F,YMUCSRFAMQITFI-UHFFFAOYSA-N,,0.92,
Cilazapril,CCOC(=O)C(CCC1=CC=CC=C1)NC1CCCN2CCCC(C(=O)O)N2C1=O,"InChI=1S/C22H31N3O5/c1-2-30-22(29)18(13-12-16-8-4-3-5-9-16)23-17-10-6-14-24-15-7-11-19(21(27)28)25(24)20(17)26/h3-5,8-9,17-19,23H,2,6-7,10-15H2,1H3,(H,27,28)/t17-,18-,19-/m0/s1",Cilazaprilat,O=C(O)C(CCC1=CC=CC=C1)NC1CCCN2CCCC(C(=O)O)N2C1=O,UVAUYSRYXACKSC-ULQDDVLXSA-N,,0.94,
Spirapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1CC2(CC1C(=O)O)SCCS2,"InChI=1S/C22H30N2O5S2/c1-3-29-21(28)17(10-9-16-7-5-4-6-8-16)23-15(2)19(25)24-14-22(30-11-12-31-22)13-18(24)20(26)27/h4-8,15,17-18,23H,3,9-14H2,1-2H3,(H,26,27)/t15-,17-,18-/m0/s1",Spiraprilat,CC(NC(CCC1=CC=CC=C1)C(=O)O)C(=O)N1CC2(CC1C(=O)O)SCCS2,FMMDBLMCSDRUPA-BPUTZDHNSA-N,,0.94,
Hexobarbital,CN1C(=O)NC(=O)C(C)(C2=CCCCC2)C1=O,"InChI=1S/C12H16N2O3/c1-12(8-6-4-3-5-7-8)9(15)13-11(17)14(2)10(12)16/h6H,3-5,7H2,1-2H3,(H,13,15,17)",3'-Hydroxyhexobarbital,CN1C(=O)N=C(O)C(C)(C2=CC(O)CCC2)C1=O,YHCGILGEMWNROZ-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 2C9",0.48,
Hexobarbital,CN1C(=O)NC(=O)C(C)(C2=CCCCC2)C1=O,"InChI=1S/C12H16N2O3/c1-12(8-6-4-3-5-7-8)9(15)13-11(17)14(2)10(12)16/h6H,3-5,7H2,1-2H3,(H,13,15,17)",Epoxy-hexobarbital,CN1C(=O)N=C(O)C(C)(C23CCCCC2O3)C1=O,WOWLNDOPAUTOTH-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.34,
3'-Hydroxyhexobarbital,CN1C(=O)N=C(O)C(C)(C2=CC(O)CCC2)C1=O,YHCGILGEMWNROZ-UHFFFAOYSA-N,3'-Oxohexobarbital,CN1C(=O)NC(=O)C(C)(C2=CC(=O)CCC2)C1=O,JLDHHLBFGIBRGN-UHFFFAOYSA-N,,0.49,
Mestranol,C#CC1(O)CCC2C3CCC4=C(C=CC(OC)=C4)C3CCC21C,"InChI=1S/C21H26O2/c1-4-21(22)12-10-19-18-7-5-14-13-15(23-3)6-8-16(14)17(18)9-11-20(19,21)2/h1,6,8,13,17-19,22H,5,7,9-12H2,2-3H3/t17-,18-,19+,20+,21+/m1/s1",Ethinylestradiol,C#CC1(O)CCC2C3CCC4=C(C=CC(O)=C4)C3CCC21C,"InChI=1S/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16-,17-,18+,19+,20+/m1/s1",Cytochrome P450 2C9,0.94,
Ephedrine,CNC(C)C(O)C1=CC=CC=C1,"InChI=1S/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10-/m0/s1",Norephedrine,CC(N)C(O)C1=CC=CC=C1,DLNKOYKMWOXYQA-VXNVDRBHSA-N,,0.85,
Colchicine,COC1=CC2=C(C3=CC=C(OC)C(=O)C=C3C(NC(C)=O)CC2)C(OC)=C1OC,"InChI=1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)/t16-/m0/s1",Colchiceine,COC1=C(OC)C(OC)=C2C(=C1)CCC(NC(C)=O)C1=CC(=O)C(O)=CC=C12,"InChI=1S/C21H23NO6/c1-11(23)22-15-7-5-12-9-18(26-2)20(27-3)21(28-4)19(12)13-6-8-16(24)17(25)10-14(13)15/h6,8-10,15H,5,7H2,1-4H3,(H,22,23)(H,24,25)",,0.99,
Drospirenone,CC12CCC(=O)C=C1C1CC1C1C2CCC2(C)C1C1CC1C21CCC(=O)O1,"InChI=1S/C24H30O3/c1-22-6-3-12(25)9-17(22)13-10-14(13)20-16(22)4-7-23(2)21(20)15-11-18(15)24(23)8-5-19(26)27-24/h9,13-16,18,20-21H,3-8,10-11H2,1-2H3/t13-,14+,15-,16+,18+,20-,21+,22-,23+,24+/m1/s1","4,5-dihydro-drospirenone-3-sulfate",CC12CCC(S(=O)(=O)O)CC1C1CC1C1C2CCC2(C)C1C1CC1C21CCC(=O)O1,ZHIWICDXDMTIEM-AAQOLUSRSA-N,,0.59,
Danazol,C#CC1(O)CCC2C3CCC4=CC5=C(C=NO5)CC4(C)C3CCC21C,"InChI=1S/C22H27NO2/c1-4-22(24)10-8-18-16-6-5-15-11-19-14(13-23-25-19)12-20(15,2)17(16)7-9-21(18,22)3/h1,11,13,16-18,24H,5-10,12H2,2-3H3/t16-,17+,18+,20+,21+,22+/m1/s1",Ethisterone,C#CC1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,CHNXZKVNWQUJIB-CEGNMAFCSA-N,,0.4,
Danazol,C#CC1(O)CCC2C3CCC4=CC5=C(C=NO5)CC4(C)C3CCC21C,"InChI=1S/C22H27NO2/c1-4-22(24)10-8-18-16-6-5-15-11-19-14(13-23-25-19)12-20(15,2)17(16)7-9-21(18,22)3/h1,11,13,16-18,24H,5-10,12H2,2-3H3/t16-,17+,18+,20+,21+,22+/m1/s1",17-hydroxymethylethisterone,C#CC1(O)CCC2C3CCC4=CC(=O)C(CO)CC4(C)C3CCC21C,JGJFMZZHCOKXHX-RIONBYPISA-N,,0.41,
Bambuterol,CN(C)C(=O)OC1=CC(C(O)CNC(C)(C)C)=CC(OC(=O)N(C)C)=C1,"InChI=1S/C18H29N3O5/c1-18(2,3)19-11-15(22)12-8-13(25-16(23)20(4)5)10-14(9-12)26-17(24)21(6)7/h8-10,15,19,22H,11H2,1-7H3",Terbutaline,CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1,"InChI=1S/C12H19NO3/c1-12(2,3)13-7-11(16)8-4-9(14)6-10(15)5-8/h4-6,11,13-16H,7H2,1-3H3",Cholinesterase,0.64,
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",,0.78,
Dihydrotestosterone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,NVKAWKQGWWIWPM-ABEVXSGRSA-N,3-alpha-Androstanediol glucuronide,CC12CCC3C(CCC4CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC43C)C1CCC2O,GYNWSIBKBBWJJW-YMRFBRODSA-N,,0.3,
Aminophenazone,CC1=C(N(C)C)C(=O)N(C2=CC=CC=C2)N1C,"InChI=1S/C13H17N3O/c1-10-12(14(2)3)13(17)16(15(10)4)11-8-6-5-7-9-11/h5-9H,1-4H3",N-Desmethylaminopyrine,CNC1=C(C)N(C)N(C2=CC=CC=C2)C1=O,JILCEWWZTBBOFS-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 2C18, Cytochrome P450 2C19, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2D6",0.96,
6-Monoacetylmorphine,CC(=O)OC1C=CC2C3CC4=C5C(=C(O)C=C4)OC1C52CCN3C,JJGYGPZNTOPXGV-SSTWWWIQSA-N,morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,BQJCRHHNABKAKU-PKBQDISRSA-N,"Liver carboxylesterase 1, Cocaine esterase",0.94,
Metamfetamine,CNC(C)CC1=CC=CC=C1,"InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1",4-Hydroxynorephedrine,CC(N)C(O)C1=CC=C(O)C=C1,JAYBQRKXEFDRER-HZGVNTEJSA-N,,0.46,
Metamfetamine,CNC(C)CC1=CC=CC=C1,"InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1",Norephedrine,CC(N)C(O)C1=CC=CC=C1,DLNKOYKMWOXYQA-VXNVDRBHSA-N,,0.56,
Metamfetamine,CNC(C)CC1=CC=CC=C1,"InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1",4-hydroxyamphetamine,CC(N)CC1=CC=C(O)C=C1,GIKNHHRFLCDOEU-UHFFFAOYSA-N,,0.64,
Phendimetrazine,CC1C(C2=CC=CC=C2)OCCN1C,"InChI=1S/C12H17NO/c1-10-12(14-9-8-13(10)2)11-6-4-3-5-7-11/h3-7,10,12H,8-9H2,1-2H3/t10-,12+/m0/s1",Phenmetrazine,CC1NCCOC1C1=CC=CC=C1,OOBHFESNSZDWIU-UHFFFAOYSA-N,,0.86,
Solifenacin,O=C(OC1CN2CCC1CC2)N1CCC2=CC=CC=C2C1C1=CC=CC=C1,"InChI=1S/C23H26N2O2/c26-23(27-21-16-24-13-10-18(21)11-14-24)25-15-12-17-6-4-5-9-20(17)22(25)19-7-2-1-3-8-19/h1-9,18,21-22H,10-16H2/t21-,22-/m0/s1",4R-hydroxy solifenacin,O=C(OC1CN2CCC1CC2)N1CC(O)C2=C(C=CC=C2)C1C1=CC=CC=C1,LRNNBJBAUXSVMH-NHNZYLEHSA-N,"Cytochrome P450 3A4, Cytochrome P450 1A1, Cytochrome P450 2D6",0.88,
Hydroxychloroquine,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,"InChI=1S/C18H26ClN3O/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21)",Desethylchloroquine,CCNCCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,,Cytochrome P450 3A4,0.94,
Etoricoxib,CC1=NC=C(C2=NC=C(Cl)C=C2C2=CC=C(S(C)(=O)=O)C=C2)C=C1,"InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3",Etoricoxib 1'-N'-oxide,CC1=[N+]([O-])C=C(C2=NC=C(Cl)C=C2C2=CC=C(S(C)(=O)=O)C=C2)C=C1,KMLFAHIIJSUUPX-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 1A2",0.89,
Etoricoxib,CC1=NC=C(C2=NC=C(Cl)C=C2C2=CC=C(S(C)(=O)=O)C=C2)C=C1,"InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3",6-Hydroxymethyletoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(CO)C=C2)C=C1,SCVWZQQMIZJGJY-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 1A2",0.95,
6-Hydroxymethyletoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(CO)C=C2)C=C1,SCVWZQQMIZJGJY-UHFFFAOYSA-N,6-Hydroxymethyletoricoxib 1'-N'-oxide,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=C[N+]([O-])=C(CO)C=C2)C=C1,SSTJTMIIIMAQMR-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 1A2",0.89,
6-Hydroxymethyletoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(CO)C=C2)C=C1,SCVWZQQMIZJGJY-UHFFFAOYSA-N,6-Carboxy-etoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(C(=O)O)C=C2)C=C1,QIHJKHCGJLIAGS-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9",0.93,
6-Hydroxymethyletoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(CO)C=C2)C=C1,SCVWZQQMIZJGJY-UHFFFAOYSA-N,6-Hydroxymethyletoricoxib glucuronide,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(COC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C=C1,UJWKCNOGFMSHNK-NDUFDKTRSA-N,UDP-glucuronosyltransferases (UGTs),0.68,
Genistein,O=C1C(C2=CC=C(O)C=C2)=COC2=C1C(O)=CC(O)=C2,"InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)11-7-20-13-6-10(17)5-12(18)14(13)15(11)19/h1-7,16-18H",3'-hydroxygenistein,O=C1C(C2=CC=C(O)C(O)=C2)=COC2=C1C(O)=CC(O)=C2,IOYHCQBYQJQBSK-UHFFFAOYSA-N,Cytochrome P450 1A2,0.94,
Roflumilast,O=C(NC1=C(Cl)C=NC=C1Cl)C1=CC(OCC2CC2)=C(OC(F)F)C=C1,"InChI=1S/C17H14Cl2F2N2O3/c18-11-6-22-7-12(19)15(11)23-16(24)10-3-4-13(26-17(20)21)14(5-10)25-8-9-1-2-9/h3-7,9,17H,1-2,8H2,(H,22,23,24)",Roflumilast N-oxide,O=C(NC1=C(Cl)C=[N+]([O-])C=C1Cl)C1=CC(OCC2CC2)=C(OC(F)F)C=C1,PCGSQNPMMSALEJ-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 1A2",0.93,
Prasterone,CC12CCC3C(CC=C4CC(O)CCC43C)C1CCC2=O,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-16,20H,4-11H2,1-2H3/t13-,14-,15-,16-,18-,19-/m0/s1",Dehydroepiandrosterone sulfate,CC12CCC3C(CC=C4CC(OS(=O)(=O)O)CCC43C)C1CCC2=O,CZWCKYRVOZZJNM-USOAJAOKSA-N,,0.77,
Vorinostat,O=C(CCCCCCC(=O)NC1=CC=CC=C1)NO,"InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18)",4-anilino-4-oxobutanoic acid,O=C(O)CCC(O)=NC1=CC=CC=C1,KTFGFGGLCMGYTP-UHFFFAOYSA-N,,0.17,
Fusidic acid,CC(=O)OC1CC2(C)C(CC(O)C3C4(C)CCC(O)C(C)C4CCC32C)C1=C(CCC=C(C)C)C(=O)O,"InChI=1S/C31H48O6/c1-17(2)9-8-10-20(28(35)36)26-22-15-24(34)27-29(5)13-12-23(33)18(3)21(29)11-14-30(27,6)31(22,7)16-25(26)37-19(4)32/h9,18,21-25,27,33-34H,8,10-16H2,1-7H3,(H,35,36)/b26-20-/t18-,21-,22-,23+,24+,25-,27-,29-,30-,31-/m0/s1",3-keto fusidic acid,CC(=O)OC1CC2(C)C(CC(O)C3C4(C)CCC(O)C(C)C4CCC32C)C1=C(C(=O)O)C(=O)CC=C(C)C,LOVQKVDREFGPKC-COCAZOITSA-N,,0.91,
Pregnenolone,CC(=O)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C,"InChI=1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19,23H,5-12H2,1-3H3/t15-,16-,17+,18-,19-,20-,21+/m0/s1",17-Hydroxypregnenolone sulfate,CC(=O)C1(O)CCC2C3CC=C4CC(OS(=O)(=O)O)CCC4(C)C3CCC21C,OMOKWYAQVYBHMG-QUPIPBJSSA-N,,0.64,
Stanolone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,"InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1",11-Oxo-androsterone glucuronide,CC12CC(=O)C3C(CCC4CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC43C)C1CCC2=O,QTXWOOLAHRQMGZ-UHFFFAOYSA-N,,0.28,
Stanolone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,"InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1",11-beta-Hydroxyandrosterone-3-glucuronide,CC12CC(O)C3C(CCC4CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC43C)C1CCC2=O,BRPLOVMHAFXVOQ-HUMIJZDLSA-N,,0.3,
Propanoyl-CoA,CCC(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC1OC(N2C=NC3=C2N=CN=C3N)C(O)C1OP(=O)(O)O,"InChI=1S/C24H40N7O17P3S/c1-4-15(33)52-8-7-26-14(32)5-6-27-22(36)19(35)24(2,3)10-45-51(42,43)48-50(40,41)44-9-13-18(47-49(37,38)39)17(34)23(46-13)31-12-30-16-20(25)28-11-29-21(16)31/h11-13,17-19,23,34-35H,4-10H2,1-3H3,(H,26,32)(H,27,36)(H,40,41)(H,42,43)(H2,25,28,29)(H2,37,38,39)/t13-,17-,18-,19+,23-/m1/s1",(R)-methylmalonyl-CoA,CC(C(=O)O)C(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC1OC(N2C=NC3=C2N=CN=C3N)C(O)C1OP(=O)(O)O,"InChI=1S/C25H40N7O19P3S/c1-12(23(37)38)24(39)55-7-6-27-14(33)4-5-28-21(36)18(35)25(2,3)9-48-54(45,46)51-53(43,44)47-8-13-17(50-52(40,41)42)16(34)22(49-13)32-11-31-15-19(26)29-10-30-20(15)32/h10-13,16-18,22,34-35H,4-9H2,1-3H3,(H,27,33)(H,28,36)(H,37,38)(H,43,44)(H,45,46)(H2,26,29,30)(H2,40,41,42)/t12-,13-,16-,17-,18+,22-/m1/s1",,0.98,
(R)-methylmalonyl-CoA,CC(C(=O)O)C(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC1OC(N2C=NC3=C2N=CN=C3N)C(O)C1OP(=O)(O)O,"InChI=1S/C25H40N7O19P3S/c1-12(23(37)38)24(39)55-7-6-27-14(33)4-5-28-21(36)18(35)25(2,3)9-48-54(45,46)51-53(43,44)47-8-13-17(50-52(40,41)42)16(34)22(49-13)32-11-31-15-19(26)29-10-30-20(15)32/h10-13,16-18,22,34-35H,4-9H2,1-3H3,(H,27,33)(H,28,36)(H,37,38)(H,43,44)(H,45,46)(H2,26,29,30)(H2,40,41,42)/t12-,13-,16-,17-,18+,22-/m1/s1",Succinyl-Coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OCC1OC(N2C=NC3=C2N=CN=C3N)C(O)C1OP(=O)(O)O)C(O)C(=O)NCCC(=O)NCCSC(=O)CCC(=O)O,"InChI=1S/C25H40N7O19P3S/c1-25(2,20(38)23(39)28-6-5-14(33)27-7-8-55-16(36)4-3-15(34)35)10-48-54(45,46)51-53(43,44)47-9-13-19(50-52(40,41)42)18(37)24(49-13)32-12-31-17-21(26)29-11-30-22(17)32/h11-13,18-20,24,37-38H,3-10H2,1-2H3,(H,27,33)(H,28,39)(H,34,35)(H,43,44)(H,45,46)(H2,26,29,30)(H2,40,41,42)/t13-,18-,19-,20+,24-/m1/s1",,0.97,
Phenacetin,CCOC1=CC=C(NC(C)=O)C=C1,"InChI=1S/C10H13NO2/c1-3-13-10-6-4-9(5-7-10)11-8(2)12/h4-7H,3H2,1-2H3,(H,11,12)",Acetaminophen,CC(=O)NC1=CC=C(O)C=C1,"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)",Cytochrome P450 1A2,0.77,
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1",Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,,0.83,
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1",Estriol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(O)C2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,0.65,
Quinestrol,C#CC1(O)CCC2C3CCC4=C(C=CC(OC5CCCC5)=C4)C3CCC21C,"InChI=1S/C25H32O2/c1-3-25(26)15-13-23-22-10-8-17-16-19(27-18-6-4-5-7-18)9-11-20(17)21(22)12-14-24(23,25)2/h1,9,11,16,18,21-23,26H,4-8,10,12-15H2,2H3/t21-,22-,23+,24+,25+/m1/s1",Ethinylestradiol,C#CC1(O)CCC2C3CCC4=C(C=CC(O)=C4)C3CCC21C,"InChI=1S/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16-,17-,18+,19+,20+/m1/s1",,0.87,
Aldosterone,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C=O)C(C(=O)CO)CCC12,"InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1",Aldosterone 18-glucuronide,CC12CCC(=O)C=C1CCC1C2C2CC3(C(OC4OC(C(=O)O)C(O)C(O)C4O)O2)C(C(=O)CO)CCC13,OMRIQCUHVVBJKI-ACOLCOCVSA-N,,0.52,
Aldosterone,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C=O)C(C(=O)CO)CCC12,"InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1",Tetrahydroaldosterone-3-glucuronide,CC12CCC(OC3OC(C(=O)O)C(O)C(O)C3O)CC1CCC1C2C2CC3(C(O)O2)C(C(=O)CO)CCC13,CGIURIOFMWUPSV-RUQPETGGSA-N,,0.38,
Licofelone,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)O)N2C1,"InChI=1S/C23H22ClNO2/c1-23(2)13-19-22(15-6-4-3-5-7-15)21(16-8-10-17(24)11-9-16)18(12-20(26)27)25(19)14-23/h3-11H,12-14H2,1-2H3,(H,26,27)",Licofelone metabolite M2,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC(O)=C(Cl)C=C3)=C(CC(=O)O)N2C1,QUCLYFKWRYCDCG-UHFFFAOYSA-N,"Cytochrome P450 2J2, Cytochrome P450 2C9, Cytochrome P450 2C8",0.94,
Cyproterone acetate,CC(=O)OC1(C(C)=O)CCC2C3C=C(Cl)C4=CC(=O)C5CC5C4(C)C3CCC21C,"InChI=1S/C24H29ClO4/c1-12(26)24(29-13(2)27)8-6-16-14-10-20(25)19-11-21(28)15-9-18(15)23(19,4)17(14)5-7-22(16,24)3/h10-11,14-18H,5-9H2,1-4H3/t14-,15+,16-,17-,18-,22-,23-,24-/m0/s1",15beta-hydroxycyproterone acetate,CC(=O)OC1(C(C)=O)CC(O)C2C3C=C(Cl)C4=CC(=O)C5CC5C4(C)C3CCC21C,HRANPRDGABOKNQ-RXHWKJIASA-N,,0.91,
Debrisoquine,N=C(N)N1CCC2=CC=CC=C2C1,"InChI=1S/C10H13N3/c11-10(12)13-6-5-8-3-1-2-4-9(8)7-13/h1-4H,5-7H2,(H3,11,12)",4-Hydroxydebrisoquine,N=C(N)N1CC2=C(C=CC=C2)C(O)C1,,Cytochrome P450 2D6,0.74,
Tetrabenazine,COC1=C(OC)C=C2C(=C1)CCN1CC(CC(C)C)C(=O)CC21,"InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3",b-dihydrotetrabenazine,COC1=C(OC)C=C2C(=C1)CCN1CC(CC(C)C)C(O)CC21,WEQLWGNDNRARGE-UHFFFAOYSA-N,,0.84,
Lorcaserin,CC1CNCCC2=CC=C(Cl)C=C21,"InChI=1S/C11H14ClN/c1-8-7-13-5-4-9-2-3-10(12)6-11(8)9/h2-3,6,8,13H,4-5,7H2,1H3/t8-/m0/s1",Lorcaserin sulfamate,CC1CN(S(=O)(=O)O)CCC2=C1C=C(Cl)C=C2,YZUNJIOOIHWHGQ-UHFFFAOYSA-N,,0.64,
Lorcaserin,CC1CNCCC2=CC=C(Cl)C=C21,"InChI=1S/C11H14ClN/c1-8-7-13-5-4-9-2-3-10(12)6-11(8)9/h2-3,6,8,13H,4-5,7H2,1H3/t8-/m0/s1",N-carbamoyl glucuronide lorcaserin,CC1CN(C(=O)OC2OC(C(=O)O)C(C)C(C)C2C)CCC2=C1C=C(Cl)C=C2,DGFKLWZCLRDMAF-IJQUCLSUSA-N,,0.37,
Trabectedin,COC1=CC2=C(C=C1O)CCNC21CSC2C3=C(OC(C)=O)C(C)=C4OCOC4=C3C(COC1=O)N1C(O)C3CC4=CC(C)=C(OC)C(O)=C4C(C21)N3C,"InChI=1S/C39H43N3O11S/c1-16-9-20-10-22-37(46)42-23-13-50-38(47)39(21-12-25(48-5)24(44)11-19(21)7-8-40-39)14-54-36(30(42)29(41(22)4)26(20)31(45)32(16)49-6)28-27(23)35-34(51-15-52-35)17(2)33(28)53-18(3)43/h9,11-12,22-23,29-30,36-37,40,44-46H,7-8,10,13-15H2,1-6H3/t22-,23-,29+,30+,36+,37-,39+/m0/s1",Trabectedin metabolite M9,COC1=CC2=C(C=C1O)CCNC21CSC2C3=C(OC(C)=O)C(C)=C(O)C(O)=C3C(COC1=O)N1C(O)C3CC4=CC(C)=C(OC)C(O)=C4C(C21)N3C,WMQKTHWOQUOPDO-BUURXMNCSA-N,,0.99,
Trabectedin,COC1=CC2=C(C=C1O)CCNC21CSC2C3=C(OC(C)=O)C(C)=C4OCOC4=C3C(COC1=O)N1C(O)C3CC4=CC(C)=C(OC)C(O)=C4C(C21)N3C,"InChI=1S/C39H43N3O11S/c1-16-9-20-10-22-37(46)42-23-13-50-38(47)39(21-12-25(48-5)24(44)11-19(21)7-8-40-39)14-54-36(30(42)29(41(22)4)26(20)31(45)32(16)49-6)28-27(23)35-34(51-15-52-35)17(2)33(28)53-18(3)43/h9,11-12,22-23,29-30,36-37,40,44-46H,7-8,10,13-15H2,1-6H3/t22-,23-,29+,30+,36+,37-,39+/m0/s1",Trabectedin metabolite M16e,COC1=CC2=C(C=C1O)CCNC21CSC2C3=C(OC(C)=O)C(C)=C4OCOC4=C3C(COC1=O)N1C(=O)C3CC4=CC(CC(=O)O)=C(OC)C(O)=C4C(C21)N3C,YHFJTMUFTQMMMD-PSCCWZGDSA-N,,0.97,
Trabectedin metabolite M8a,COC1=CC2=C(C=C1O)CCNC21CSC2C3=C(OC(C)=O)C(C)=C4OCOC4=C3C(COC1=O)N1C(O)C3CC4=CC(CC(=O)O)=C(OC)C(O)=C4C(C21)N3C,JJILVPKJCPIGNI-PBCNNVIESA-N,Trabectedin metabolite M16e,COC1=CC2=C(C=C1O)CCNC21CSC2C3=C(OC(C)=O)C(C)=C4OCOC4=C3C(COC1=O)N1C(=O)C3CC4=CC(CC(=O)O)=C(OC)C(O)=C4C(C21)N3C,YHFJTMUFTQMMMD-PSCCWZGDSA-N,,0.97,
Rotigotine,CCCN(CCC1=CC=CS1)C1CCC2=C(O)C=CC=C2C1,"InChI=1S/C19H25NOS/c1-2-11-20(12-10-17-6-4-13-22-17)16-8-9-18-15(14-16)5-3-7-19(18)21/h3-7,13,16,21H,2,8-12,14H2,1H3/t16-/m0/s1",N-despropyl-rotigotine,OC1=CC=CC2=C1CCC(NCCC1=CC=CS1)C2,RDMWWGLKUMLLTG-UHFFFAOYSA-N,,0.91,
Rotigotine,CCCN(CCC1=CC=CS1)C1CCC2=C(O)C=CC=C2C1,"InChI=1S/C19H25NOS/c1-2-11-20(12-10-17-6-4-13-22-17)16-8-9-18-15(14-16)5-3-7-19(18)21/h3-7,13,16,21H,2,8-12,14H2,1H3/t16-/m0/s1",N-desthienylethyl-rotigotine,CCCNC1CCC2=C(C=CC=C2O)C1,VCYPZWCFSAHTQT-UHFFFAOYSA-N,,0.77,
Vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,"InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)",N-desmethyl vandetanib,COC1=C(OCC2CCNCC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,HTCPERSEGREUFC-UHFFFAOYSA-N,,0.99,
Apremilast,CCOC1=CC(C(CS(C)(=O)=O)N2C(=O)C3=CC=CC(NC(C)=O)=C3C2=O)=CC=C1OC,"InChI=1S/C22H24N2O7S/c1-5-31-19-11-14(9-10-18(19)30-3)17(12-32(4,28)29)24-21(26)15-7-6-8-16(23-13(2)25)20(15)22(24)27/h6-11,17H,5,12H2,1-4H3,(H,23,25)/t17-/m1/s1",O-desmethyl Apremilast,CCOC1=C(O)C=CC(C(CS(C)(=O)=O)N2C(=O)C3=C(C2=O)C(N=C(C)O)=CC=C3)=C1,PEUJABWEZWJNBO-MRXNPFEDSA-N,"Cytochrome P450 3A4, Cytochrome P450 2A6, Cytochrome P450 1A2",0.83,
Abiraterone,CC12CCC(O)CC1=CCC1C2CCC2(C)C(C3=CC=CN=C3)=CCC12,"InChI=1S/C24H31NO/c1-23-11-9-18(26)14-17(23)5-6-19-21-8-7-20(16-4-3-13-25-15-16)24(21,2)12-10-22(19)23/h3-5,7,13,15,18-19,21-22,26H,6,8-12,14H2,1-2H3/t18-,19-,21-,22-,23-,24+/m0/s1",N-oxide abiraterone sulfate,CC12CCC(OS(=O)(=O)O)CC1=CCC1C2CCC2(C)C(C3=CC=C[N+]([O-])=C3)=CCC12,AEEMBGRHVQPUBV-VJLLXTKPSA-N,Bile salt sulfotransferase,0.82,
Acetylcysteine,CC(=O)NC(CS)C(=O)O,"InChI=1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1",Cysteine,NC(CS)C(=O)O,XUJNEKJLAYXESH-REOHCLBHSA-N,Aminoacylase-1,0.39,
Pentaerythritol tetranitrate,O=[N+]([O-])OCC(CO[N+](=O)[O-])(CO[N+](=O)[O-])CO[N+](=O)[O-],"InChI=1S/C5H8N4O12/c10-6(11)18-1-5(2-19-7(12)13,3-20-8(14)15)4-21-9(16)17/h1-4H2",Pentaerithrityl,OCC(CO)(CO)CO,"InChI=1S/C5H12O4/c6-1-5(2-7,3-8)4-9/h6-9H,1-4H2",Pentaerythritol tetranitrate reductase,0.28,
Romidepsin,CC=C1NC(=O)C2CSSCCC=CC(CC(=O)NC(C(C)C)C(=O)N2)OC(=O)C(C(C)C)NC1=O,"InChI=1S/C24H36N4O6S2/c1-6-16-21(30)28-20(14(4)5)24(33)34-15-9-7-8-10-35-36-12-17(22(31)25-16)26-23(32)19(13(2)3)27-18(29)11-15/h6-7,9,13-15,17,19-20H,8,10-12H2,1-5H3,(H,25,31)(H,26,32)(H,27,29)(H,28,30)/b9-7+,16-6-/t15-,17-,19-,20+/m1/s1",Romidepsin (active),CC=C1N=C(O)C(CS)N=C(O)C(C(C)C)CC(=O)CC(C=CCCS)OC(=O)C(C(C)C)N=C1O,UPCFDQLGZODPFB-BXJZLCHMSA-N,,0.41,
Rufinamide,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,"InChI=1S/C10H8F2N4O/c11-7-2-1-3-8(12)6(7)4-16-5-9(10(13)17)14-15-16/h1-3,5H,4H2,(H2,13,17)",CGP-47292,O=C(O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,OPJHWTKDQYKYHL-UHFFFAOYSA-N,,0.75,
Tapentadol,CCC(C1=CC(O)=CC=C1)C(C)CN(C)C,"InChI=1S/C14H23NO/c1-5-14(11(2)10-15(3)4)12-7-6-8-13(16)9-12/h6-9,11,14,16H,5,10H2,1-4H3/t11-,14+/m0/s1",N-Desmethyl tapentadol,CCC(C1=CC(O)=CC=C1)C(C)CNC,PQQINTFVECNXLC-GXFFZTMASA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.94,
Prasugrel,CC(=O)OC1=CC2=C(CCN(C(C(=O)C3CC3)C3=CC=CC=C3F)C2)S1,"InChI=1S/C20H20FNO3S/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21/h2-5,10,13,19H,6-9,11H2,1H3",R-95913,O=C(C1CC1)C(C1=CC=CC=C1F)N1CCC2=C(C=C(O)S2)C1,MPLQNQUWLWGOET-UHFFFAOYSA-N,Cholinesterase,0.9,
Doripenem,CC(O)C1C(=O)N2C(C(=O)O)=C(SC3CNC(CNS(N)(=O)=O)C3)C(C)C12,"InChI=1S/C15H24N4O6S2/c1-6-11-10(7(2)20)14(21)19(11)12(15(22)23)13(6)26-9-3-8(17-5-9)4-18-27(16,24)25/h6-11,17-18,20H,3-5H2,1-2H3,(H,22,23)(H2,16,24,25)/t6-,7-,8+,9+,10-,11-/m1/s1",doripenem-M1,CC(O)C(C(=O)O)C1NC(C(=O)O)C(SC2CNC(CNS(N)(=O)=O)C2)C1C,PJNKVKHAJNEENW-OZULOKFQSA-N,Dipeptidase 1,0.52,
Lacosamide,COCC(NC(C)=O)C(=O)NCC1=CC=CC=C1,"InChI=1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1",O-Desmethyl lacosamide,CC(=O)NC(CO)C(=O)NCC1=CC=CC=C1,XRKSCJLQKGLSKU-LLVKDONJSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2C19",0.88,
Udenafil,CCCOC1=C(C2=NC(=O)C3=C(N2)C(CCC)=NN3C)C=C(S(=O)(=O)NCCC2CCCN2C)C=C1,"InChI=1S/C25H36N6O4S/c1-5-8-20-22-23(31(4)29-20)25(32)28-24(27-22)19-16-18(10-11-21(19)35-15-6-2)36(33,34)26-13-12-17-9-7-14-30(17)3/h10-11,16-17,26H,5-9,12-15H2,1-4H3,(H,27,28,32)",N-desalkyludenafil,CCCOC1=C(C2=NC3=C(C(=O)N2)N(C)N=C3CCC)C=C(S(N)(=O)=O)C=C1,WQAFYWMRZOZKJD-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.93,
Dapagliflozin,CCOC1=CC=C(CC2=C(Cl)C=CC(C3OC(CO)C(O)C(O)C3O)=C2)C=C1,"InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1",Dapagliflozin 3-O-glucuronide,CCOC1=CC=C(CC2=CC(C3OC(CO)C(O)C(OC4OC(C(=O)O)C(O)C(O)C4O)C3O)=CC=C2Cl)C=C1,ZYZULHSUKTZGTR-PTNNFGGUSA-N,UDP-glucuronosyltransferase 1-9,0.79,
Ambrisentan,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(C)=N1)C(=O)O,"InChI=1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1",Ambrisentan glucuronide,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(C)=N1)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,QBHJFBFSJYTXDX-KFXNSFBMSA-N,"UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-3",0.72,
Ambrisentan,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(C)=N1)C(=O)O,"InChI=1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1",4-hydroxymethyl ambrisentan,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(CO)=N1)C(=O)O,PDUAYPFMBRYSNN-LJQANCHMSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Cytochrome P450 3A5",0.96,
4-hydroxymethyl ambrisentan,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(CO)=N1)C(=O)O,PDUAYPFMBRYSNN-LJQANCHMSA-N,4-hydroxymethyl ambrisentan glucuronide,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(CO)=CC(C)=N1)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,HYNPRXQATWYSER-UDFRSJDBSA-N,,0.74,
Ceftaroline fosamil,CCON=C(C(=O)NC1C(=O)N2C(C(=O)[O-])=C(SC3=NC(C4=CC=[N+](C)C=C4)=CS3)CSC12)C1=NSC(NP(=O)(O)O)=N1,"InChI=1S/C22H21N8O8PS4/c1-3-38-26-13(16-25-21(43-28-16)27-39(35,36)37)17(31)24-14-18(32)30-15(20(33)34)12(9-40-19(14)30)42-22-23-11(8-41-22)10-4-6-29(2)7-5-10/h4-8,14,19H,3,9H2,1-2H3,(H4-,24,25,27,28,31,33,34,35,36,37)/b26-13-/t14-,19-/m1/s1",ceftaroline,CCON=C(C(O)=NC1C(=O)N2C(C(=O)O)=C(SC3=NC(C4=CC=[N+](C)C=C4)=CS3)CSC12)C1=NC(=NP(=O)(O)O)SN1,ZCCUWMICIWSJIX-NQJJCJBVSA-O,,0.86,
Midostaurin,COC1C(N(C)C(=O)C2=CC=CC=C2)CC2OC1(C)N1C3=C(C=CC=C3)C3=C4CNC(=O)C4=C4C5=C(C=CC=C5)N2C4=C31,"InChI=1S/C35H30N4O4/c1-35-32(42-3)25(37(2)34(41)19-11-5-4-6-12-19)17-26(43-35)38-23-15-9-7-13-20(23)28-29-22(18-36-33(29)40)27-21-14-8-10-16-24(21)39(35)31(27)30(28)38/h4-16,25-26,32H,17-18H2,1-3H3,(H,36,40)/t25-,26-,32-,35+/m1/s1",CGP 52421,COC1C(N(C)C(=O)C2=CC=CC=C2)CC2OC1(C)N1C3=C(C=CC=C3)C3=C4C(=C5C6=C(C=CC=C6)N2C5=C31)C(=O)NC4O,ZZSBPGIGIUFJRA-YMZPHHGTSA-N,Cytochrome P450 3A4,0.97,
Midostaurin,COC1C(N(C)C(=O)C2=CC=CC=C2)CC2OC1(C)N1C3=C(C=CC=C3)C3=C4CNC(=O)C4=C4C5=C(C=CC=C5)N2C4=C31,"InChI=1S/C35H30N4O4/c1-35-32(42-3)25(37(2)34(41)19-11-5-4-6-12-19)17-26(43-35)38-23-15-9-7-13-20(23)28-29-22(18-36-33(29)40)27-21-14-8-10-16-24(21)39(35)31(27)30(28)38/h4-16,25-26,32H,17-18H2,1-3H3,(H,36,40)/t25-,26-,32-,35+/m1/s1",CGP 62221,CN(C(=O)C1=CC=CC=C1)C1CC2OC(C)(C1O)N1C3=C(C=CC=C3)C3=C4CNC(=O)C4=C4C5=C(C=CC=C5)N2C4=C31,PXOCRDZEEXVZQC-AFUPZKSLSA-N,Cytochrome P450 3A4,0.98,
Isavuconazonium,CNCC(=O)OCC1=C(N(C)C(=O)OC(C)[N+]2=CN(CC(O)(C3=C(F)C=CC(F)=C3)C(C)C3=NC(C4=CC=C(C#N)C=C4)=CS3)N=C2)N=CC=C1,"InChI=1S/C35H35F2N8O5S/c1-22(33-42-30(18-51-33)25-9-7-24(15-38)8-10-25)35(48,28-14-27(36)11-12-29(28)37)19-45-21-44(20-41-45)23(2)50-34(47)43(4)32-26(6-5-13-40-32)17-49-31(46)16-39-3/h5-14,18,20-23,39,48H,16-17,19H2,1-4H3/q+1/t22-,23?,35+/m0/s1",Isavuconazole,CC(C1=NC(C2=CC=C(C#N)C=C2)=CS1)C(O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1,"InChI=1S/C22H17F2N5OS/c1-14(21-28-20(10-31-21)16-4-2-15(9-25)3-5-16)22(30,11-29-13-26-12-27-29)18-8-17(23)6-7-19(18)24/h2-8,10,12-14,30H,11H2,1H3/t14-,22+/m0/s1",Cholinesterase,0.82,
Vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,"InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1",O-Desmethylvicriviroc,CC1=C(C(=O)N2CCC(C)(N3CCN(C(CO)C4=CC=C(C(F)(F)F)C=C4)C(C)C3)CC2)C(C)=NC=N1,KKISTQPVRGXETN-MBSDFSHPSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 3A5",0.97,
Vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,"InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1",Vicriviroc hydroxylamine,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN(O)C3C)CC2)CC1C,CKBGTTZQHDIDOD-YZARGUDJSA-N,Cytochrome P450 3A4,0.58,
Vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,"InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1",Vicriviroc N-oxide,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)[N+]([O-])=CN=C3C)CC2)CC1C,FJGWJMSLTFKZKY-CYFREDJKSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4",0.88,
Vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,"InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1",N-Desalkylvicriviroc,CC1=C(C(=O)N2CCC(C)(N3CCNC(C)C3)CC2)C(C)=NC=N1,JBIGWLFHMIEHKP-ZDUSSCGKSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4",0.69,
Vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,"InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1","N,N-Desalkylvicriviroc",COCC(NCCNC1(C)CCN(C(=O)C2=C(C)N=CN=C2C)CC1)C1=CC=C(C(F)(F)F)C=C1,VYTNUMGJUZTAEH-NRFANRHFSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4",0.88,
Vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,"InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1",Vicriviroc carboxylic acid,CC1=C(C(=O)N2CCC(C)(N3CCN(C(C(=O)O)C4=CC=C(C(F)(F)F)C=C4)C(C)C3)CC2)C(C)=NC=N1,MBIPBXMGYUYGFC-NVHKAFQKSA-N,Cytochrome P450 3A4,0.91,
Odanacatib,CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,"InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1",M6 (Odanacatib),CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C2=NC(C(=O)NCC(=O)O)CS2)CC1,UEBZMZSLTYWZTH-WKJLPXBYSA-N,,0.67,
Odanacatib,CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,"InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1",M9 (Odanacatib),CS(=O)(=O)C1=CC=C(C2=CC=C(C(OC3OC(C(=O)O)C(O)C(O)C3O)C(F)(F)F)C=C2)C=C1,ARJFPVWOMJKCQD-DOZWFGMRSA-N,,0.43,
Odanacatib,CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,"InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1",M10 (Odanacatib),CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,CLXDIFUURVULNN-WTOYAVKFSA-N,,0.58,
Odanacatib,CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,"InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1",M8 (Odanacatib),CC(F)(CO)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,JCZDLZKSPMKOPS-MMBKUXRPSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C8",0.95,
M8 (Odanacatib),CC(F)(CO)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,JCZDLZKSPMKOPS-MMBKUXRPSA-N,M3 (Odanacatib),CC(F)(COC1OC(C(=O)O)C(O)C(O)C1O)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,XHSMOYVDHUJUTE-XNMFSWTPSA-N,,0.75,
M8 (Odanacatib),CC(F)(CO)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,JCZDLZKSPMKOPS-MMBKUXRPSA-N,M7-B (Odanacatib),CC(F)(C=O)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,HJVPPQGUHTYYIX-MMBKUXRPSA-N,,0.91,
Dexmethylphenidate,COC(=O)C(C1=CC=CC=C1)C1CCCCN1,"InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3/t12-,13-/m1/s1",Ritalinic acid,O=C(O)C(C1=CC=CC=C1)C1CCCCN1,INGSNVSERUZOAK-UHFFFAOYSA-N,Carboxylesterase,0.89,
Lumefantrine,CCCCN(CCCC)CC(O)C1=C2C(=CC(Cl)=C1)C(=CC1=CC=C(Cl)C=C1)C1=C2C=CC(Cl)=C1,"InChI=1S/C30H32Cl3NO/c1-3-5-13-34(14-6-4-2)19-29(35)28-18-23(33)17-27-25(15-20-7-9-21(31)10-8-20)26-16-22(32)11-12-24(26)30(27)28/h7-12,15-18,29,35H,3-6,13-14,19H2,1-2H3/b25-15-",desbutyl-lumefantrine,CCCCNCC(O)C1=CC(Cl)=CC2=C1C1=C(C=C(Cl)C=C1)C2=CC1=CC=C(Cl)C=C1,YLBUTQNEBVPTES-NHDPSOOVSA-N,Cytochrome P450 3A4,0.98,
Fospropofol,CC(C)C1=CC=CC(C(C)C)=C1OCOP(=O)(O)O,"InChI=1S/C13H21O5P/c1-9(2)11-6-5-7-12(10(3)4)13(11)17-8-18-19(14,15)16/h5-7,9-10H,8H2,1-4H3,(H2,14,15,16)",Propofol,CC(C)C1=CC=CC(C(C)C)=C1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,,0.57,
Lornoxicam,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O,"InChI=1S/C13H10ClN3O4S2/c1-17-10(13(19)16-9-4-2-3-5-15-9)11(18)12-7(23(17,20)21)6-8(14)22-12/h2-6,18H,1H3,(H,15,16,19)",5'-Hydroxylornoxicam,CN1C(=C(O)NC2=NC=C(O)C=C2)C(=O)C2=C(C=C(Cl)S2)S1(=O)=O,CDAPXAMBZODQBD-JLHYYAGUSA-N,Cytochrome P450 2C9,0.68,
Ketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCN(C)CC1,"InChI=1S/C15H21NO2/c1-3-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3",Dihydroxy ketobemidone,CCC(=O)C1(C2=CC(O)=C(O)C=C2)CCN(C)CC1,MDTMDEIAXKFDTH-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.94,
Ketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCN(C)CC1,"InChI=1S/C15H21NO2/c1-3-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3",Reduced ketobemidone,CCC(O)C1(C2=CC(O)=CC=C2)CCN(C)CC1,CUWNYXLTWXEDNK-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.61,
Ketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCN(C)CC1,"InChI=1S/C15H21NO2/c1-3-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3",Norketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCNCC1,BJTDPLRIKDSWIS-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.95,
Ketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCN(C)CC1,"InChI=1S/C15H21NO2/c1-3-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3",Ketobemidone N-oxide,CCC(=O)C1(C2=CC(O)=CC=C2)CC[N+](C)([O-])CC1,HFMYBXUKKOZQHG-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.89,
Norketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCNCC1,BJTDPLRIKDSWIS-UHFFFAOYSA-N,Dihydroxy norketobemidone,CCC(=O)C1(C2=CC(O)=C(O)C=C2)CCNCC1,XOZROGPZDNSCPU-UHFFFAOYSA-N,,0.94,
Dihydroxy ketobemidone,CCC(=O)C1(C2=CC(O)=C(O)C=C2)CCN(C)CC1,MDTMDEIAXKFDTH-UHFFFAOYSA-N,p-Hydroxymethoxy ketobemidone,CCC(=O)C1(C2=CC(OC)=C(O)C=C2)CCN(C)CC1,QNSHRSXJXIHEDC-UHFFFAOYSA-N,,0.91,
Dihydroxy ketobemidone,CCC(=O)C1(C2=CC(O)=C(O)C=C2)CCN(C)CC1,MDTMDEIAXKFDTH-UHFFFAOYSA-N,m-Hydroxymethoxy ketobemidone,CCC(=O)C1(C2=CC(O)=C(OC)C=C2)CCN(C)CC1,YMCUUJLOWHXMHJ-UHFFFAOYSA-N,,0.94,
Betaine,C[N+](C)(C)CC(=O)[O-],"InChI=1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3","N,N-dimethylglycine",CN(C)CC(=O)O,"InChI=1S/C4H9NO2/c1-5(2)3-4(6)7/h3H2,1-2H3,(H,6,7)",Betaine--homocysteine S-methyltransferase 1,0.81,
Bendamustine,CN1C(CCCC(=O)O)=NC2=CC(N(CCCl)CCCl)=CC=C21,"InChI=1S/C16H21Cl2N3O2/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23/h5-6,11H,2-4,7-10H2,1H3,(H,22,23)",-hydroxybendamustine (Bendamustine metabolite M3),CN1C(C(O)CCC(=O)O)=NC2=C1C=CC(N(CCCl)CCCl)=C2,GPYWLSZJZNELNN-UHFFFAOYSA-N,Cytochrome P450 1A2,0.88,
Bendamustine,CN1C(CCCC(=O)O)=NC2=CC(N(CCCl)CCCl)=CC=C21,"InChI=1S/C16H21Cl2N3O2/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23/h5-6,11H,2-4,7-10H2,1H3,(H,22,23)",N-desmethyl-bendamustine (Bendamustine metabolite M4),O=C(O)CCCC1=NC2=C(C=CC(N(CCCl)CCCl)=C2)N1,BPZIKXXNXMYQPN-UHFFFAOYSA-N,Cytochrome P450 1A2,0.76,
Bendamustine,CN1C(CCCC(=O)O)=NC2=CC(N(CCCl)CCCl)=CC=C21,"InChI=1S/C16H21Cl2N3O2/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23/h5-6,11H,2-4,7-10H2,1H3,(H,22,23)",monohydroxy-bendamustine (bendamustine metabolite HP1),CN1C(CCCC(=O)O)=NC2=C1C=CC(N(CCO)CCCl)=C2,PFTRYOMJJKBZKV-UHFFFAOYSA-N,,0.96,
monohydroxy-bendamustine (bendamustine metabolite HP1),CN1C(CCCC(=O)O)=NC2=C1C=CC(N(CCO)CCCl)=C2,PFTRYOMJJKBZKV-UHFFFAOYSA-N,dihydroxy-bendamustine (bendamustine metabolite HP2),CN1C(CCCC(=O)O)=NC2=C1C=CC(N(CCO)CCO)=C2,XQMDIDKYVZPCNV-UHFFFAOYSA-N,,0.96,
Cabazitaxel,COC1C(=O)C2(C)C(OC)CC3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(NC(=O)OC(C)(C)C)C3=CC=CC=C3)C(C)=C1C2(C)C,"InChI=1S/C45H57NO14/c1-24-28(57-39(51)33(48)32(26-17-13-11-14-18-26)46-40(52)60-41(3,4)5)22-45(53)37(58-38(50)27-19-15-12-16-20-27)35-43(8,36(49)34(55-10)31(24)42(45,6)7)29(54-9)21-30-44(35,23-56-30)59-25(2)47/h11-20,28-30,32-35,37,48,53H,21-23H2,1-10H3,(H,46,52)/t28-,29-,30+,32-,33+,34+,35-,37-,43+,44-,45+/m0/s1",Docetaxel,CC(=O)OC12COC1CC(O)C1(C)C(=O)C(O)C3=C(C)C(OC(=O)C(O)C(NC(=O)OC(C)(C)C)C4=CC=CC=C4)CC(O)(C(OC(=O)C4=CC=CC=C4)C21)C3(C)C,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 2C8",0.99,
Cabazitaxel,COC1C(=O)C2(C)C(OC)CC3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(NC(=O)OC(C)(C)C)C3=CC=CC=C3)C(C)=C1C2(C)C,"InChI=1S/C45H57NO14/c1-24-28(57-39(51)33(48)32(26-17-13-11-14-18-26)46-40(52)60-41(3,4)5)22-45(53)37(58-38(50)27-19-15-12-16-20-27)35-43(8,36(49)34(55-10)31(24)42(45,6)7)29(54-9)21-30-44(35,23-56-30)59-25(2)47/h11-20,28-30,32-35,37,48,53H,21-23H2,1-10H3,(H,46,52)/t28-,29-,30+,32-,33+,34+,35-,37-,43+,44-,45+/m0/s1",RPR123142,COC1CC2OCC2(OC(C)=O)C2C(OC(=O)C3=CC=CC=C3)C3(O)CC(OC(=O)C(O)C(NC(=O)OC(C)(C)C)C4=CC=CC=C4)C(C)=C(C(O)C(=O)C12C)C3(C)C,CIHAXHLPSYZREI-BGKJQISDSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 2C8",0.99,
Phenylbutyric acid,O=C(O)CCCC1=CC=CC=C1,"InChI=1S/C10H12O2/c11-10(12)8-4-7-9-5-2-1-3-6-9/h1-3,5-6H,4,7-8H2,(H,11,12)",Phenylacetic acid,O=C(O)CC1=CC=CC=C1,WLJVXDMOQOGPHL-UHFFFAOYSA-N,,0.41,
Phenylacetic acid,O=C(O)CC1=CC=CC=C1,WLJVXDMOQOGPHL-UHFFFAOYSA-N,Phenylacetylglutamine,NC(=O)CCC(NC(=O)CC1=CC=CC=C1)C(=O)O,,,0.24,
Tiopronin,CC(S)C(=O)NCC(=O)O,"InChI=1S/C5H9NO3S/c1-3(10)5(9)6-2-4(7)8/h3,10H,2H2,1H3,(H,6,9)(H,7,8)",2-mercaptopropionic acid,CC(S)C(=O)O,PMNLUUOXGOOLSP-UHFFFAOYSA-N,,0.21,
Triethylenetetramine,NCCNCCNCCN,"InChI=1S/C6H18N4/c7-1-3-9-5-6-10-4-2-8/h9-10H,1-8H2",N1-acetyltriethylenetetramine,CC(=O)NCCNCCNCCN,GMXQUOKWLVCFEG-UHFFFAOYSA-N,Diamine acetyltransferase 1,0.52,
Chloramphenicol succinate,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)C1=CC=C([N+](=O)[O-])C=C1,"InChI=1S/C15H16Cl2N2O8/c16-14(17)15(24)18-10(7-27-12(22)6-5-11(20)21)13(23)8-1-3-9(4-2-8)19(25)26/h1-4,10,13-14,23H,5-7H2,(H,18,24)(H,20,21)/t10-,13-/m1/s1",Chloramphenicol,O=C(NC(CO)C(O)C1=CC=C([N+](=O)[O-])C=C1)C(Cl)Cl,"InChI=1S/C11H12Cl2N2O5/c12-10(13)11(18)14-8(5-16)9(17)6-1-3-7(4-2-6)15(19)20/h1-4,8-10,16-17H,5H2,(H,14,18)/t8-,9-/m1/s1",,0.78,
Harmine,COC1=CC2=C(C=C1)C1=C(N2)C(C)=NC=C1,"InChI=1S/C13H12N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-7,15H,1-2H3",Harmol,CC1=C2NC3=C(C=CC(O)=C3)C2=CC=N1,,"Cytochrome P450 2D6, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 1A2",0.93,
Nandrolone decanoate,CCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4C3CCC12C,"InChI=1S/C28H44O3/c1-3-4-5-6-7-8-9-10-27(30)31-26-16-15-25-24-13-11-20-19-21(29)12-14-22(20)23(24)17-18-28(25,26)2/h19,22-26H,3-18H2,1-2H3/t22-,23+,24+,25-,26-,28-/m0/s1",Nandrolone,CC12CCC3C4CCC(=O)C=C4CCC3C1CCC2O,"InChI=1S/C18H26O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-17,20H,2-9H2,1H3/t13-,14+,15+,16-,17-,18-/m0/s1","cAMP-specific 3',5'-cyclic phosphodiesterase 7B",0.76,
Nandrolone,CC12CCC3C4CCC(=O)C=C4CCC3C1CCC2O,"InChI=1S/C18H26O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-17,20H,2-9H2,1H3/t13-,14+,15+,16-,17-,18-/m0/s1",19-Norandrosterone,CC12CCC3C4CCC(O)CC4CCC3C1CCC2=O,,,0.39,
Bupranolol,CC1=CC(OCC(O)CNC(C)(C)C)=C(Cl)C=C1,"InChI=1S/C14H22ClNO2/c1-10-5-6-12(15)13(7-10)18-9-11(17)8-16-14(2,3)4/h5-7,11,16-17H,8-9H2,1-4H3","carboxybupranolol, 4-chloro-3-[3-(1,1-dimethylethylamino)-2-hydroxy-propyloxy]benzoic acid",CCCCNCC(O)COC1=C(Cl)C=CC(C(=O)O)=C1,IZPPAHZRVDTEHO-UHFFFAOYSA-N,,0.71,
Triflusal,CC(=O)OC1=C(C(=O)O)C=CC(C(F)(F)F)=C1,"InChI=1S/C10H7F3O4/c1-5(14)17-8-4-6(10(11,12)13)2-3-7(8)9(15)16/h2-4H,1H3,(H,15,16)",2-hydroxy-4-trifluoromethyl benzoic acid,O=C(O)C1=C(O)C=C(C(F)(F)F)C=C1,XMLFPUBZFSJWCN-UHFFFAOYSA-N,,0.66,
Lurasidone,O=C1C2C3CCC(C3)C2C(=O)N1CC1CCCCC1CN1CCN(C2=NSC3=CC=CC=C23)CC1,"InChI=1S/C28H36N4O2S/c33-27-24-18-9-10-19(15-18)25(24)28(34)32(27)17-21-6-2-1-5-20(21)16-30-11-13-31(14-12-30)26-22-7-3-4-8-23(22)35-29-26/h3-4,7-8,18-21,24-25H,1-2,5-6,9-17H2/t18-,19+,20-,21-,24+,25-/m0/s1",ID14326,O=C1C2C3CCC(C3O)C2C(=O)N1CC1CCCCC1CN1CCN(C2=NSC3=C2C=CC=C3)CC1,VKVBDORNIIAKBR-UJKUZCFGSA-N,,0.91,
Tafluprost,CC(C)OC(=O)CCCC=CCC1C(O)CC(O)C1C=CC(F)(F)COC1=CC=CC=C1,"InChI=1S/C25H34F2O5/c1-18(2)32-24(30)13-9-4-3-8-12-20-21(23(29)16-22(20)28)14-15-25(26,27)17-31-19-10-6-5-7-11-19/h3,5-8,10-11,14-15,18,20-23,28-29H,4,9,12-13,16-17H2,1-2H3/b8-3-,15-14+/t20-,21-,22+,23-/m1/s1",Tafluprost free acid,O=C(O)CCCC=CCC1C(O)CC(O)C1C=CC(F)(F)COC1=CC=CC=C1,KIQXRQVVYTYYAZ-MTNCBHNASA-N,,0.92,
Icosapent ethyl,CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC,"InChI=1S/C22H34O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24-4-2/h5-6,8-9,11-12,14-15,17-18H,3-4,7,10,13,16,19-21H2,1-2H3/b6-5-,9-8-,12-11-,15-14-,18-17-",EPA,CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O,JAZBEHYOTPTENJ-JLNKQSITSA-N,,0.69,
Dimethyl fumarate,COC(=O)C=CC(=O)OC,"InChI=1S/C6H8O4/c1-9-5(7)3-4-6(8)10-2/h3-4H,1-2H3/b4-3+",Monomethyl fumarate,COC(=O)C=CC(=O)O,"InChI=1S/C5H6O4/c1-9-5(8)3-2-4(6)7/h2-3H,1H3,(H,6,7)/b3-2+",,0.97,
(4R)-limonene,C=C(C)C1CC=C(C)CC1,"InChI=1S/C10H16/c1-8(2)10-6-4-9(3)5-7-10/h4,10H,1,5-7H2,2-3H3/t10-/m0/s1",Uroterpenol,CC1=CCC(C(C)(O)CO)CC1,ZJALAEQNHJQSTN-UHFFFAOYSA-N,,0.38,
Perillyl alcohol,C=C(C)C1CC=C(CO)CC1,NDTYTMIUWGWIMO-UHFFFAOYSA-N,Perillyl acid,C=C(C)C1=CCC(CO)CC1,HBYMEORZYADIJJ-UHFFFAOYSA-N,,0.43,
Uroterpenol,CC1=CCC(C(C)(O)CO)CC1,ZJALAEQNHJQSTN-UHFFFAOYSA-N,Uroterpenol-O-glucuronide,CC1=CCC(C(C)(O)COC2OC(C(=O)O)C(O)C(O)C2O)CC1,QLUXQCRCCGIUTP-LVSORJHWSA-N,,0.34,
Sofosbuvir,CC(C)OC(=O)C(C)NP(=O)(OCC1OC(N2C=CC(=O)NC2=O)C(C)(F)C1O)OC1=CC=CC=C1,"InChI=1S/C22H29FN3O9P/c1-13(2)33-19(29)14(3)25-36(31,35-15-8-6-5-7-9-15)32-12-16-18(28)22(4,23)20(34-16)26-11-10-17(27)24-21(26)30/h5-11,13-14,16,18,20,28H,12H2,1-4H3,(H,25,31)(H,24,27,30)/t14-,16+,18+,20+,22+,36-/m0/s1",GS-56650,CC(C)OC(=O)C(C)NP(=O)(O)OCC1OC(N2C=CC(=O)NC2=O)C(C)(F)C1O,IPNWIJCJSQLNQC-YAWKKRDBSA-N,"Carboxylesterase, Lysosomal protective protein",0.93,
GS-56650,CC(C)OC(=O)C(C)NP(=O)(O)OCC1OC(N2C=CC(=O)NC2=O)C(C)(F)C1O,IPNWIJCJSQLNQC-YAWKKRDBSA-N,GS-606965,CC1(F)C(O)C(COP(=O)(O)O)OC1N1C=CC(=O)NC1=O,JAJZLQMRDFLNSW-WDKMEHGUSA-N,Histidine triad nucleotide-binding protein 1,0.87,
GS-606965,CC1(F)C(O)C(COP(=O)(O)O)OC1N1C=CC(=O)NC1=O,JAJZLQMRDFLNSW-WDKMEHGUSA-N,GS-461203,CC1(F)C(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)OC1N1C=CC(O)=NC1=O,IPHULAIUXUVCHH-WDKMEHGUSA-N,"UMP-CMP kinase, Nucleoside diphosphate kinase A",0.85,
Vorapaxar,CCOC(=O)NC1CCC2C(C1)CC1C(=O)OC(C)C1C2C=CC1=CC=C(C2=CC(F)=CC=C2)C=N1,"InChI=1S/C29H33FN2O4/c1-3-35-29(34)32-23-10-11-24-20(14-23)15-26-27(17(2)36-28(26)33)25(24)12-9-22-8-7-19(16-31-22)18-5-4-6-21(30)13-18/h4-9,12-13,16-17,20,23-27H,3,10-11,14-15H2,1-2H3,(H,32,34)/b12-9+/t17-,20+,23-,24-,25+,26-,27+/m1/s1",amine metabolite (M19),CC1OC(=O)C2CC3CC(N)CCC3C(C=CC3=NC=C(C4=CC(F)=CC=C4)C=C3)C12,GTYWVNGLHQVHBJ-FRGGEYDCSA-N,Cytochrome P450 3A4,0.91,
Vorapaxar,CCOC(=O)NC1CCC2C(C1)CC1C(=O)OC(C)C1C2C=CC1=CC=C(C2=CC(F)=CC=C2)C=N1,"InChI=1S/C29H33FN2O4/c1-3-35-29(34)32-23-10-11-24-20(14-23)15-26-27(17(2)36-28(26)33)25(24)12-9-22-8-7-19(16-31-22)18-5-4-6-21(30)13-18/h4-9,12-13,16-17,20,23-27H,3,10-11,14-15H2,1-2H3,(H,32,34)/b12-9+/t17-,20+,23-,24-,25+,26-,27+/m1/s1",monohydroxy-vorapaxar (M20),CC1OC(=O)C2CC3CC(N=C(O)OCCO)CCC3C(C=CC3=NC=C(C4=CC(F)=CC=C4)C=C3)C12,ZHYYTGYLGLSISZ-VERGWIBFSA-N,"Cytochrome P450 3A4, Cytochrome P450 2J2",0.85,
Miltefosine,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,"InChI=1S/C21H46NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-25-27(23,24)26-21-19-22(2,3)4/h5-21H2,1-4H3",Choline,C[N+](C)(C)CCO,"InChI=1S/C5H14NO/c1-6(2,3)4-5-7/h7H,4-5H2,1-3H3/q+1",Phospholipase D1,0.17,
Tedizolid phosphate,CN1N=NC(C2=CC=C(C3=CC=C(N4CC(COP(=O)(O)O)OC4=O)C=C3F)C=N2)=N1,"InChI=1S/C17H16FN6O6P/c1-23-21-16(20-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)18)24-8-12(30-17(24)25)9-29-31(26,27)28/h2-7,12H,8-9H2,1H3,(H2,26,27,28)/t12-/m1/s1",Tedizolid,CN1N=NC(C2=NC=C(C3=C(F)C=C(N4CC(CO)OC4=O)C=C3)C=C2)=N1,"InChI=1S/C17H15FN6O3/c1-23-21-16(20-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)18)24-8-12(9-25)27-17(24)26/h2-7,12,25H,8-9H2,1H3/t12-/m1/s1",,0.93,
Netupitant,CC1=CC=CC=C1C1=CC(N2CCN(C)CC2)=NC=C1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,"InChI=1S/C30H32F6N4O/c1-19-8-6-7-9-23(19)24-17-26(40-12-10-38(4)11-13-40)37-18-25(24)39(5)27(41)28(2,3)20-14-21(29(31,32)33)16-22(15-20)30(34,35)36/h6-9,14-18H,10-13H2,1-5H3",Desmethyl Netupitant,CC1=CC=CC=C1C1=CC(N2CCNCC2)=NC=C1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,SRVSDBHUBFLSFE-UHFFFAOYSA-N,Cytochrome P450 3A43,0.99,
Netupitant,CC1=CC=CC=C1C1=CC(N2CCN(C)CC2)=NC=C1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,"InChI=1S/C30H32F6N4O/c1-19-8-6-7-9-23(19)24-17-26(40-12-10-38(4)11-13-40)37-18-25(24)39(5)27(41)28(2,3)20-14-21(29(31,32)33)16-22(15-20)30(34,35)36/h6-9,14-18H,10-13H2,1-5H3",N-oxide Netupitant,CC1=CC=CC=C1C1=CC(N2CCC(C)(O)CC2)=NC=C1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,GMWVPBPDWXVQEG-UHFFFAOYSA-N,Cytochrome P450 3A43,0.91,
Idelalisib,CCC(NC1=NC=NC2=C1N=CN2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1,"InChI=1S/C22H18FN7O/c1-2-15(28-20-18-19(25-11-24-18)26-12-27-20)21-29-16-10-6-9-14(23)17(16)22(31)30(21)13-7-4-3-5-8-13/h3-12,15H,2H2,1H3,(H2,24,25,26,27,28)/t15-/m0/s1",GS-563117,CCC(NC1=NC=NC2NC(=O)N=C12)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1,MMFWEWZUIJPIPC-KTQQKIMGSA-N,"Aldehyde oxidase, Cytochrome P450 3A Subfamily",0.74,
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,"InChI=1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3",Vortioxetine Metabolite 1,CC1=C(SC2=CC=CC=C2N2CC[NH2+]CC2)C=CC(CO)=C1,INVFGIUFVDSKAT-UHFFFAOYSA-O,"Cytochrome P450 2D6, Cytochrome P450 2C9",0.93,
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,"InChI=1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3",M8,CC1=CC(C)=C(SC2=CC(O)=CC=C2N2CC[NH2+]CC2)C=C1,GZGSAICCNTYGOF-UHFFFAOYSA-O,"Cytochrome P450 2D6, Cytochrome P450 2C9",0.87,
Nintedanib,COC(=O)C1=CC=C2C(=C(NC3=CC=C(N(C)C(=O)CN4CCN(C)CC4)C=C3)C3=CC=CC=C3)C(=O)NC2=C1,"InChI=1S/C31H33N5O4/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38/h4-14,19,32H,15-18,20H2,1-3H3,(H,33,38)/b29-28-",BIBF 1202,CN1CCN(CC(=O)N(C)C2=CC=C(NC(=C3C(O)=NC4=C3C=CC(C(=O)O)=C4)C3=CC=CC=C3)C=C2)CC1,KEHNCEDHZGQSNP-DQSJHHFOSA-N,,0.69,
Olodaterol,COC1=CC=C(CC(C)(C)NCC(O)C2=C3OCC(=O)NC3=CC(O)=C2)C=C1,"InChI=1S/C21H26N2O5/c1-21(2,10-13-4-6-15(27-3)7-5-13)22-11-18(25)16-8-14(24)9-17-20(16)28-12-19(26)23-17/h4-9,18,22,24-25H,10-12H2,1-3H3,(H,23,26)/t18-/m0/s1",O-demethylated olodaterol,CC(C)(CC1=CC=C(O)C=C1)NCC(O)C1=C2OCC(O)=NC2=CC(O)=C1,OSJGFHCFUOVFPN-KRWDZBQOSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C8",0.68,
Vilanterol,OCC1=C(O)C=CC(C(O)CNCCCCCCOCCOCC2=C(Cl)C=CC=C2Cl)=C1,"InChI=1S/C24H33Cl2NO5/c25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28/h5-9,14,24,27-30H,1-4,10-13,15-17H2/t24-/m0/s1",M29 (GW630200),OCCOCCCCCCNCC(O)C1=CC(CO)=C(O)C=C1,BOBWIDWDXFEGNK-KRWDZBQOSA-N,,0.76,
Tetracaine,CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1,"InChI=1S/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H3",para-aminobenzoic acid,NC1=CC=C(C(=O)O)C=C1,ALYNCZNDIQEVRV-UHFFFAOYSA-N,,0.48,
Benzoyl peroxide,O=C(OOC(=O)C1=CC=CC=C1)C1=CC=CC=C1,InChI=1S/C14H10O4/c15-13(11-7-3-1-4-8-11)17-18-14(16)12-9-5-2-6-10-12/h1-10H,Benzoyloxyl radical,O=C([O-])C1=CC=CC=C1,WPYMKLBDIGXBTP-UHFFFAOYSA-M,,0.54,
Coenzyme M,O=S(=O)(O)CCS,"InChI=1S/C2H6O3S2/c3-7(4,5)2-1-6/h6H,1-2H2,(H,3,4,5)",dimesna,O=S(=O)(O)CCSSCCS(=O)(=O)O,BYUKOOOZTSTOOH-UHFFFAOYSA-N,,0.54,
Eslicarbazepine acetate,CC(=O)OC1CC2=CC=CC=C2N(C(N)=O)C2=CC=CC=C21,"InChI=1S/C17H16N2O3/c1-11(20)22-16-10-12-6-2-4-8-14(12)19(17(18)21)15-9-5-3-7-13(15)16/h2-9,16H,10H2,1H3,(H2,18,21)/t16-/m0/s1",Eslicarbazepine [(S)-licarbazepine],NC(=O)N1C2=CC=CC=C2CC(O)C2=C1C=CC=C2,BMPDWHIDQYTSHX-CQSZACIVSA-N,,0.81,
Eslicarbazepine [(S)-licarbazepine],NC(=O)N1C2=CC=CC=C2CC(O)C2=C1C=CC=C2,BMPDWHIDQYTSHX-CQSZACIVSA-N,Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,CTRLABGOLIVAIY-UHFFFAOYSA-N,,0.64,
Eslicarbazepine [(S)-licarbazepine],NC(=O)N1C2=CC=CC=C2CC(O)C2=C1C=CC=C2,BMPDWHIDQYTSHX-CQSZACIVSA-N,Eslicarbazepine-O-glucuronide,NC(=O)N1C2=CC=CC=C2CC(NC(C=O)CCC(=O)O)C2=C1C=CC=C2,NRSIPYUVLOFFHV-GOEBONIOSA-N,,0.56,
Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,CTRLABGOLIVAIY-UHFFFAOYSA-N,Eslicarbazepine,NC(=O)N1C2=C(C=CC=C2)CC(O)C2=C1C=CC=C2,"InChI=1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)/t14-/m0/s1",,0.64,
Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,CTRLABGOLIVAIY-UHFFFAOYSA-N,10-hydroxycarbazepine sulfate,NC(=O)N1C2=CC=CC=C2CC(OS(=O)(=O)O)C2=CC=CC=C21,DQCMJSSQBFEDHL-UHFFFAOYSA-N,,0.57,
Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,CTRLABGOLIVAIY-UHFFFAOYSA-N,10-hydroxycarbazepine glucuronide,NC(=O)N1C2=CC=CC=C2CC(NC(C=O)CCC(=O)O)C2=CC=CC=C21,NRSIPYUVLOFFHV-LBAUFKAWSA-N,,0.54,
Uridine triacetate,CC(=O)OCC1OC(N2C=CC(=O)NC2=O)C(OC(C)=O)C1OC(C)=O,"InChI=1S/C15H18N2O9/c1-7(18)23-6-10-12(24-8(2)19)13(25-9(3)20)14(26-10)17-5-4-11(21)16-15(17)22/h4-5,10,12-14H,6H2,1-3H3,(H,16,21,22)/t10-,12-,13-,14-/m1/s1",Uridine,O=C1C=CN(C2OC(CO)C(O)C2O)C(=O)N1,DRTQHJPVMGBUCF-XVFCMESISA-N,,0.82,
Florbetapir (18F),CNC1=CC=C(C=CC2=CN=C(OCCOCCOCCF)C=C2)C=C1,"InChI=1S/C20H25FN2O3/c1-22-19-7-4-17(5-8-19)2-3-18-6-9-20(23-16-18)26-15-14-25-13-12-24-11-10-21/h2-9,16,22H,10-15H2,1H3/b3-2+/i21-1",[18F]AV-160 (desmethyl-[18F]AV-45),NC1=CC=C(C=CC2=CN=C(OCCOCCOCCF)C=C2)C=C1,HWDCMGOFOLKQBU-YHRRMKGCSA-N,,0.95,
Florbetapir (18F),CNC1=CC=C(C=CC2=CN=C(OCCOCCOCCF)C=C2)C=C1,"InChI=1S/C20H25FN2O3/c1-22-19-7-4-17(5-8-19)2-3-18-6-9-20(23-16-18)26-15-14-25-13-12-24-11-10-21/h2-9,16,22H,10-15H2,1H3/b3-2+/i21-1",[18F]AV-267 (N-acetyl[18F]AV-160),CC(=O)NC1=CC=C(C=CC2=CN=C(OCCOCCOCCF)C=C2)C=C1,KWNBGGMKKPCFDH-FWZJPQCDSA-N,,0.91,
Etoperidone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CC,"InChI=1S/C19H28ClN5O/c1-3-18-21-25(19(26)24(18)4-2)10-6-9-22-11-13-23(14-12-22)17-8-5-7-16(20)15-17/h5,7-8,15H,3-4,6,9-14H2,1-2H3",m-Chlorophenylpiperazine,ClC1=CC(N2CCNCC2)=CC=C1,"InChI=1S/C10H13ClN2/c11-9-2-1-3-10(8-9)13-6-4-12-5-7-13/h1-3,8,12H,4-7H2",,0.29,
Pholcodine,CN1CCC23C4=C5C=CC(OCCN6CCOCC6)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C23H30N2O4/c1-24-7-6-23-16-3-4-18(26)22(23)29-21-19(5-2-15(20(21)23)14-17(16)24)28-13-10-25-8-11-27-12-9-25/h2-5,16-18,22,26H,6-14H2,1H3/t16-,17+,18-,22-,23-/m0/s1",Morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1",,0.98,
Droxicam,CN1C2=C(OC(=O)N(C3=CC=CC=N3)C2=O)C2=CC=CC=C2S1(=O)=O,"InChI=1S/C16H11N3O5S/c1-18-13-14(10-6-2-3-7-11(10)25(18,22)23)24-16(21)19(15(13)20)12-8-4-5-9-17-12/h2-9H,1H3",Piroxicam,CN1C(C(=O)NC2=NC=CC=C2)=C(O)C2=C(C=CC=C2)S1(=O)=O,"InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20)",,0.54,
Molsidomine,CCOC(=O)[N-]C1=C[N+](N2CCOCC2)=NO1,"InChI=1S/C9H14N4O4/c1-2-16-9(14)10-8-7-13(11-17-8)12-3-5-15-6-4-12/h7H,2-6H2,1H3",Linsidomine,[NH-]C1=C[N+](N2CCOCC2)=NO1,"InChI=1S/C6H10N4O2/c7-6-5-10(8-12-6)9-1-3-11-4-2-9/h5,7H,1-4H2","cGMP-specific 3',5'-cyclic phosphodiesterase",0.64,
Propacetamol,CCN(CC)CC(=O)OC1=CC=C(NC(C)=O)C=C1,"InChI=1S/C14H20N2O3/c1-4-16(5-2)10-14(18)19-13-8-6-12(7-9-13)15-11(3)17/h6-9H,4-5,10H2,1-3H3,(H,15,17)",Acetaminophen,CC(=O)NC1=CC=C(O)C=C1,"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)",Cholinesterase,0.5,
Rolapitant,CC(OCC1(C2=CC=CC=C2)CCC2(CCC(=O)N2)CN1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,"InChI=1S/C25H26F6N2O2/c1-16(17-11-19(24(26,27)28)13-20(12-17)25(29,30)31)35-15-23(18-5-3-2-4-6-18)10-9-22(14-32-23)8-7-21(34)33-22/h2-6,11-13,16,32H,7-10,14-15H2,1H3,(H,33,34)/t16-,22-,23-/m1/s1",Rolapitant metabolite M19,CC(OCC1(C2=CC=CC=C2)CCC2(CN1)NC(=O)CC2O)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,FCWJCWUZMPITLV-OYGALRCHSA-N,Cytochrome P450 3A4,0.92,
Sacubitril,CCOC(=O)C(C)CC(CC1=CC=C(C2=CC=CC=C2)C=C1)NC(=O)CCC(=O)O,"InChI=1S/C24H29NO5/c1-3-30-24(29)17(2)15-21(25-22(26)13-14-23(27)28)16-18-9-11-20(12-10-18)19-7-5-4-6-8-19/h4-12,17,21H,3,13-16H2,1-2H3,(H,25,26)(H,27,28)/t17-,21+/m1/s1",Sacubitrilat (LBQ657),CC(CC(CC1=CC=C(C2=CC=CC=C2)C=C1)NC(=O)CCC(=O)O)C(=O)O,DOBNVUFHFMVMDB-BEFAXECRSA-N,,0.91,
Tenofovir,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,SGOIRFVFHAKUTI-ZCFIWIBFSA-N,Tenofovir Monophosphate,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)OP(=O)(O)O,BQDRSOMUPPCKPB-ZCFIWIBFSA-N,"Adenylate kinase isoenzyme 1, Adenylate kinase 2, mitochondrial",0.88,
Dexpanthenol,CC(C)(CO)C(O)C(=O)NCCCO,"InChI=1S/C9H19NO4/c1-9(2,6-12)7(13)8(14)10-4-3-5-11/h7,11-13H,3-6H2,1-2H3,(H,10,14)/t7-/m0/s1",Pantothenic acid,CC(C)(CO)C(O)C(=O)NCCC(=O)O,"InChI=1S/C9H17NO5/c1-9(2,5-11)7(14)8(15)10-4-3-6(12)13/h7,11,14H,3-5H2,1-2H3,(H,10,15)(H,12,13)/t7-/m0/s1",,0.9,
Xylose,O=CC(O)C(O)C(O)CO,"InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h1,3-5,7-10H,2H2/t3-,4+,5+/m0/s1",Xylitol,OCC(O)C(O)C(O)CO,"InChI=1S/C5H12O5/c6-1-3(8)5(10)4(9)2-7/h3-10H,1-2H2/t3-,4+,5+",,0.58,
Xylitol,OCC(O)C(O)C(O)CO,"InChI=1S/C5H12O5/c6-1-3(8)5(10)4(9)2-7/h3-10H,1-2H2/t3-,4+,5+",D-Xylulose,O=C(CO)C(O)C(O)CO,"InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h3,5-8,10H,1-2H2/t3-,5-/m0/s1",,0.44,
Cetyl alcohol,CCCCCCCCCCCCCCCCO,"InChI=1S/C16H34O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17/h17H,2-16H2,1H3",Palmitic Acid,CCCCCCCCCCCCCCCC(=O)O,"InChI=1S/C16H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h2-15H2,1H3,(H,17,18)",Alcohol dehydrogenase [NADP(+)],0.52,
Methyl salicylate,COC(=O)C1=CC=CC=C1O,"InChI=1S/C8H8O3/c1-11-8(10)6-4-2-3-5-7(6)9/h2-5,9H,1H3",Salicylic acid,COC(=O)C1=C(O)C=C(C)C=C1,UITFCFWKYAOJEJ-UHFFFAOYSA-N,Liver esterases,0.84,
Arbutin,OCC1OC(OC2=CC=C(O)C=C2)C(O)C(O)C1O,"InChI=1S/C12H16O7/c13-5-8-9(15)10(16)11(17)12(19-8)18-7-3-1-6(14)2-4-7/h1-4,8-17H,5H2/t8-,9-,10+,11-,12-/m1/s1",D-glucose,O=CC(O)C(O)C(O)C(O)CO,"InChI=1S/C6H12O6/c7-1-3(9)5(11)6(12)4(10)2-8/h1,3-6,8-12H,2H2/t3-,4+,5+,6+/m0/s1",,0.16,
Prezatide,NCCCCC(NC(=O)C(CC1=CNC=N1)NC(=O)CN)C(=O)O,"InChI=1S/C14H24N6O4/c15-4-2-1-3-10(14(23)24)20-13(22)11(19-12(21)6-16)5-9-7-17-8-18-9/h7-8,10-11H,1-6,15-16H2,(H,17,18)(H,19,21)(H,20,22)(H,23,24)/t10-,11-/m0/s1",Histidyl-lysine,NCCCCC(NC(=O)C(N)CC1=CNC=N1)C(=O)O,,,0.8,
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-","Elongation of very long chain fatty acids protein 5, Elongation of very long chain fatty acids protein 4",0.85,
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",Prostaglandin E1,CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(=O)O,,"Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2",0.22,
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",Fatty acid desaturase 2,0.75,
Selexipag,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)C1=NC(C2=CC=CC=C2)=C(C2=CC=CC=C2)N=C1,"InChI=1S/C26H32N4O4S/c1-20(2)30(16-10-11-17-34-19-24(31)29-35(3,32)33)23-18-27-25(21-12-6-4-7-13-21)26(28-23)22-14-8-5-9-15-22/h4-9,12-15,18,20H,10-11,16-17,19H2,1-3H3,(H,29,31)",ACT-333679,CC(C)N(CCCCOCC(=O)O)C1=NC(C2=CC=CC=C2)=C(C2=CC=CC=C2)N=C1,OJQMKCBWYCWFPU-UHFFFAOYSA-N,Liver carboxylesterase 1,0.87,
Alectinib,CCC1=CC2=C(C=C1N1CCC(N3CCOCC3)CC1)C(C)(C)C1=C(C2=O)C2=CC=C(C#N)C=C2N1,"InChI=1S/C30H34N4O2/c1-4-20-16-23-24(17-26(20)34-9-7-21(8-10-34)33-11-13-36-14-12-33)30(2,3)29-27(28(23)35)22-6-5-19(18-31)15-25(22)32-29/h5-6,15-17,21,32H,4,7-14H2,1-3H3",M4,CCC1=CC2=C(C=C1N1CCC(NCCO)CC1)C(C)(C)C1=C(C2=O)C2=C(C=C(C#N)C=C2)N1,XNKBNGIKXNABDO-UHFFFAOYSA-N,Cytochrome P450 3A4,0.99,
Sennidin A,O=C(O)C1=CC(O)=C2C(=O)C3=C(O)C=CC=C3C(C3C4=CC=CC(O)=C4C(=O)C4=C(O)C=C(C(=O)O)C=C43)C2=C1,JPMRHWLJLNKRTJ-UHFFFAOYSA-N,Rheinanthrone,O=C(O)C1=CC2CC3=C(C(=O)C2C(O)=C1)C(O)=CC=C3,RRMMJVMTHXZXEG-UHFFFAOYSA-N,Beta-glucosidase,0.36,
Rheinanthrone,O=C(O)C1=CC2CC3=C(C(=O)C2C(O)=C1)C(O)=CC=C3,RRMMJVMTHXZXEG-UHFFFAOYSA-N,Rhein,O=C(O)C1=CC2C(=O)C3=C(C(=O)C2C(O)=C1)C(O)=CC=C3,HHQNGUQUHZYDEP-UHFFFAOYSA-N,,0.95,
Benzyl alcohol,OCC1=CC=CC=C1,"InChI=1S/C7H8O/c8-6-7-4-2-1-3-5-7/h1-5,8H,6H2",Benzoic acid,O=C(O)C1=CC=CC=C1,WPYMKLBDIGXBTP-UHFFFAOYSA-N,,0.6,
Levoleucovorin,NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C3)N2C=O)N1,"InChI=1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32)/t12-,13-/m0/s1",5-Methyltetrahydrofolate,CN1C2=C(N=C(N)NC2=O)NCC1CNC1=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C1,ZNOVTXRBGFNYRX-ZGTCLIOFSA-N,,0.95,
Fostemsavir,COC1=CN=C(N2C=NC(C)=N2)C2=C1C(C(=O)C(=O)N1CCN(C(=O)C3=CC=CC=C3)CC1)=CN2COP(=O)(O)O,"InChI=1S/C25H26N7O8P/c1-16-27-14-32(28-16)23-21-20(19(39-2)12-26-23)18(13-31(21)15-40-41(36,37)38)22(33)25(35)30-10-8-29(9-11-30)24(34)17-6-4-3-5-7-17/h3-7,12-14H,8-11,15H2,1-2H3,(H2,36,37,38)",Temsavir,COC1=CN=C(N2C=NC(C)=N2)C2=C1C(C(=O)C(=O)N1CCN(C(=O)C3=CC=CC=C3)CC1)=CN2,"InChI=1S/C24H23N7O4/c1-15-27-14-31(28-15)22-20-19(18(35-2)13-26-22)17(12-25-20)21(32)24(34)30-10-8-29(9-11-30)23(33)16-6-4-3-5-7-16/h3-7,12-14,25H,8-11H2,1-2H3",Intestinal-type alkaline phosphatase,0.88,
Valbenazine,COC1=C(OC)C=C2C(=C1)CCN1CC(CC(C)C)C(OC(=O)C(N)C(C)C)CC21,"InChI=1S/C24H38N2O4/c1-14(2)9-17-13-26-8-7-16-10-21(28-5)22(29-6)11-18(16)19(26)12-20(17)30-24(27)23(25)15(3)4/h10-11,14-15,17,19-20,23H,7-9,12-13,25H2,1-6H3/t17-,19-,20-,23+/m1/s1",NBI-136110,COC1=C(OC)C=C2C(=C1)CCN1CC(CC(C)C)C(OC(=O)C(N)C(C)(C)O)CC21,RPHPRWCGGJGIHI-WGQQHEPDSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.97,
Valbenazine,COC1=C(OC)C=C2C(=C1)CCN1CC(CC(C)C)C(OC(=O)C(N)C(C)C)CC21,"InChI=1S/C24H38N2O4/c1-14(2)9-17-13-26-8-7-16-10-21(28-5)22(29-6)11-18(16)19(26)12-20(17)30-24(27)23(25)15(3)4/h10-11,14-15,17,19-20,23H,7-9,12-13,25H2,1-6H3/t17-,19-,20-,23+/m1/s1",[+]--HTBZ,COC1=C(OC)C=C2C(=C1)CCN1CC(CC(C)C)C(O)CC21,WEQLWGNDNRARGE-DJIMGWMZSA-N,,0.85,
Diacerein,CC(=O)OC1=CC=CC2=C1C(=O)C1=C(OC(C)=O)C=C(C(=O)O)C=C1C2=O,"InChI=1S/C19H12O8/c1-8(20)26-13-5-3-4-11-15(13)18(23)16-12(17(11)22)6-10(19(24)25)7-14(16)27-9(2)21/h3-7H,1-2H3,(H,24,25)",Rhein,O=C(O)C1=CC2C(=O)C3=C(C(=O)C2C(O)=C1)C(O)=CC=C3,HHQNGUQUHZYDEP-UHFFFAOYSA-N,,0.37,
Telotristat ethyl,CCOC(=O)C(N)CC1=CC=C(C2=NC(N)=NC(OC(C3=CC=C(Cl)C=C3N3C=CC(C)=N3)C(F)(F)F)=C2)C=C1,"InChI=1S/C27H26ClF3N6O3/c1-3-39-25(38)20(32)12-16-4-6-17(7-5-16)21-14-23(35-26(33)34-21)40-24(27(29,30)31)19-9-8-18(28)13-22(19)37-11-10-15(2)36-37/h4-11,13-14,20,24H,3,12,32H2,1-2H3,(H2,33,34,35)/t20-,24+/m0/s1",Telotristat,CC1=NN(C2=CC(Cl)=CC=C2C(OC2=NC(N)=NC(C3=CC=C(CC(N)C(=O)O)C=C3)=C2)C(F)(F)F)C=C1,"InChI=1S/C25H22ClF3N6O3/c1-13-8-9-35(34-13)20-11-16(26)6-7-17(20)22(25(27,28)29)38-21-12-19(32-24(31)33-21)15-4-2-14(3-5-15)10-18(30)23(36)37/h2-9,11-12,18,22H,10,30H2,1H3,(H,36,37)(H2,31,32,33)/t18-,22+/m0/s1","Liver carboxylesterase 1, Cocaine esterase",0.98,
Brincidofovir,CCCCCCCCCCCCCCCCOCCCOP(=O)(O)COC(CO)CN1C=CC(N)=NC1=O,"InChI=1S/C27H52N3O7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-35-20-16-21-37-38(33,34)24-36-25(23-31)22-30-18-17-26(28)29-27(30)32/h17-18,25,31H,2-16,19-24H2,1H3,(H,33,34)(H2,28,29,32)/t25-/m0/s1",Cidofovir,NC1=NC(=O)N(CC(CO)OCP(=O)(O)O)C=C1,"InChI=1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1",,0.83,
Oxetacaine,CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC1=CC=CC=C1)C(C)(C)CC1=CC=CC=C1,"InChI=1S/C28H41N3O3/c1-27(2,19-23-13-9-7-10-14-23)29(5)25(33)21-31(17-18-32)22-26(34)30(6)28(3,4)20-24-15-11-8-12-16-24/h7-16,32H,17-22H2,1-6H3",Mephentermine,CNC(C)(C)CC1=CC=CC=C1,"InChI=1S/C11H17N/c1-11(2,12-3)9-10-7-5-4-6-8-10/h4-8,12H,9H2,1-3H3",,0.43,
Oxetacaine,CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC1=CC=CC=C1)C(C)(C)CC1=CC=CC=C1,"InChI=1S/C28H41N3O3/c1-27(2,19-23-13-9-7-10-14-23)29(5)25(33)21-31(17-18-32)22-26(34)30(6)28(3,4)20-24-15-11-8-12-16-24/h7-16,32H,17-22H2,1-6H3",Phentermine,CC(C)(N)CC1=CC=CC=C1,"InChI=1S/C10H15N/c1-10(2,11)8-9-6-4-3-5-7-9/h3-7H,8,11H2,1-2H3",,0.35,
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",Ifosfamide,O=P1(NCCCl)OCCCN1CCCl,"InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)","Cytochrome P450 3A4, Cytochrome P450 2B6",0.96,
Nicoboxil,CCCCOCCOC(=O)C1=CN=CC=C1,"InChI=1S/C12H17NO3/c1-2-3-7-15-8-9-16-12(14)11-5-4-6-13-10-11/h4-6,10H,2-3,7-9H2,1H3",Niacin,O=C(O)C1=CN=CC=C1,"InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)",Serum albumin,0.58,
Darolutamide,CC(CN1C=CC(C2=CC=C(C#N)C(Cl)=C2)=N1)NC(=O)C1=NNC(C(C)O)=C1,"InChI=1S/C19H19ClN6O2/c1-11(22-19(28)18-8-17(12(2)27)23-24-18)10-26-6-5-16(25-26)13-3-4-14(9-21)15(20)7-13/h3-8,11-12,27H,10H2,1-2H3,(H,22,28)(H,23,24)/t11-,12?/m0/s1",Ketodarolutamide,CC(=O)C1=CC(C(=O)NC(C)CN2C=CC(C3=CC=C(C#N)C(Cl)=C3)=N2)=NN1,"InChI=1S/C19H17ClN6O2/c1-11(22-19(28)18-8-17(12(2)27)23-24-18)10-26-6-5-16(25-26)13-3-4-14(9-21)15(20)7-13/h3-8,11H,10H2,1-2H3,(H,22,28)(H,23,24)/t11-/m0/s1","Cytochrome P450 3A4, UDP-glucuronosyltransferase 1-9",0.91,
Rheinanthrone,O=C(O)C1=CC(O)=C2C(=O)C3=C(C=CC=C3O)CC2=C1,"InChI=1S/C15H10O5/c16-10-3-1-2-7-4-8-5-9(15(19)20)6-11(17)13(8)14(18)12(7)10/h1-3,5-6,16-17H,4H2,(H,19,20)",Rhein,O=C(O)C1=CC2C(=O)C3=C(C(=O)C2C(O)=C1)C(O)=CC=C3,HHQNGUQUHZYDEP-UHFFFAOYSA-N,,0.31,
Rheinanthrone,O=C(O)C1=CC(O)=C2C(=O)C3=C(C=CC=C3O)CC2=C1,"InChI=1S/C15H10O5/c16-10-3-1-2-7-4-8-5-9(15(19)20)6-11(17)13(8)14(18)12(7)10/h1-3,5-6,16-17H,4H2,(H,19,20)",Sennidin A,O=C(O)C1=CC(O)=C2C(=O)C3=C(O)C=CC=C3C(C3C4=CC=CC(O)=C4C(=O)C4=C(O)C=C(C(=O)O)C=C43)C2=C1,JPMRHWLJLNKRTJ-UHFFFAOYSA-N,,0.74,
Oxabolone cipionate,CC12CCC3C4CCC(=O)C(O)=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H38O4/c1-26-15-14-18-17-9-11-22(27)25(29)20(17)8-7-19(18)21(26)10-12-23(26)30-24(28)13-6-16-4-2-3-5-16/h16-19,21,23,29H,2-15H2,1H3/t17-,18-,19-,21+,23+,26+/m1/s1",Oxabolone,CC12CCC3C4CCC(=O)C(O)=C4CCC3C1CCC2O,"InChI=1S/C18H26O3/c1-18-9-8-11-10-4-6-15(19)17(21)13(10)3-2-12(11)14(18)5-7-16(18)20/h10-12,14,16,20-21H,2-9H2,1H3/t10-,11-,12-,14+,16+,18+/m1/s1",,0.81,
Dichlorobenzyl alcohol,OCC1=C(Cl)C=C(Cl)C=C1,"InChI=1S/C7H6Cl2O/c8-6-2-1-5(4-10)7(9)3-6/h1-3,10H,4H2",Hippuric acid,O=C(O)CNC(=O)C1=CC=CC=C1,QIAFMBKCNZACKA-UHFFFAOYSA-N,,0.15,
Acemetacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OCC(=O)O,"InChI=1S/C21H18ClNO6/c1-12-16(10-20(26)29-11-19(24)25)17-9-15(28-2)7-8-18(17)23(12)21(27)13-3-5-14(22)6-4-13/h3-9H,10-11H2,1-2H3,(H,24,25)",Indomethacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)O,"InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)",,0.96,
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",Dinoprostone,CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(=O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1","Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2, Phospholipase A2, membrane associated",0.2,
Harmaline,COC1=CC2=C(C=C1)C1=C(N2)C(C)=NCC1,"InChI=1S/C13H14N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-4,7,15H,5-6H2,1-2H3",Harmalol,CC1=NCCC2=C1NC1=C2C=CC(O)=C1,,"Cytochrome P450 2D6, Cytochrome P450 1A2",0.96,
Methyl nicotinate,COC(=O)C1=CN=CC=C1,"InChI=1S/C7H7NO2/c1-10-7(9)6-3-2-4-8-5-6/h2-5H,1H3",Niacin,O=C(O)C1=CN=CC=C1,"InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)",,0.8,
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",,0.77,
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",,0.77,
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1",Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",,0.86,
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,"InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1",Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",,0.78,
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1",Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",,0.85,
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,"InChI=1S/C32H48O4/c1-4-6-8-10-12-30(33)35-24-15-17-25-23(22-24)14-16-27-26(25)20-21-32(3)28(27)18-19-29(32)36-31(34)13-11-9-7-5-2/h15,17,22,26-29H,4-14,16,18-21H2,1-3H3/t26-,27-,28+,29+,32+/m1/s1",Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",,0.74,
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1",Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",,0.85,
alpha-Linolenic acid,CCC=CCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9-",Docosahexaenoic acid,CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)O,,,0.56,
alpha-Linolenic acid,CCC=CCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9-",Eicosapentaenoic acid,CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O,,,0.71,
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",,0.73,
Isopropyl myristate,CCCCCCCCCCCCCC(=O)OC(C)C,"InChI=1S/C17H34O2/c1-4-5-6-7-8-9-10-11-12-13-14-15-17(18)19-16(2)3/h16H,4-15H2,1-3H3",Myristic acid,CCCCCCCCCCCCCC(=O)O,"InChI=1S/C14H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h2-13H2,1H3,(H,15,16)",Carboxylesterase,0.5,
Baloxavir marboxil,COC(=O)OCOC1=C2C(=O)N3CCOCC3N(C3C4=CC=CC=C4SCC4=C(F)C(F)=CC=C43)N2C=CC1=O,"InChI=1S/C27H23F2N3O7S/c1-36-27(35)39-14-38-25-19(33)8-9-31-24(25)26(34)30-10-11-37-12-21(30)32(31)23-15-6-7-18(28)22(29)17(15)13-40-20-5-3-2-4-16(20)23/h2-9,21,23H,10-14H2,1H3/t21-,23+/m1/s1",Baloxavir,O=C1C2=C(O)C(=O)C=CN2N(C2C3=C(C=CC=C3)SCC3=C2C=CC(F)=C3F)C2COCCN12,"InChI=1S/C24H19F2N3O4S/c25-16-6-5-13-15(20(16)26)12-34-18-4-2-1-3-14(18)21(13)29-19-11-33-10-9-27(19)24(32)22-23(31)17(30)7-8-28(22)29/h1-8,19,21,31H,9-12H2/t19-,21+/m1/s1",,0.97,
Cinnamyl alcohol,OCC=CC1=CC=CC=C1,"InChI=1S/C9H10O/c10-8-4-7-9-5-2-1-3-6-9/h1-7,10H,8H2/b7-4+",Cinnamaldehyde,O=CC=CC1=CC=CC=C1,InChI=1S/C9H8O/c10-8-4-7-9-5-2-1-3-6-9/h1-8H/b7-4+,,0.72,
Mometasone furoate,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)C1=CC=CO1)C(=O)CCl,"InChI=1S/C27H30Cl2O6/c1-15-11-19-18-7-6-16-12-17(30)8-9-24(16,2)26(18,29)21(31)13-25(19,3)27(15,22(32)14-28)35-23(33)20-5-4-10-34-20/h4-5,8-10,12,15,18-19,21,31H,6-7,11,13-14H2,1-3H3/t15-,18+,19+,21+,24+,25+,26+,27+/m1/s1",6-beta-hydroxy-mometasone furoate,CC1CC2C3C(O)CC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)C1=CC=CO1)C(=O)CCl,NVZADOUZVHKHSK-PWHXNIGKSA-N,,0.96,
Mometasone furoate,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)C1=CC=CO1)C(=O)CCl,"InChI=1S/C27H30Cl2O6/c1-15-11-19-18-7-6-16-12-17(30)8-9-24(16,2)26(18,29)21(31)13-25(19,3)27(15,22(32)14-28)35-23(33)20-5-4-10-34-20/h4-5,8-10,12,15,18-19,21,31H,6-7,11,13-14H2,1-3H3/t15-,18+,19+,21+,24+,25+,26+,27+/m1/s1",Mometasone,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(O)C(=O)CCl,"InChI=1S/C22H28Cl2O4/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,24)17(26)10-20(16,3)22(12,28)18(27)11-23/h6-7,9,12,15-17,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1",,0.74,
Betamethasone phosphate,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COP(=O)(O)O,"InChI=1S/C22H30FO8P/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)21(15,23)17(25)10-20(16,3)22(12,27)18(26)11-31-32(28,29)30/h6-7,9,12,15-17,25,27H,4-5,8,10-11H2,1-3H3,(H2,28,29,30)/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1",Betamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,"InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1",,0.9,
Diroximel fumarate,COC(=O)C=CC(=O)OCCN1C(=O)CCC1=O,"InChI=1S/C11H13NO6/c1-17-10(15)4-5-11(16)18-7-6-12-8(13)2-3-9(12)14/h4-5H,2-3,6-7H2,1H3/b5-4+",Monomethyl fumarate,COC(=O)C=CC(=O)O,"InChI=1S/C5H6O4/c1-9-5(8)3-2-4(6)7/h2-3H,1H3,(H,6,7)/b3-2+",Liver esterases,0.24,
Monomethyl fumarate,COC(=O)C=CC(=O)O,"InChI=1S/C5H6O4/c1-9-5(8)3-2-4(6)7/h2-3H,1H3,(H,6,7)/b3-2+",Fumaric acid,O=C(O)C=CC(=O)O,"InChI=1S/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/b2-1+",,0.65,
Benzhydrocodone,COC1=C2OC3C(OC(=O)C4=CC=CC=C4)=CCC4C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C25H25NO4/c1-26-13-12-25-17-9-11-20(29-24(27)15-6-4-3-5-7-15)23(25)30-22-19(28-2)10-8-16(21(22)25)14-18(17)26/h3-8,10-11,17-18,23H,9,12-14H2,1-2H3/t17-,18-,23+,25+/m1/s1",Hydrocodone,COC1=C2OC3C(=O)CCC4C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-12,17H,4-5,7-9H2,1-2H3/t11-,12+,17-,18-/m0/s1",,0.8,
Prednisolone acetate,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,"InChI=1S/C23H30O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h6,8,10,16-18,20,26,28H,4-5,7,9,11-12H2,1-3H3/t16-,17-,18-,20+,21-,22-,23-/m0/s1",Prednisolone,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,"InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",,0.89,
Melphalan flufenamide,CCOC(=O)C(CC1=CC=C(F)C=C1)NC(=O)C(N)CC1=CC=C(N(CCCl)CCCl)C=C1,"InChI=1S/C24H30Cl2FN3O3/c1-2-33-24(32)22(16-18-3-7-19(27)8-4-18)29-23(31)21(28)15-17-5-9-20(10-6-17)30(13-11-25)14-12-26/h3-10,21-22H,2,11-16,28H2,1H3,(H,29,31)/t21-,22-/m0/s1",Melphalan,NC(CC1=CC=C(N(CCCl)CCCl)C=C1)C(=O)O,"InChI=1S/C13H18Cl2N2O2/c14-5-7-17(8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19/h1-4,12H,5-9,16H2,(H,18,19)/t12-/m0/s1",Aminopeptidase N,0.5,
Serdexmethylphenidate,COC(=O)C(C1=CC=CC=C1)C1CCCCN1C(=O)OC[N+]1=CC=CC(C(=O)NC(CO)C(=O)[O-])=C1,"InChI=1S/C25H29N3O8/c1-35-24(33)21(17-8-3-2-4-9-17)20-11-5-6-13-28(20)25(34)36-16-27-12-7-10-18(14-27)22(30)26-19(15-29)23(31)32/h2-4,7-10,12,14,19-21,29H,5-6,11,13,15-16H2,1H3,(H-,26,30,31,32)/t19-,20+,21+/m0/s1",Dexmethylphenidate,COC(=O)C(C1=CC=CC=C1)C1CCCCN1,"InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3/t12-,13-/m1/s1",,0.54,
(R)-halothane,FC(F)(F)C(Cl)Br,,trifluoroacetic acid,O=C(O)C(F)(F)F,,CYP2E1,0.19,Oxidation of halotrifluoroethane
(-)-limonene,C=C(C)C1CC=C(C)CC1,,Carveol,C=C(C)C1CC=C(C)C(O)C1,,CYP2C9; CYP2C19,0.58,Allylic hydroxylation
(-)-limonene,C=C(C)C1CC=C(C)CC1,,Perillyl alcohol,C=C(C)C1CC=C(CO)CC1,,CYP2C9; CYP2C19; CYP3A4,0.76,Allylic hydroxylation
(r)-azelastine,CN1CCCC(N2N=C(CC3=CC=C(Cl)C=C3)C3=CC=CC=C3C2=O)CC1,,"(r)-azelastine, N-desmethyl",O=C1C2=CC=CC=C2C(CC2=CC=C(Cl)C=C2)=NN1C1CCCNCC1,,CYP3A4; CYP2D6; CYP1A2 (minor),0.98,N-dealkylation of alicyclic tertiary amine
(r)-metoprolol,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,,alpha-Hydroxymetoprolol,COCC(O)C1=CC=C(OCC(O)CNC(C)C)C=C1,,CYP2D6,0.83,Hydroxylation of non-terminal aliphatic carbon adjacent to aromatic ring
(s)-(+)-ibuprofen,CC(C)CC1=CC=C(C(C)C(=O)O)C=C1,,2-Hydroxyibuprofen,CC(C(=O)O)C1=CC=C(CC(C)(C)O)C=C1,,CYP2C9; CYP2C8,0.91,Hydroxylation of penultimate aliphatic tertiary carbon
(s)-(+)-ibuprofen,CC(C)CC1=CC=C(C(C)C(=O)O)C=C1,,3-Hydroxyibuprofen,CC(CO)CC1=CC=C(C(C)C(=O)O)C=C1,,CYP2C9; CYP2C8,0.92,Hydroxylation of terminal methyl
(s)-fluoxetine,CNCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,,(s)-Norfluoxetine,NCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,,CYP2C9 (major); CYP2D6; CYP2C19; CYP3A4; CYP3A5,0.95,N-dealkylation of acyclic secondary amine
(s)-fluoxetine,CNCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,,p-Trifluoromethyl phenol,OC1=CC=C(C(F)(F)F)C=C1,,CYP2C19; CYP3A4,0.32,O-dealkylation
(s)-oxybutynin,CCN(CC)CC#CCOC(=O)C(O)(C1=CC=CC=C1)C1CCCCC1,,N-desethyloxybutynin,CCNCC#CCOC(=O)C(O)(C1=CC=CC=C1)C1CCCCC1,,CYP3A4,0.99,N-dealkylation of acyclic tertiary amine
4-Hydroxytamoxifen,CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,,Endoxifen,CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,,CYP3A4; CYP3A5,0.98,N-dealkylation of acyclic tertiary amine
aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,,Diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,,CYP2C9,0.85,HYDROLYSIS_OF_CARBOXYLIC_ESTER
alphacetylmethadol,CCC(OC(C)=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,,norLAAM,CCC(OC(C)=O)C(CC(C)NC)(C1=CC=CC=C1)C1=CC=CC=C1,,CYP2B6;CYP2C8;CYP2C19;CYP3A4,0.97,N-DEMETHYLATION
amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,,Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,,CYP2C19; CYP3A4; CYP2C9; CYP1A2,0.99,N-dealkylation of acyclic tertiary amine
amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,,E-10-OH-amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,,CYP2D6,0.73,Hydroxylation of alicyclic secondary carbon
bosentan,COC1=CC=CC=C1OC1=C(OCCO)N=C(C2=NC=CC=N2)N=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1,,"4-(2-hydroxy-1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2]bipyrimidinyl-4-yl]-benzenesulfonamide",COC1=CC=CC=C1OC1=C(OCCO)N=C(C2=NC=CC=N2)N=C1NS(=O)(=O)C1=CC=C(C(C)(C)CO)C=C1,,CYP3A4 (major); CYP2C9 (minor),0.98,Hydroxylation of terminal methyl
bosentan,COC1=CC=CC=C1OC1=C(OCCO)N=C(C2=NC=CC=N2)N=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1,,"4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-hydroxyphenoxy)-[2,2]bipyrimidinyl-4-yl]-benzenesulfonamide",CC(C)(C)C1=CC=C(S(=O)(=O)NC2=NC(C3=NC=CC=N3)=NC(OCCO)=C2OC2=CC=CC=C2O)C=C1,,CYP3A4 (major); CYP2C9 (minor),0.99,O-aryl demethylation
codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,,morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,,CYP2D6,0.99,O-aryl demethylation
codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,,norcodeine,COC1=CC=C2CC3NCCC45C2=C1OC4C(O)C=CC35,,CYP3A4,0.98,N-dealkylation of alicyclic tertiary amine
cyclobenzaprine,CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12,,N-Desmethylcyclobenzaprine,CNCCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12,,CYP1A2 (major); CYP3A4 (major); CYP2D6 (minor),0.98,N_DEALKYLATION_OF_ALIPHATIC_TERTIARY_AMINES_PATTERN1; N_DEALKYLATION_OF_ACYCLIC_TERTIARY_AMINES
dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N)C=C2)C=C1,,N-Hydroxydapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(NO)C=C2)C=C1,,CYP2E1; CYP3A4; CYP2C9; CYP2C8,0.87,N-hydroxylation of aniline to hydroxylamine
desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,,3-alpha-OH-desogestrel,C#CC1(O)CCC2C3CCC4=CC(O)CCC4C3C(=C)CC21CC,,CYP2C9; CYP2C19,0.9,Allylic hydroxylation
desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,,3-beta-OH-desogestrel,C#CC1(O)CCC2C3CCC4=CC(O)CCC4C3C(=C)CC21CC,,CYP2C9; CYP2C19,0.9,Allylic hydroxylation
diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,,N-Desmethyldiphenhydramine,CNCCOC(C1=CC=CC=C1)C1=CC=CC=C1,,CYP2D6; CYP1A2; CYP2C9; CYP2C19; CYP2B6,0.96,N-dealkylation of acyclic tertiary amine
fentanyl,CCC(=O)N(C1=CC=CC=C1)C1CCN(CCC2=CC=CC=C2)CC1,,Norfentanyl,CCC(=O)N(C1=CC=CC=C1)C1CCNCC1,,CYP3A4,0.78,N-dealkylation of alicyclic tertiary amine
flunarizine,FC1=CC=C(C(C2=CC=C(F)C=C2)N2CCN(CC=CC3=CC=CC=C3)CC2)C=C1,,1[bis(4fluorophenyl)methyl]piperazine,FC1=CC=C(C(C2=CC=C(F)C=C2)N2CCNCC2)C=C1,,CYP1A2; CYP2C9,0.79,N-dealkylation of alicyclic tertiary amine
flunarizine,FC1=CC=C(C(C2=CC=C(F)C=C2)N2CCN(CC=CC3=CC=CC=C3)CC2)C=C1,,p-Hydroxyflunarizine,OC1=CC=C(C=CCN2CCN(C(C3=CC=C(F)C=C3)C3=CC=C(F)C=C3)CC2)C=C1,,CYP2D6,0.91,p-Hydroxylation of monosubstituted benzene
flunarizine,FC1=CC=C(C(C2=CC=C(F)C=C2)N2CCN(CC=CC3=CC=CC=C3)CC2)C=C1,,bis(4fluorophenyl)methanone,O=C(C1=CC=C(F)C=C1)C1=CC=C(F)C=C1,,CYP2C9; CYP1A1,0.28,N-dealkylation of alicyclic tertiary amine
imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C21,,2-Hydroxyimipramine ,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(O)=CC=C21,,CYP2C19 (major); CYP2D6 ,0.86,Aromatic hydroxylation of fused benzene ring
imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C21,,Desimipramine ,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C21,,CYP2C19; CYP2C18; CYP2D6; CYP1A2 ,0.99,N-dealkylation of acyclic tertiary amine
irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,"2-(3-hydroxybutyl)-3-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one",CC(O)CCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,CYP2C9,0.98,Hydroxylation of penultimate aliphatic secondary carbon
irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,M7,CCCCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,CYP2C9,0.92,Hydroxylation of alicyclic secondary carbon
irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,M3,O=C(O)CCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,CYP2C9,0.98,C-Oxidation
l-ifosfamide,O=P1(NCCCl)OCCCN1CCCl,,3-Dechloroethylifosfamide,O=P1(NCCCl)NCCCO1,,CYP2B6; CYP3A4; CYP3A5,0.59,N-dechloroethylation
l-ifosfamide,O=P1(NCCCl)OCCCN1CCCl,,2-Dechloroethylifosfamide,NP1(=O)OCCCN1CCCl,,CYP2B6; CYP3A4; CYP3A5,0.83,N-dechloroethylation
l-ifosfamide,O=P1(NCCCl)OCCCN1CCCl,,4-Hydroxyifosfamide,O=P1(NCCCl)OCCC(O)N1CCCl,,CYP2B6 (major); CYP3A4 (major); CYP2A6 (minor); CYP2C8 (minor); CYP2C9 (minor); CYP2C19 (minor); CYP3A5 (minor),0.68,4-alkyl hydroxylation of oxoazaphosphorine
lisofylline,CC(O)CCCCN1C(=O)C2=C(N=CN2C)N(C)C1=O,,pentoxifylline,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C)C1=O,,CYP1A2,0.97,Oxidation of secondary alcohol to ketone
nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,,E-10-OH-nortriptyline,CNCCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,,CYP2D6,0.73,Hydroxylation of alicyclic secondary carbon
nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,,demethylnortriptyline,NCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,,CYP2C19,0.98,N-dealkylation of acyclic secondary amine
olanzapine,CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCN(C)CC2)S1,,,CN1CCN(C2=NC3=CC=CC=C3NC3=C2C=C(CO)S3)CC1,,CYP1A2;CYP2D6;CYP3A4,0.95,ALIPHATIC HYDROXYLATION
progesterone,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,,6beta-OH-progesterone,CC(=O)C1CCC2C3CC(O)C4=CC(=O)CCC4(C)C3CCC12C,,CYP3A4; CYP3A4; CYP4B1,0.73,Hydroxylation of carbon gamma to conjugated carbonyl
quinidine,C=CC1CN2CCC1CC2C(O)C1=CC=NC2=CC=C(OC)C=C12,,3-Hydroxyquinidine,C=CC1(O)CN2CCC1CC2C(O)C1=CC=NC2=CC=C(OC)C=C12,,CYP3A4,0.89,Allylic hydroxylation
quinine,C=CC1CN2CCC1CC2C(O)C1=CC=NC2=CC=C(OC)C=C12,,,C=CC1(O)CN2CCC1CC2C(O)C1=CC=NC2=CC=C(OC)C=C12,,CYP2C19;CYP3A4,0.89,Aliphatic Hydroxylation
tamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,,N-Desmethyltamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,,CYP2D6; CYP1A2; CYP1A1; CYP3A4; CYP1B1 (at a high concentration (250M)); CYP2C9 (at a high concentration (250M)); CYP2C19 (at a high concentration (250M)); CYP3A5 (at a high concentration (250M)); CYP2E1,0.98,N-dealkylation of acyclic tertiary amine
testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,,6Hydroxytestosterone ,CC12CCC(=O)C=C1C(O)CC1C2CCC2(C)C(O)CCC12,,CYP3A4; CYP3A5;  CYP2C9; CYP1A1; CYP1B1,0.81,Hydroxylation of carbon gamma to conjugated carbonyl
testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,,Androstenedione ,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,,CYP2C19; CYP2C9 ,0.7,Oxidation of secondary alcohol to ketone
ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,,Thienodihydropyridinium,ClC1=CC=CC=C1CN1C=C2C=C[S+]=C2CC1,,CYP3A4; CYP2C19,0.32,Formation of imminium ion from N-substituted piperidine
ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,,Ticlopidine S-oxide,O=S1C=CC2=C1CCN(CC1=CC=CC=C1Cl)C2,,CYP2C19; CYP2D6,0.33,Thiohene S-oxidation
toremifene,CN(C)CCOC1=CC=C(C(=C(CCCl)C2=CC=CC=C2)C2=CC=CC=C2)C=C1,,N-desmethyltoremifene,CNCCOC1=CC=C(C(=C(CCCl)C2=CC=CC=C2)C2=CC=CC=C2)C=C1,,CYP1A1; CYP1A2; CYP3A4 (major),0.98,N_DEALKYLATION_OF_ALIPHATIC_TERTIARY_AMINES_PATTERN1; N_DEALKYLATION_OF_ACYCLIC_TERTIARY_AMINES
toremifene,CN(C)CCOC1=CC=C(C(=C(CCCl)C2=CC=CC=C2)C2=CC=CC=C2)C=C1,,N-desmethyltoremifene,CNCCOC1=CC=C(C(=C(CCCl)C2=CC=CC=C2)C2=CC=CC=C2)C=C1,,CYP1A1; CYP1A2; CYP3A4 (major),0.98,Deamino
unii-ku5u13xy7j component vwcugcyzzgrkee-dyesrhjhsa-n,CCC(OC(C)=O)C(CC(C)NC)(C1=CC=CC=C1)C1=CC=CC=C1,,,CCC(OC(C)=O)C(CC(C)N)(C1=CC=CC=C1)C1=CC=CC=C1,,CYP2B6,0.94,N-demethylation
zinc03978059,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,,free cortisol,CC12CCC(=O)C=C1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,,CYP3A4,0.89,Alipathic Hydroxylation (6-hydroxylation)
"Retinoic acid, all-trans",CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,,4-Hydroxyretinoic acid,CC(C=CC1=C(C)C(O)CCC1(C)C)=CC=CC(C)=CC(=O)O,,CYP1A2; CYP3A7; CYP2C8 (major); CYP3A4; CYP2C9 (minor); CYP2B6; CYP3A5; CYP2A6,0.75,Hydroxylation of alicyclic secondary carbon
"Retinoic acid, all-trans",CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,,18-Hydroxyretinoic acid,CC(C=CC1=C(CO)CCCC1(C)C)=CC=CC(C)=CC(=O)O,,CYP4A11; CYP3A7; CYP1A1; CYP2C8; CYP2C9; CYP2C18; CYP3A4; CYP3A5,0.86,Hydroxlation of methyl carbon adjacent to an aliphatic ring
"Retinoic acid, all-trans",CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,,"5,6-Epoxy-retinoic acid",CC(C=CC12OC1(C)CCCC2(C)C)=CC=CC(C)=CC(=O)O,,CYP2C8; CYP2C9; CYP1A1; CYP2D6,0.35,EPOXIDATION_OF_1122_TETRASUBSTITUTED_ALKLENE
Metamphetamine,CNC(C)CC1=CC=CC=C1,,4-Hydroxymethamphetamine,CNC(C)CC1=CC=C(O)C=C1,,CYP2D6,0.77,p-Hydroxylation of monosubstituted benzene
Metamphetamine,CNC(C)CC1=CC=CC=C1,,Amphetamine,CC(N)CC1=CC=CC=C1,,CYP2D6,0.84,N-dealkylation of acyclic secondary amine
(r)-fluoxetine,CNCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,,(r)-Norfluoxetine,NCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,,CYP2C9 (major); CYP2D6; CYP2C19; CYP3A5 ,0.95,N-dealkylation of acyclic secondary amine
(r)-fluoxetine,CNCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,,p-Trifluoromethyl phenol,OC1=CC=C(C(F)(F)F)C=C1,,CYP2D6,0.32,O-dealkylation
(s)-azelastine,CN1CCCC(N2N=C(CC3=CC=C(Cl)C=C3)C3=CC=CC=C3C2=O)CC1,,"(s)-azelastine, N-desmethyl",O=C1C2=CC=CC=C2C(CC2=CC=C(Cl)C=C2)=NN1C1CCCNCC1,,CYP3A4; CYP2D6; CYP1A2 (minor),0.98,N-dealkylation of alicyclic tertiary amine
"2,6-Xylidine",CC1=CC=CC(C)=C1N,,"4-hydroxy-2,6-dimethylaniline",CC1=CC(O)=CC(C)=C1N,,CYP2A6; CYP2E1,0.61,Hydroxylation of benzene on carbon para to a strongly electron donating group
Fluoxetine ,CNCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,,Norfluoxetine,NCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,,CYP2C9 (major); CYP2D6,0.95,N-dealkylation of acyclic secondary amine
Fluoxetine ,CNCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,,p-Trifluoromethylphenol,OC1=CC=C(C(F)(F)F)C=C1,,CYP2C19; CYP3A4,0.32,O-aryl dealkylation not adjacent to substituted carbon
R-Ibuprofen,CC(C)CC1=CC=C(C(C)C(=O)O)C=C1,,"R,S-3-Hydroxyibuprofen",CC(CO)CC1=CC=C(C(C)C(=O)O)C=C1,,CYP2C8; CYP2C9,0.92,Hydroxylation of terminal methyl
R-Ibuprofen,CC(C)CC1=CC=C(C(C)C(=O)O)C=C1,,R-2-Hydroxyibuprofen,CC(C(=O)O)C1=CC=C(CC(C)(C)O)C=C1,,CYP2C8; CYP2C9,0.91,Hydroxylation of alkyl methine
M7,CCCCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,M1,CC(O)CCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,CYP2C9,0.99,Hydroxylation of alicyclic secondary carbon
(+)-limonene,C=C(C)C1CC=C(C)CC1,,Carveol,C=C(C)C1CC=C(C)C(O)C1,,CYP2C9; CYP2C19,0.58,Hydroxylation of alicyclic secondary carbon
(+)-limonene,C=C(C)C1CC=C(C)CC1,,Perillyl alcohol,C=C(C)C1CC=C(CO)CC1,,CYP2C9; CYP2C19; CYP3A4,0.76,Hydroxlation of methyl carbon adjacent to an aliphatic ring
suprofen,CC(C(=O)O)C1=CC=C(C(=O)C2=CC=CS2)C=C1,,Suprofen -sulfoxide,CC(C(=O)O)C1=CC=C(C(=O)C2=CC=CS2=O)C=C1,,CYP2C9,0.35,Thiohene S-oxidation
suprofen,CC(C(=O)O)C1=CC=C(C(=O)C2=CC=CS2)C=C1,,"Thiophene-4,5-epoxide",CC(C(=O)O)C1=CC=C(C(=O)C2=CC3OC3S2)C=C1,,CYP2C9,0.32,Epoxidation of thiophene
4-hydroxytamoxifen,CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,,Tamoxifen 4-O-sulfate,CCC(=C(C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OS(=O)(=O)O)C=C1)C1=CC=CC=C1,,SULT1A1,0.84,4-OH sulfonation of phenolic compound
All-trans-retinoic acid,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,,All-trans-retinoyl glucuronide,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.37,O-glucuronidation of aliphatic acid
Epitestosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,,Epitestosterone O-glucuronide,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,,UGT,0.49,17-OH glucuronidation of sterol
Diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,,Diphenhydramine N-glucuronide,C[N+](C)(CCOC(C1=CC=CC=C1)C1=CC=CC=C1)C1OC(C(=O)O)C(O)C(O)C1O,,UGT1A3,0.28,N-glucuronidation of tertiary aliphatic amine
testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,,,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OS(=O)(=O)O)CCC12,,SULT,0.75,O-sulfonation
Codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,,,COC1=CC=C2CC3C4C=CC(OC5OC(C(=O)O)C(O)C(O)C5O)C5OC1=C2C45CCN3C,,UGT,0.9,O-glucuronidation
Fluoxetine,CNCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,,,CN(CCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1)C1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.45,O-glucuronidation
4-OH-propofol,CC(C)C1=CC(O)=CC(C(C)C)=C1O,,,CC(C)C1=CC(O)=CC(C(C)C)=C1OC1OC(C(=O)O)C(O)C(O)C1O,,"UGT1A8, UGT1A9",0.29,O-glucuronidation
4-OH-propofol,CC(C)C1=CC(O)=CC(C(C)C)=C1O,,,CC(C)C1=CC(OS(=O)(=O)O)=CC(C(C)C)=C1O,,SULT,0.65,O-sulfonation
4-Hydroxyandrostenedione,CC12CCC3C(CCC4=C(O)C(=O)CCC43C)C1CCC2=O,,,CC12CCC3C(CCC4=C(OC5OC(C(=O)O)C(O)C(O)C5O)C(=O)CCC43C)C1CCC2=O,,UGT,0.49,O-glucuronidation
(R)-(-)-Ibuprofen,CC(C)CC1=CC=C(C(C)C(=O)O)C=C1,,,CC(C)CC1=CC=C(C(C)C(=O)OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,"UGT1A1, UGT1A3, UGTA9, UGT2B4, UGT2B7",0.29,O-glucuronidation of aliphatic acid
